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Abstract 
Inspiratory muscle weakness is a consequence of prolonged mechanical ventilation and 
may contribute to the residual physical disability which has been observed in intensive 
care survivors. Inspiratory muscle weakness is associated with duration of mechanical 
ventilation, with those ventilated for 7 days or longer most at risk of developing both 
strength and endurance deficits. 
 
Specific resistance training of the inspiratory muscles (inspiratory muscle training) 
improves inspiratory muscle strength and endurance in normal people, athletes and 
patients with a wide variety of underlying pathologies. Mechanisms of improvement include 
proliferation of both Type 1 and Type 2 inspiratory muscle fibres, enhanced metabolism 
resulting in reduced lactate production, attenuation of a fatigue-induced metaboreflex, 
adaptations to neural pathways and modulation of the perception of dyspnoea. 
Furthermore, inspiratory muscle training enhances exercise tolerance and reduces 
dyspnoea in both patients and athletes, while improving quality of life for patients with 
chronic lung or heart disease.  
 
There is a lack of evidence for inspiratory muscle training in intensive care patients, 
despite the potential benefits of training in this group. This project explores the feasibility, 
safety and efficacy of inspiratory muscle training in intensive care patients who have been 
mechanically ventilated for 7 days or longer, as this subset of patients is most likely to 
demonstrate inspiratory muscle weakness and therefore benefit from specific training. This 
project includes patient-centred outcome measures, as most studies of inspiratory muscle 
training to date have focused solely on impairments, rather than the patient experiences of 
quality of life, physical function or dyspnoea.   
 
Study 1 establishes the safety and feasibility of high-intensity interval-based inspiratory 
muscle training in selected ventilator-dependent patients. Across 195 inspiratory muscle 
training sessions, there were no adverse events recorded during or immediately following 
the treatment. No significant changes were observed in heart rate, blood pressure, 
respiratory rate or oxygen saturation. Furthermore, mean training pressures increased by 
a mean difference of 18.6 cm H2O across the 10 patients studied. Thus Study 1 confirms 
that inspiratory muscle training is safe in selected ventilator-dependent patients. 
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At time of project design, there was a lack of established outcome measures to assess 
global physical function in intensive care patients. Study 2 explores the clinimetric 
properties of the Acute Care Index of Function (ACIF) in a heterogeneous group of 
intensive care patients. Study 2 demonstrates that the ACIF has excellent inter-rater 
reliability (ICC 0.94 for total ACIF scores), and correlates well with the ICU Mobility Scale 
(r=0.84). Moreover, an ACIF score of less than 0.40 at intensive care discharge predicts 
discharge from hospital to a destination other than home (sensitivity 0.78). Thus Study 2 
confirms the reliability and validity of ACIF as a tool to measure physical function in 
Studies 3, 4 and 5. 
 
Study 3 is an observational study that describes the residual impairments of inspiratory 
muscle strength and endurance in a cohort of 43 patients recently weaned from 
mechanical ventilation. In this group, 37% demonstrated impaired inspiratory muscle 
endurance (fatigue resistance index < 0.80), while mean strength scores were only 38% of 
predicted values (mean 38.6, SD 19.7). This study also captured deficits in physical 
function, with mean ACIF score of 0.40/1.00, and raised perception of exertion both at rest 
(1.95/10) and during exercise (3.40/10). Thus even in an intensive care unit where minimal 
sedation, early rehabilitation and spontaneous modes of ventilation are the norm, patients 
recently weaned from mechanical ventilation have major residual impairments and 
functional deficits.  
 
Study 4 is a randomised trial of high-intensity inspiratory muscle training in patients 
recently weaned from mechanical ventilation. Using concealed allocation, blinded outcome 
assessors and intention-to-treat analysis, Study 4 measures the effects of 2 weeks of 
inspiratory muscle training (in addition to usual care) compared to usual care. Patients in 
the experimental group demonstrated greater improvements in inspiratory muscle strength 
(mean difference 11%), but not endurance, while quality of life improved more in the 
experimental group than the control (mean difference 12%). Improvements in physical 
function and dyspnoea were equivalent. Thus 2 weeks of inspiratory muscle training 
improves inspiratory muscle strength and quality of life in the post-weaning period. 
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Finally, Study 5 is a protocol for a randomised trial of inspiratory muscle training performed 
by patients while mechanically-ventilated. Study 5 measures the impact of inspiratory 
muscle training on duration of mechanical ventilation, as well as residual inspiratory 
muscle strength and endurance, quality of life, physical function and perceived exertion.  
 
The clinical implications of this project are that inspiratory muscle training can be used in 
the post-weaning period to ameliorate respiratory muscle weakness, which may enhance 
quality of life for patients mechanically ventilated for seven days or longer. Furthermore, 
the ACIF can be utilised in intensive care patients to map the improvement trajectory and 
predict likely hospital discharge destination. Thus this project contributes to the body of 
knowledge regarding the rehabilitation of intensive care patients, providing feasible 
strategies to enhance patient care. 
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RATIONALE OF THE PROJECT 
Modern intensive care saves lives. In 2012 – 2013 more than 160 000 adults and children 
were admitted to intensive care units across Australia and New Zealand, and while 5.8% 
of patients died in intensive care, 74% were ultimately discharged home (ANZICS Centre 
for Research Outcome 2014). With many patients now surviving intensive care and 
returning to the community, the burden of intensive care survivorship has been examined. 
In a longitudinal study from the United States of America in 2010 (Unroe et al., 2010) the 
mean costs of one year of intensive care survivorship were estimated to be US$306 135, 
with 67% of patients readmitted to hospital at least once in that period. With increasing 
numbers of intensive care survivors around the world, these costs cannot be ignored. 
 
The cost burden of intensive care survivorship can be better understood in terms of the 
residual physical and cognitive impairments affecting intensive care survivors. In patients 
with acute lung injury managed in intensive care, measures of physical and cognitive 
activity at 12 months following intensive care admission are approximately 25% of 
predicted values(Needham et al., 2013). Even at five years following intensive care 
admission, objective measures of physical activity in survivors of acute respiratory distress 
syndrome only improve to a mean of 76% of predicted values(Herridge et al., 2011). The 
longer term outcomes are even worse for intensive care survivors aged over 70, with more 
than half experiencing functional decline or early death (within 30 days of hospital 
admission) following critical illness(Ferrante et al., 2015). As described in an editorial by 
Iwashyna(2010): 
 
“Distracted by the high mortality rate of critical illness, we tend to overlook the 
essential fact that most patients survive the intensive care unit. Every year, millions 
of patients are discharged from the ICU to face the challenges of critical illness 
survivorship – the complex burdens and legacies of surviving a potentially fatal 
disease, often after harsh and painful treatment.” 
 
Invasive mechanical ventilation may be considered one such ‘harsh and painful treatment’ 
that saves lives. Of those admitted to intensive care in Australia and New Zealand from 
2012 to 2013, 39% required invasive mechanical ventilation (ANZICS Centre for Outcome 
Resource ANZICS, 2014). Whilst unarguably life-saving for many, mechanical ventilation 
has deleterious consequences for respiratory muscle function which may lead to ventilator-
dependence. Within just 70 hours of intubation, invasive controlled mechanical ventilation 
-11- 
results in diaphragmatic catabolism(Levine et al., 2003). This catabolism manifests as 
respiratory muscle weakness which is detectable whilst patients are ventilated(De Jonghe 
et al., 2007) and persists even following successful weaning from mechanical 
ventilation(Chang et al., 2005a, Bissett et al., 2015b). This respiratory muscle weakness 
may contribute to the phenomenon of difficult weaning from mechanical ventilation(Bissett 
et al., 2012a), leading to prolonged intensive care stays. As intensive care is expensive 
(e.g. $4490 per day (St Vincent's Hospital, 2015)), any intervention which may at least in 
part ameliorate respiratory muscle weakness, and consequent ventilator-dependence and 
potential long-term disability, deserves exploration.  
 
Over the past 40 years, sports scientists have explored the potential of inspiratory muscle 
training to enhance the strength and endurance of inspiratory muscles. Inspiratory muscle 
training provides resistance on inspiration and unimpeded expiration, thereby providing a 
training stimulus isolated to the inspiratory muscles. There is now unequivocal evidence 
that specific high-intensity inspiratory muscle training leads to increased inspiratory muscle 
strength in a variety of athletes and healthy individuals(Volianitis et al., 2001, Klusiewicz et 
al., 2008, Riganas et al., 2008, Gething et al., 2004b, Johnson et al., 2007, Sonetti et al., 
2001, Kilding et al., 2010, Williams et al., 2002, Inbar et al., 2000, McConnell and Sharpe, 
2005, Chatham et al., 1999, Enright et al., 2006), and these improvements have translated 
into performance benefits in some endurance sports including rowing(Volianitis et al., 
2001), cycling(Johnson et al., 2007) and running(Leddy et al., 2007). Similarly, in patients 
with chronic obstructive lung disease, inspiratory muscle training increases inspiratory 
muscle strength, reduces dyspnoea and improves exercise tolerance(Shoemaker et al., 
2009). It is somewhat surprising that in intensive care patients, where inspiratory muscle 
weakness has been identified, there is little evidence regarding the efficacy of inspiratory 
muscle training.  
 
Thus, drawing primarily on the lessons learned from sports medicine, the rationale of this 
thesis is to explore whether inspiratory muscle training is safe and feasible in intensive 
care patients, and determine whether inspiratory muscle training enhances the outcomes 
of intensive care survivors. These studies will contribute to the existing body of knowledge 
in intensive care from a pragmatic and patient-centred perspective, including a focus not 
just on measures of muscle strength and endurance, but also quality of life, dyspnoea and 
physical activity. With increasing numbers of patients surviving intensive care, and limited 
resources in financially-constrained healthcare systems around the world, the findings of 
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this work have direct implications for the prioritisation of interventions used by 
physiotherapists in the modern intensive care unit.  
 
RESPIRATORY DYSFUNCTION IN VENTILATED PATIENTS 
Ventilator-dependence is a significant burden for both individuals and health systems. 
Prolonged mechanical ventilation is associated with higher mortality, poor functional 
outcomes, lower quality of life and higher incidence of nursing home placement(Cox et al., 
2007, Douglas et al., 2002). In this context, there has been surprisingly little research into 
the mechanisms of ventilator-dependence or treatment strategies to facilitate liberation 
from mechanical ventilation. 
 
There is mounting evidence that mechanical ventilation itself results in pathological 
changes to the respiratory system which may contribute to prolonged ventilator-
dependence and the clinical phenomenon of difficult weaning(Ambrosino and Gabbrielli, 
2010). Potential contributors to ventilator-dependent respiratory dysfunction include 
inspiratory muscle weakness, polyneuropathy, pharmaceutical influences and nutritional 
and psychological factors.  
 
Inspiratory muscle changes with mechanical ventilation 
Muscle atrophy 
Animal studies have clearly demonstrated that controlled mechanical ventilation results in 
measurable changes to the diaphragm. In a study of rats mechanically ventilated for 18 
hours(Shanely et al., 2002) atrophy of both Type 1 and Type 2 muscle fibres was 
detected, with greater atrophy of Type 2 fibres, and a concurrent increase in diaphragmatic 
protease activity and oxidative stress, suggesting muscle catabolism. Another study using 
a rodent model(Powers et al., 2002), which rigorously excluded any contribution of 
phenobarbital to muscle changes, found that 12 hours of controlled mechanical ventilation 
resulted in an 18% reduction in diaphragmatic force, whereas 24 hours resulted in a 46% 
reduction. These studies indicate that a dose-dependent relationship between duration of 
ventilation and subsequent weakness is likely. Extrapolation of these results to humans is 
limited by the infrequent use of completely controlled mechanical ventilation in 
contemporary intensive care practice. Many modern intensive care units preferentially use 
spontaneous modes of ventilation where possible, whereby patients initiate effort to trigger 
each ventilator-supported breath. However, controlled ventilation is still used in some 
-13- 
cases (e.g. when patients are paralysed to minimise intracranial pressure immediately 
following traumatic brain injury) and therefore the potential consequences of controlled 
ventilation are still relevant.  
 
Observational studies in humans have similarly shown that longer periods of mechanical 
ventilation are associated with greater weaning difficulty(Epstein et al., 2002, De Jonghe et 
al., 2007, Hermans et al., 2010). While longer periods of ventilation may be due to the 
underlying pathology, it is possible that mechanical ventilation further compounds 
respiratory muscle weakness in these patients, contributing to delayed weaning. Even 
following successful weaning, prolonged mechanical ventilation appears to affect 
respiratory muscle endurance. In a study of 20 patients who received mechanical 
ventilation for at least 24 hours(Chang et al., 2005a), there was a 12% reduction in 
endurance detectable approximately 1 week following weaning. Importantly, those 
ventilated for longer than 7 days showed significantly less fatigue resistance than those 
ventilated for fewer than 7 days. Furthermore, in a study of 116 patients ventilated longer 
than 7 days(De Jonghe et al., 2007), maximum inspiratory pressure (MIP) was found to be 
reduced and correlated with limb weakness. Although these studies do not provide any 
direct evidence of muscle atrophy, the results would be consistent with an atrophic 
response to mechanical ventilation.  
 
Direct evidence for diaphragmatic atrophy with mechanical ventilation has been obtained 
in mechanically ventilated, brain-dead organ donors (Levine et al., 2008). Diaphragmatic 
biopsies from 14 brain-dead patients ventilated for between 18 and 69 hours were 
compared with biopsies from 8 surgical patients ventilated for no more than 3 hours. The 
biopsies from the brain-dead patients demonstrated statistically significant reductions in 
mean cross sectional area of both Type 1 and Type 2 muscle fibres, reduced glutathione 
and elevated levels of enzyme active caspase-3, suggesting increased proteolysis. These 
changes were not detectable in the control muscle studied for each patient (pectoralis 
major), suggesting that the atrophy and proteolysis observed was specific to the 
diaphragm and not a generalised phenomenon in skeletal muscle due to the abnormal 
physiology associated with brain death. As previously discussed, extrapolation of these 
results to mechanically ventilated patients whose ventilation has not been completely 
controlled should be done with caution. However, this study provides the most convincing 
evidence to date that mechanical ventilation has a direct adverse effect on the respiratory 
muscles(Tobin et al., 2010). 
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Muscle length-tension changes 
The development of inspiratory muscle weakness with prolonged mechanical ventilation is 
likely to be compounded by other factors that impact on muscle performance. For 
example, positive end expiratory pressure (PEEP) is widely used as a therapeutic tool in 
patients with respiratory failure, but one of its effects is an adverse impact on the length-
tension relationship of the diaphragm. 
 
Like all skeletal muscles, the diaphragm’s ability to generate force is related to the length 
of the muscle fibres(McCully and Faulkner, 1983). The implications of the diaphragm’s 
length-tension relationship are well described in the literature pertaining to patients with 
COPD(Soicher J, 1998, McConnell and Romer, 2004a, Roussos, 1985). In this clinical 
group, chronic hyper-inflation, with average intrinsic PEEP of 2.4 cm H2O (Dal Vecchio et 
al., 1990), results in adaptive shortening of the diaphragm causing a more flattened, less 
domed structure. This produces an adverse shift along the length-tension curve, so that 
diaphragmatic contraction generates less muscular force(McConnell and Romer, 2004a). 
 
Mechanically ventilated patients are often prescribed relatively high levels of extrinsic 
PEEP (typically between 5 and 15 cm H2O) as a mechanism to maintain alveolar 
recruitment, enhance oxygenation and counteract autoPEEP(Hess and Kacmarek, 2003). 
Unfortunately, this extrinsic PEEP may also lead to a flattening of the diaphragm and 
muscular shortening with disadvantageous shifts along the length-tension curve, further 
compounding inspiratory muscle weakness (as demonstrated in animal models(Torres et 
al., 1993)). Thus, in considering diaphragmatic weakness, the ideal prescription of 
mechanical ventilation should minimise PEEP wherever possible to reduce the negative 
impact on diaphragm strength. However, this must be balanced against the potential 
benefits of PEEP in patients with respiratory failure(Amato et al., 1998, Haitsma and 
Lachmann, 2006). Both impairment of the diaphragmatic length-tension relationship 
associated with excessive PEEP, and the worsening of respiratory mechanics seen with 
inadequate PEEP, may lead to an increase in respiratory drive and neuroventilatory 
efficiency(Passath et al., 2010). Recent work investigating the effects of PEEP in patients 
receiving Neurally Adjusted Ventilatory Assist confirms that increasing PEEP reduces 
respiratory drive, but also suggests that patients are able to adapt their neuroventilatory 
efficiency over a wide range of applied PEEP levels. In addition, it is possible to identify a 
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PEEP level at which breathing occurs with an optimum relationship between tidal volume 
and diaphragmatic electrical activity(Passath et al., 2010).  
 
While the effects of mechanical ventilation on the diaphragm are relatively well-studied, the 
only available evidence regarding the effects of mechanical ventilation and PEEP on the 
performance of other inspiratory muscles, such as the parasternal intercostals, comes 
from animal research where positive pressure ventilation has been found to reduce 
intercostal force generation. However, it has been suggested that this force reduction may 
be due to rib orientation changes rather than muscular shortening (De Troyer and Wilson, 
2009). In ventilator-dependent patients, the relative contribution of intercostal muscle 
dysfunction to inspiratory muscle weakness remains to be determined. 
 
It has been suggested that when patients fail a spontaneous breathing trial, they typically 
exhibit rapid shallow breathing which causes a degree of dynamic hyperinflation (Tobin et 
al., 2010). As previously discussed, this hyperinflation will impair the length-tension 
relationship of the diaphragm and thus compromise inspiratory muscle strength(Tobin et 
al., 1998). Furthermore, both intrinsic PEEP and dynamic hyperinflation have been 
demonstrated in ventilator-dependent patients when they are removed from ventilatory 
support (Zakynthinos et al., 1995), indicating the presence of a high residual inspiratory 
load. It is yet to be established whether this intrinsic PEEP remains following successful 
weaning from ventilation. 
 
Thus it is important to consider the possibility that the presence of intrinsic or either 
inadequate or excessive extrinsic PEEP may be contributing to impaired inspiratory 
muscle performance and apparent inspiratory muscle weakness. 
 
Muscle weakness and failure to wean 
Studies of patients who fail to wean from ventilation have been performed to determine 
whether there are physiological characteristics which distinguish those who wean from 
those who fail to wean. A small (n =10) prospective cohort study of ventilator-dependent 
patients found that those who could be weaned had significantly higher maximum 
inspiratory pressures (MIP) (mean 40 cm H2O) than those who failed (mean 20 cm H2O) 
(Epstein et al., 2002). Similar results were found in a second prospective cohort study of 
30 patients who had failed initial weaning attempts in a weaning centre(Carlucci et al., 
2009). In this study, an invasive device at the tip of the tracheostomy tube was used to 
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measure transdiaphragmatic pressures during spontaneous breathing trials (SBT). 
Patients who consistently failed these SBT concurrently demonstrated lower 
diaphragmatic pressures than those who weaned successfully, while those who 
successfully weaned demonstrated significantly higher MIP (mean 57 compared to mean 
38 cm H2O in success and failure groups respectively). The authors concluded that 
recovery of inspiratory muscle force may be a critical determinant of weaning success in 
this slow-to-wean population. 
 
A larger prospective cohort study (n = 116) of patients ventilated for 7 days or longer(De 
Jonghe et al., 2007) found that not only was MIP significantly reduced in this group (mean 
30 cm H2O), but a low MIP was an independent predictor of delayed weaning. Yet 
paradoxically, other researchers have failed to demonstrate that measures of inspiratory 
muscle strength (e.g. MIP or negative inspiratory force) predict accurately weaning 
success or failure in the acute setting(Conti et al., 2004, Meade et al., 2001). For example, 
in a prospective blinded study of 93 patients, neither the MIP values, nor any other 
parameter investigated, had sufficient predictive power to distinguish between those who 
would wean successfully and those who would fail(Conti et al., 2004). Although inspiratory 
muscle weakness is a problem for patients undergoing prolonged ventilation, it may be 
that measures of inspiratory muscle strength only weakly reflect the overall complexity of 
respiratory dysfunction (and hence readiness to wean) and cannot be considered in 
isolation. 
 
Implications of inspiratory muscle changes with mechanical ventilation 
The available evidence strongly suggests that even relatively short durations of 
mechanical ventilation result in diaphragmatic atrophy, with associated abnormally high 
proteolysis. In healthy people, it is well established that high-resistance strengthening 
exercise causes both muscle anabolism and catabolism in skeletal muscle, with a net 
anabolic effect(Tipton and Ferrando, 2008). Resultant intra-muscular remodeling and 
gains in muscle cross-sectional area have been demonstrated in healthy participants 
following a 3-week high resistance training program(Seynnes et al., 2007). Therefore it is 
plausible that inspiratory muscle training could reverse or ameliorate inspiratory muscle 
proteolysis in ventilator-dependent patients, by providing a net anabolic stimulus. The 
associated inspiratory muscle strength gains could thus enhance weaning. However, 
appealing as this hypothesis may be, it remains unclear whether the respiratory muscle 
weakness associated with prolonged mechanical ventilation is reversible. In addition, 
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numerous other factors may contribute to muscle atrophy and apparent weakness in 
ventilator-dependent patients, which also must be considered. 
 
Polyneuropathy 
ICU-acquired weakness (ICUAW) is the current term used to describe the 
pathophysiological weakness observed in many critically ill patients, and while definitions 
and diagnostic guidelines have recently been clarified(Stevens et al., 2009), interpretation 
of data currently available in this area is clouded by the variations in definitions and 
terminology used prior to this (e.g. critical illness neuromyopathy, critical illness 
polyneuropathy). Critical illness polyneuropathy (CIP), a subset of ICUAW, is frequently 
present in critically ill patients but remains relatively under-diagnosed(Pandit and Agrawal, 
2006). CIP has long been considered a contributor to difficulty in weaning from mechanical 
ventilation(Hund, 1999) and in an observational study of 21 patients with ‘inability to 
wean’(Spitzer et al., 1992), 62% were found to have neuromuscular disease severe 
enough to account for ventilator dependence. A subsequent study of 40 patients ventilated 
for 5 days or longer (Maher et al., 1995) found that 83% had polyneuropathy, with a 
correlation between the severity of the polyneuropathy and weaning duration. In addition, 
while 25% of patients had reduced central drive, 15% had a combination of disorders. 
Thus any apparent muscle weakness in critically ill patients may be due to neuropathic as 
well as myopathic factors. 
 
It has been suggested that as CIP is associated with duration of mechanical ventilation, 
then measures taken to reduce the period of ventilator-dependence may lessen the 
potential impact of CIP(Pandit and Agrawal, 2006). This association is confounded by the 
likelihood that severity of illness will contribute to both duration of mechanical ventilation 
and the development of CIP. A recent systematic review has observed that the respiratory 
muscles in patients with ICU-acquired weakness may be relatively spared the negative 
effects observed in peripheral muscles, possibly due to the intermittent stretch provided by 
the ventilator(Prentice et al., 2010). However, it is also possible that CIP is a contributor to 
ventilator dependence, rather than a consequence of it, and while the possible 
mechanisms for this remain unclear, lack of core stability due to weakness of structural 
trunk muscles may adversely impact respiratory function. In the absence of data, it is 
reasonable to consider CIP as a potential factor contributing to respiratory muscle 
dysfunction in ventilator-dependent patients.  
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In addition to ICUAW, pathologies of the peripheral neurological or neuromuscular 
systems, including Myasthenia Gravis and Guillain-Barre syndrome, frequently result in 
long-term ventilator-dependence and these underlying pathologies will almost certainly 
contribute to respiratory dysfunction. There is some limited evidence that inspiratory 
muscle training may increase inspiratory muscle strength and endurance in non-ventilated 
patients with myasthenia gravis(Fregonezi et al., 2005). 
 
Further investigation of the interaction between peripheral neuromuscular disease and 
muscle retraining would be helpful. In the interim, the possible impact of muscle training on 
the pathophysiological processes involved in ICUAW must be considered. 
 
Pharmacological effects 
The potential effects of pharmacological agents on respiratory muscle strength also must 
be considered in critically ill patients. Neuromuscular blocking agents (NMBAs) and 
corticosteroids have both been implicated in the development of ICU acquired 
weakness(Schweickert and Hall, 2007). Although use has declined in recent years, 
NMBAs are still commonly used in the critical care environment, for management of both 
intracranial hypertension and ventilator dyssynchrony. It has been suggested that 
blockade of normal neuromuscular transmission and interference with endplate structure 
leads to an acceleration of critical illness myopathy; and that muscle will not recover until 
normal functional stimulation is provided(Wagenmakers, 2001). 
 
Corticosteroids are prescribed for a diverse range of indications in the critically 
ill(Confalonieri and Meduri, 2011, Mason et al., 2009, van de Beek and de Gans, 2004), 
however the effect of corticosteroids on inspiratory muscle function in ventilator-dependent 
patients has not been studied in detail. In patients without underlying lung disease, 
extended duration high dose steroids (prednisone 1 to 1.5 mg/kg/day for 8 weeks) have 
been shown to reduce inspiratory muscle strength and endurance(Weiner et al., 1993). 
Interestingly, these reductions were reversed when corticosteroid doses were tapered. A 
subsequent study(Weiner et al., 1995) found that inspiratory muscle training prevented 
these negative effects of corticosteroid therapy. In contrast, no impact on inspiratory 
muscle strength was demonstrated in a study of moderate doses of corticosteroids (20mg 
daily) in 16 healthy participants(Wang et al., 1991). In asthmatic patients, the combination 
of corticosteroids and NMBAs may lead to profound and prolonged ICU acquired 
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weakness(Douglass et al., 1992, Griffin et al., 1992). Again, the specific effects on 
respiratory muscles have not been well studied. 
 
It is therefore possible that the administration of either NMBAs or corticosteroids could 
further compound respiratory muscle weakness in ventilator-dependent patients. The 
degree to which these changes can be ameliorated by inspiratory muscle training is yet to 
be investigated. 
 
Nutrition 
A comprehensive analysis of the nutritional requirements of ventilator-dependent patients 
is beyond the scope of this review. However, while overfeeding has been on the list of 
factors to be considered in the difficult to wean patient for many years(Hess and 
Kacmarek, 2003), inadequate nutrition may also contribute to weaning difficulty.  
 
It must be acknowledged that there is wide variability in the nutritional requirements 
between and within patients across their intensive care admission(Griffiths and Bongers, 
2005). Trauma, major surgery and short-term starvation are all known to reduce protein 
synthesis(Griffiths and Bongers, 2005) . Furthermore, sepsis impairs mitochondrial 
function in both respiratory and limb muscles(Fredriksson and Rooyackers, 2007). 
However, septic patients demonstrate a relative preservation of energy sources 
(adenosine triphosphate, creatine phosphate) in respiratory muscles(Fredriksson and 
Rooyackers, 2007). This could enhance the training potential of respiratory muscles 
relative to peripheral muscles. 
 
In healthy people, timing and quality of nutrition (particularly amino acid availability) directly 
affects muscle synthesis pathways(Tipton and Ferrando, 2008). Thus it would seem 
reasonable to conclude that adequate nutrition, titrated to account for anabolic muscle 
development, is necessary for successful inspiratory muscle training in critically ill patients. 
Conversely, ventilator-dependent patients with inadequate nutrition, or poor baseline 
metabolic status, may have inadequate substrate availability to match protein synthetic 
demand, reducing the efficacy of muscle training. However, the determination of nutritional 
requirements in critical illness remains controversial. There is some limited data from the 
bed rest (aerospace) literature suggesting that overfeeding may be harmful, with increased 
inflammatory markers and accelerated muscle atrophy in participants who do not reduce 
caloric intake after the initiation of bed rest(Biolo et al., 2008). Congruent with this, a recent 
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study in critical illness found that permissive underfeeding (goal 60-70% of estimated 
nutritional requirements) resulted in lower hospital mortality compared to those fed with a 
goal of 100% of estimated requirements(Arabi et al., 2011). These results are consistent 
with previous evidence that feeding goals of 33-65% of estimated requirements resulted in 
significantly improved hospital mortality than goals of >66%.  
 
Specific supplementation to augment muscle hypertrophy and overall physical 
performance in response to training has long been studied in the sports literature, with 
relatively little cross over work to clinical populations. With particular relevance to muscle 
weakness and potential training effects, creatine supplements have been shown to 
augment training effects in healthy participants(Volek et al., 2004, Vandenberghe et al., 
1997). However a randomised trial of creatine supplementation in 100 patients with COPD 
undergoing pulmonary rehabilitation failed to find improvements in exercise capacity in the 
creatine group(Deacon et al., 2008). To date no studies of creatine supplementation have 
been performed in critically ill patients.  
 
Thus the interaction between the potential training benefits of inspiratory muscle training 
and nutritional status is complex. In the absence of clear guidelines regarding overall 
nutrition goals, or specific supplementation, inspiratory muscle training should be 
conducted with an appreciation of the potential influence of nutritional factors on resistance 
training benefits.  
 
Psychological factors 
Psychological stress has been identified as a potential factor contributing to difficult 
ventilatory weaning(Ambrosino and Gabbrielli, 2010, McCartney and Boland, 1994), yet 
there is limited data describing the extent of this problem. In a descriptive study of patient 
experiences of ventilator-dependence (Gale and O'Shanick, 1985) reported experiences 
included perceived catastrophic loss of control, perceiving the ventilator as an extension of 
one’s self, a spectrum of attitudes from depressed passivity to an agitated fight for control, 
and a dislike or fear of change, particularly with regard to weaning. While it must be 
acknowledged that this research is relatively old (1985), from a time when ventilators were 
less synchronised with patient effort, the findings are consistent with more recent studies. 
A prospective cohort study of 250 ventilator-dependent patients found that 88% of patients 
described their experience of being intubated and ventilated as moderately to extremely 
stressful(Samuelson, 2011). A follow-up study of these patients focused on memories of 
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intensive care and revealed prominent themes of physical and emotional ventilator-related 
distress (e.g. feeling unable to breathe, fear and panic, anxiety). Thus psychological 
distress should not be underestimated in ventilator-dependent patients. 
 
The relationship between psychological stress or anxiety and dyspnoea has not been 
studied in ventilated patients. However, extrapolation from sports psychology, and 
specifically the perception of exertion, may be useful here. In athletes it has been 
proposed that during exercise the perception of exertion is not linear, but rather is best 
understood as a highly complex system where physiological feedback (e.g. via 
mechanoreceptors and chemoreceptors) is analysed by a central controller which also 
considers variables such as time to endpoint (e.g. how long until the end of the race) and 
previous experience34,35. Thus the perception of exertion (and therefore dyspnoea) is 
conscious and potentially modulated by psychological variables(Edwards and Walker, 
2009, Edwards et al., 2008). If a ventilator-dependent patient’s experience of weaning is 
analogous to an athlete’s exercise conditions (i.e. both characterised by high ventilatory 
workloads and limited by perceived exertion), anxiety or psychological stress may well 
modulate the overall perception of effort and manifest as increased dyspnoea.  
 
Although the subjective perception of dyspnoea has not been well studied in ventilated 
patients, it could be argued that one of the key methods employed to measure or predict 
weaning failure (i.e. rapid shallow breathing index(Yang and Tobin, 1991)) may be in fact 
an attempt to objectively quantify the subjective experience of dyspnoea. If subjective 
dyspnoea, rather than ventilatory capacity or fatigue, is actually the limiting factor in the 
context of weaning failure, it is not surprising that physiological-level measurement tools 
have failed to predict weaning success with great accuracy(Conti et al., 2004, Meade et 
al., 2001). This is clearly an area requiring further research, but in the interim a possible 
role for psychological factors as determinants of ventilator-dependence should be 
considered. 
 
Indications for inspiratory muscle training 
In light of the above evidence regarding ventilator-dependent respiratory dysfunction, 
clinicians have been urged to minimise controlled ventilation and reduce the doses of 
drugs known to affect respiratory muscle function(Cader et al., 2010). These approaches 
may reduce inspiratory muscle dysfunction but are unlikely to completely avoid it; even 
with these strategies, respiratory muscle weakness remains detectable approximately 7 
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days following successful weaning(Chang et al., 2005a). As skeletal muscle weakness is 
generally a reversible phenomenon, it seems logical to employ training methods as early 
as possible to minimise the predictable effects of reduced inspiratory muscle work with 
mechanical ventilation. Furthermore, as prolonged mechanical ventilation is associated 
with poor functional outcomes (e.g. 21% complete functional dependency at 12 
months(Unroe et al., 2010)), any intervention with the potential to hasten ventilatory 
weaning, or avoid long-term ventilator dependence, deserves consideration.  
 
MECHANISM OF INSPIRATORY MUSCLE TRAINING 
Definition of inspiratory muscle training 
Inspiratory muscle training uses progressive resistance to provide loading to the 
inspiratory muscles to achieve a strengthening effect. Inspiratory muscle training devices 
have evolved considerably and now most commonly consist of a commercially available 
spring-loaded threshold valve which can be easily adjusted to provide incremental 
resistance. Importantly, the threshold design requires a specified pressure-level to be 
achieved with each breath, regardless of flow-rate, allowing the intensity of resistance to 
be titrated and progressed accurately. In non-ventilated patients this device is used with a 
mouthpiece and nose clip, but for ventilator-dependent patients it can be attached directly 
to the tracheostomy or endotracheal tube via a simple connector while patients are briefly 
removed from ventilatory support.  
 
Mechanisms of improvement with inspiratory muscle training 
The evidence explaining possible mechanisms of change can be grouped into 4 
categories: adaptations in muscle structure, changes in muscle perfusion and metabolism, 
neural adaptations and modulation of dyspnoea. Each of these will be described in detail 
with specific reference to inspiratory muscle training. 
 
Muscle structure and fibre type 
There is some direct evidence for the effect of inspiratory muscle training on muscle 
structure and specifically muscle fibre type. One key randomised trial (Ramirez-Sarmiento 
et al., 2002) investigated the effects of inspiratory muscle training in patients with chronic 
obstructive pulmonary disease by taking biopsies of both the external intercostal muscles 
and the vastus lateralis muscle (control) before and after an inspiratory muscle training 
program. These researchers found that training for 30 minutes, 5 days a week for 5 weeks 
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at 40-50% of maximal inspiratory pressure (MIP) resulted in increases in both Type 1 
(38%) and Type 2 fibres (21%), whereas no changes were detected in the control muscle. 
This study was the first to provide clear evidence of muscular adaptation in response to a 
loading stimulus, but given the load was relatively low (40 – 50% of MIP) and subsequent 
training regimes in the literature have tended towards higher training intensities (e.g. 45% - 
101% of baseline MIP)(Hill et al., 2006), the full potential of muscle fibre adaptation in 
response to inspiratory muscle training remains to be elucidated. 
 
In the aforementioned study, inspiratory muscle training resulted in proliferation of both 
fibre types but Type 1 to a greater extent. Patients with chronic obstructive pulmonary 
disease have an abnormally high ratio of Type 1 to Type 2 fibres in the diaphragm(Levine 
et al., 2003). It is yet to be determined whether it is the inspiratory muscle training that 
preferentially increased Type 1 fibres in relation to Type 2, or whether this is solely a 
reflection of the underlying pathology of chronic obstructive pulmonary disease in this 
particular study. 
 
There is corroborative evidence that inspiratory muscle training increases proliferation of 
muscle fibres in healthy people. A randomised trial of 20 participants who performed 
inspiratory muscle training at 80% of MIP for 8 weeks found not just increases in MIP and 
exercise capacity, but also in diaphragm thickness in the treatment group(Enright et al., 
2006). Similarly a smaller randomised trial of healthy participants reported an 8 – 12% 
increase in diaphragm thickness in response to 4 weeks of inspiratory muscle training at 
50% of MIP(Downey et al., 2007). Thus proliferation of inspiratory muscle fibres in 
response to inspiratory muscle training is neither unique to patients with chronic 
obstructive pulmonary disease, nor to the external intercostal muscles alone. Accordingly, 
muscle fibre proliferation may be considered a key mechanism of improvement attributable 
to inspiratory muscle training.  
 
Enhanced muscle perfusion, metabolism and reduced lactate production 
There is evidence that inspiratory muscle training enhances muscle metabolism by 
affecting the sensitivity of a fatigue-induced metaboreflex (Figure 1). In healthy humans, 
inspiratory muscle work during maximal exercise is inversely related to limb muscle 
perfusion(Harms et al., 1997) and it has been suggested that this is due to a 
sympathetically mediated metaboreflex which preferentially redistributes blood flow away 
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from exercising limb muscles in order to return blood supply to the fatiguing inspiratory 
muscles (Harms et al., 1997, Witt et al., 2007, Romer and Polkey, 2008).  
 
In 2006, a small study of 8 healthy participants (McConnell and Lomax, 2006) 
demonstrated that fatigue of the inspiratory muscles hastened fatigue of the plantar 
flexors, but inspiratory muscle training abolished this effect. These authors speculated that 
this reduced fatigue of peripheral muscles following inspiratory muscle training, possibly as 
a result of decreased or delayed responsiveness of the metaboreflex, may partially explain 
improvement in exercise tolerance reported as a benefit of inspiratory muscle training.  
 
 
Figure 1: Respiratory muscle metaboreflex. 
From Romer & Polkey (2008). Journal of Applied Physiology 104 (3), 879-888. 
 
 
A subsequent randomised trial of 16 healthy participants (Witt et al., 2007) specifically 
analysed the effect of inspiratory muscle training on the metaboreflex as measured by 
changes in heart rate and blood pressure. These authors confirmed that inspiratory muscle 
training attenuates the metaboreflex response during fatiguing respiratory work, describing 
a blunted sympathetic response (i.e. significantly lower heart rate and blood pressures 
measured in the training group during fatiguing inspiration). These authors suggested that 
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the blunted sympathetic response could be a result of decreased sensitivity to lactic acid 
produced during fatiguing work, or alternatively an increased aerobic capacity which leads 
to lower levels of lactate production.  
 
A more detailed analysis of aerobic pathways in 16 healthy participants(Bailey et al., 2010) 
found that inspiratory muscle training resulted in improved VO2 dynamics, specifically the 
slow component amplitude, as well as reduced dyspnoea and increased exercise 
tolerance. These authors attributed this improved aerobic capacity to the enhanced blood 
flow in the exercising limbs as a result of a reduced metaboreflex. 
 
Following an early observational study that suggested inspiratory muscle training reduces 
lactate levels (Spengler et al., 1999), the relationship between inspiratory muscle training 
and lactate has been clarified. In a randomised trial of 22 healthy participants (Brown et 
al., 2008), inspiratory muscle training resulted in significantly lower blood lactate levels in 
the treatment group during a high intensity voluntary hyperpnoea task. These results 
indicate that the inspiratory muscles themselves are a significant source of the blood 
lactate levels detected during fatiguing inspiratory workloads. This is consistent with 
previous studies showing that inspiratory muscle training reduces lactate levels during 
treadmill running in competitive athletes (Leddy et al., 2007) as well as during cycling in 
healthy untrained people (McConnell and Sharpe, 2005). 
 
Together, this evidence suggests that inspiratory muscle training enhances overall aerobic 
capacity by not just reducing lactate production in the inspiratory muscles themselves 
(possibly due to an increased ratio of Type 1 muscle fibres), but also by enhancing blood 
flow to peripheral muscles by attenuating the metaboreflex that would otherwise ‘steal’ 
blood flow and redirect it to fatiguing respiratory muscles during high intensity exercise. 
This overall enhancement of aerobic capacity may explain the global improvements in 
exercise performance described as a result of inspiratory muscle training in both healthy 
people and those with underlying pathology. 
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Neural adaptations 
It is well accepted that the strength gains observed with skeletal muscle training are at 
least partly attributable to neural mechanisms, particularly early in the training phase 
where increases in strength precede changes in muscle mass (Enoka, 1997, Gabriel et al., 
2006). Using magnetic resonance imaging it has been shown with quadriceps training, 
less muscle is required to lift the same load and strength gains are also apparent in a 
contralateral untrained muscle (Ploutz et al., 1994). Furthermore, strength gains 
associated with mental practice alone can be attributed to neural changes in the absence 
of muscle-level changes (Yue and Cole, 1992). Possible elements of neural adaptation 
include enhanced synchronisation of motor unit firing, decreased co-activation of 
antagonistic muscles, increased reflex potentiation and more efficient motor programming 
as manifested by reduced motor drive (Kellerman et al., 2000, Enoka, 1997, Yue and Cole, 
1992, Gabriel et al., 2006). 
 
There are 2 studies which specifically investigate the neural adaptations that occur with 
inspiratory muscle training. The first (Huang et al., 2003) measured the effect of inspiratory 
muscle training on inspiratory motor drive in 23 healthy participants who underwent 
inspiratory muscle training 5 days a week, training at 75% of MIP. After 4 weeks of 
training, which resulted in a 36% increase in MIP, there was a 22% decrease in inspiratory 
motor drive when measured as mouth occlusion pressure. Moreover there was a 
significant negative correlation between MIP and motor drive. These results suggest that 
inspiratory muscle training causes a down-regulation in motor programming, reflecting less 
drive required for a given respiratory workload. 
 
The second study (Ross et al., 2007) measured the effect of inspiratory muscle training on 
the peripheral and corticospinal excitability of the diaphragm in 10 healthy participants. 
Following submaximal loads (40% MIP, 2 sets of 30 breaths), there was an increase in 
neuromuscular junction and muscle membrane propagation indicating increased 
peripheral excitability. Conversely there was a reduction in diaphragmatic excitability at the 
corticospinal level, possibly indicating better neuronal synchronisation, increased motor 
unit firing or more efficient programming. However within 15 minutes of cessation of 
inspiratory muscle training these changes in excitability were no longer detectable. The 
benefit of transient changes in neural excitability remains unclear, but may be relevant to 
specific treatment scenarios (e.g. immediately prior to extubation for ventilated patients, or 
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immediately prior to a race for an elite athlete). Nonetheless, this study provides further 
evidence that inspiratory muscle training causes neural adaptations at multiple levels. 
 
Given that some inspiratory muscle training studies have reported strength gains within the 
first 2 weeks of training (Johnson et al., 2007), and it is generally accepted that structural 
changes in the muscle are unlikely before approximately 8 weeks of strengthening (Gabriel 
et al., 2006), it seems highly likely that neural adaptations are a critical element of the 
training effect of inspiratory muscle training particularly in the first few weeks.  
 
Modulation of dyspnoea 
Evidence regarding purely physiological explanations of fatigue and dyspnoea have been 
recently challenged (Edwards and Walker, 2009). A randomised trial of 16 healthy 
participants (Edwards et al., 2008) compared concurrent inspiratory muscle training and 
running training with running alone (control). Within 4 weeks of training, there was no 
significant difference between inspiratory muscle training and control groups in terms of 
MIP, whereas there were significant between-group differences in both exercise 
performance (5000 km running) and related dyspnoea (RPE scores during running). These 
results suggest that, at least in the first few weeks of inspiratory muscle training, strength 
gains are much less important than changes in the perception of breathing effort in 
determining exercise performance.  
 
The authors of this study argue that respiratory muscle receptor feedback is only one of a 
complex web of factors (both physiological and psychological) which are processed 
centrally to derive an overall perception of dyspnoea. Insofar as exercise performance is 
limited by dyspnoea, inspiratory muscle training could well play a role in desensitising the 
conscious mind to the effort associated with high respiratory workloads and in doing so 
allow the athlete to achieve greater performance. This hypothesis, although in its infancy, 
sits neatly with the evidence of improvement noted with inspiratory muscle training in 
patients with chronic obstructive pulmonary disease, where dyspnoea is often a critical 
determinant of independence and quality of life (Hill et al., 2004). Such modulation of 
dyspnoea may also be highly relevant to intensive care patients during the weaning 
process. Future research into the mechanisms of improvement noted with inspiratory 
muscle training should not underestimate psychological dimensions. 
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Summary of mechanisms of improvement with inspiratory muscle training 
While the precise mechanisms of improvement produced by inspiratory muscle training are 
not yet fully understood, there is reasonable evidence that inspiratory muscle training 
increases the proliferation of inspiratory muscle fibres; reduces blood lactate production 
and the impact of the sympathetically-mediated metaboreflex, allowing enhanced blood 
flow to peripheral muscles; and increases the efficiency of motor programming and / or 
peripheral neural networks as reflected by reduced motor outflow for a given inspiratory 
workload. In general, changes in the first few weeks of inspiratory muscle training are likely 
to be related to neural adaptations and central modulations of the perception of dyspnoea, 
whereas later improvements may also be attributable to structural and metabolic changes. 
These changes help to explain not just the improvement in inspiratory muscle strength 
observed with inspiratory muscle training, but also the enhancement of exercise 
performance that has been reported in both healthy people and those with underlying 
pathophysiology. 
 
EFFICACY OF INSPIRATORY MUSCLE TRAINING IN OTHER POPULATIONS 
Inspiratory muscle training has evolved considerably over the past 35 years, with 
proliferation of evidence supporting its efficacy in both chronic obstructive pulmonary 
disease and athletes. Whilst these two groups boast the majority of published research on 
inspiratory muscle training, there has also been a gradual emergence of evidence for the 
efficacy of inspiratory muscle training in a broad range of other patient groups. This review 
summarises the evidence to date for the efficacy of inspiratory muscle training in both 
patients with chronic obstructive pulmonary disease and athletes. For a detailed 
discussion of the evidence for inspiratory muscle training in other patient groups in the 
context of the wider literature, please refer to Appendix A. 
 
The effects of inspiratory muscle training in chronic obstructive pulmonary disease 
Since 1991, a series of systematic reviews and meta-analyses of the effects of inspiratory 
muscle training in chronic obstructive pulmonary disease have shown dramatically 
different results (see Table 1). Whereas the first review in 1991(Smith et al., 1992) 
revealed no significant effects of inspiratory muscle training, the major limitation of this 
review was the inclusion of many studies which failed to control for the intensity of the 
resistance provided during inspiratory muscle training (e.g. by using non-linear resistors for 
training, in which the intensity of the resistance is flow-dependent and can therefore be 
manipulated by the patient’s pattern of breathing)(Belman et al., 1994). By 1997 limited 
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evidence emerged that training at 30% of MIP resulted in improved inspiratory strength, 
endurance, dyspnoea and exercise tolerance, whereas training at 10 – 17% of MIP either 
did not result in any change (Lisboa et al., 1994) or resulted in small increases in 
inspiratory strength only (Lisboa et al., 1997). When Lotters and colleagues (Lotters et al., 
2002) subsequently reviewed studies where the training intensity was a minimum of 30% 
of MIP, a very different picture emerged: inspiratory muscle training resulted in significant 
improvements in inspiratory muscle strength and endurance, as well as reduction in 
dyspnoea; however no significant effect of inspiratory muscle training on exercise 
tolerance could be detected. Nonetheless Lotters and colleagues suggested that 
inspiratory muscle training may be a useful addition to pulmonary rehabilitation programs 
for patients with known inspiratory muscle weakness. 
 
Table 1: Outcomes of inspiratory muscle training in chronic obstructive pulmonary 
disease from systematic reviews  
Systematic Review 
/Meta-analysis 
Inspiratory 
muscle 
strength 
Inspiratory 
muscle 
endurance 
Dyspnoea Exercise 
tolerance 
Quality 
of life 
Smith et al. (1992) X X N/A X N/A 
Lotters et al. (2002)    X N/A 
Geddes et al. (2005)  
& update Geddes et al. (2008) 
    X 
Crowe et al. (2005)   * * * 
Shoemaker et al. (2009)      
* = compared to education only; results equivocal comparing inspiratory muscle training to exercise;  = 
significant at p<0.05 
 
As the number and quality of trials investigating the effects of inspiratory muscle training 
increased, further evidence mounted regarding exercise tolerance and quality of life in this 
patient group. In the meta-analysis performed by Geddes et al (2005), significant effects 
for increased exercise capacity could be detected, while Crowe et al (2005) similarly 
reported benefits for both exercise tolerance and quality of life when comparing inspiratory 
muscle training to education programs. Most recently, Shoemaker and colleagues (2009) 
reported significant effects for inspiratory muscle training for not just inspiratory muscle 
strength, endurance and dyspnoea, but also health related quality of life and exercise 
tolerance when measured using walking tests.  
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Whether or not inspiratory muscle training offers additional benefits to a standard whole 
body pulmonary rehabilitation program for patients with chronic obstructive pulmonary 
disease remains controversial. In a randomised trial, Magadle and colleagues (2007) 
found inspiratory muscle training conveyed additional benefits (increased MIP, reduced 
dyspnoea and increased health-related quality of life) beyond those detected following 
pulmonary rehabilitation alone. However, a subsequent systematic review by O’Brien et al 
(O'Brien et al., 2008) comparing combined inspiratory muscle training and exercise with 
exercise alone did not detect any significant outcome for quality of life, despite finding 
increase inspiratory muscle strength and one significant measure of improved exercise 
tolerance in the training group. This suggests that further studies are required to determine 
if the addition of inspiratory muscle training to pulmonary rehabilitation results in clinically 
significant outcomes beyond improving muscle strength alone. 
 
Few studies have assessed the long-term impact of inspiratory muscle training in patients 
with chronic obstructive pulmonary disease. One study of 38 patients (Weiner et al., 2004) 
trained patients with inspiratory muscle training at 60% MIP for 30 minutes 6 days a week 
for 3 months. Following the initial 3 month program, patients were randomised to either a 
maintenance program (same intensity and duration but only 3 sessions per week) or a 
sham comparison (minimal load at same intensity, frequency and duration) for another 12 
months. While this study was hampered by high drop-out rates (7 from the control group, 4 
from inspiratory muscle training group), the results indicated that without a maintenance 
program, the benefits of the initial inspiratory muscle training program progressively 
declined to baseline levels over 1 year. A subsequent long-term randomised trial 
(Beckerman et al., 2005) compared inspiratory muscle training and sham training at 3, 6, 9 
and 12 months. While the improved MIP and exercise tolerance at 3 months were 
predictable, somewhat more impressive was a reduction in hospitalisation days by 30% in 
the inspiratory muscle training group across the one year period. Furthermore, significant 
quality of life differences in favour of the training group were not detectable until 6 months, 
but these were then maintained until 12 months. Surprisingly, changes in dyspnoea were 
not detectable until 9 months but were in favour of the training group. Care must be taken 
interpreting the results of this study due to the high drop-out rate (11 of 42) and low 
attendance rates reported. However these results do suggest that the effects of long-term 
inspiratory muscle training in these patients warrant further investigation. 
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As inspiratory muscle training intensity has increased and training methods have become 
more standardised (i.e. by using pressure threshold devices as opposed to more variable 
equipment), the effects of inspiratory muscle training have become clearer for patients with 
chronic obstructive pulmonary disease. It is now well accepted that inspiratory muscle 
training is a useful and feasible treatment option for these patients and guidelines for 
clinicians are now available (Hill et al., 2010). The actual pattern of usage of inspiratory 
muscle training by physiotherapists is yet to be determined. 
 
The effects of inspiratory muscle training in athletes and healthy people 
Respiratory muscle training in healthy people has been reported in the literature since 
1976 (Leith and Bradley, 1976). The potential of inspiratory muscle training to enhance 
athletic performance has fuelled much research, particularly in the endurance disciplines 
of rowing, cycling, running and swimming, all of which may be limited by respiratory 
muscle capacity. There is substantial evidence that inspiratory muscle training increases 
inspiratory muscle strength in healthy or athletic people (Table 2). It is less clear how these 
changes occur or how increased strength translates into enhanced exercise performance. 
However, like patients with chronic obstructive pulmonary disease, athletes’ perception of 
dyspnoea may be a critical limiting factor for exercise tolerance. 
 
Considering the importance of intensity described for patients with chronic obstructive 
pulmonary disease, it is interesting that the intensity of resistance featured in all training 
programs in Table 2 is a minimum of 50% of MIP. While the duration of training programs 
studied ranges from 4 to 11 weeks, the largest changes in MIP were typically detected 
within the first 4 to 6 weeks of training (Volianitis et al., 2001, Klusiewicz et al., 2008) and 
in some studies, as early as 2 weeks (Johnson et al., 2007, Downey et al., 2007). One 
particularly well-designed study (Gething et al., 2004b), with both sham and control 
groups, further demonstrated that the improvements in MIP were not due to familiarisation 
or placebo effects. Most studies did not follow up patients beyond the training period, but 
one study of elite rowers (Klusiewicz et al., 2008) showed that at 14 weeks post training 
cessation, MIP remained higher than baseline measurements. 
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Table 2: Changes in inspiratory muscle strength in healthy participants and trained 
athletes  
Randomised Trial Sport / 
Healthy 
Participants 
Intensity 
(%MIP) 
Duration 
(wk) 
Frequency 
(sessions/wk
) 
MIP* 
Volianitis et al. (2001) Rowing 50% 11 14 ↑ 45% 
Klusiewicz et al. (2008)  Rowing 62-77% 11 14 ↑ 34% 
Riganas et al. (2008) Rowing 80% 6 7 ↑ 28% 
Gething et al. (2004b) Cycling 80% 10 3  ↑ 34% 
Johnson et al. (2007) Cycling 50% 6  14  ↑ 17% 
Sonetti et al. (2001) Cycling 50% 5  5  ↑ 8% 
Kilding et al. (2010) Swimming 50% 6  14  ↑ 9% 
Williams et al. (2002) Running 50-65% 4  4 – 5  ↑ 31% 
Inbar et al. (2000) Mixed 80% 10  6 ↑25% 
McConnell and Sharpe 
(2005) 
Healthy 50% 6  14  ↑26% 
Enright et al. (2006) Healthy 80% 8  3  ↑ 41% 
Downey et al. (2007) Healthy 50% 4  10 ↑ 24% 
Bailey et al. (2010) Healthy 50% 4  14 ↑ 17% 
* = significant at p<0.05, MIP = maximum inspiratory pressure 
 
Increased MIP was frequently associated with improved exercise performance (Volianitis 
et al., 2001, Gething et al., 2004b, Johnson et al., 2007, Enright et al., 2006, Bailey et al., 
2010, Leddy et al., 2007), although not directly correlated to it(Johnson et al., 2007, Bailey 
et al., 2010) suggesting that MIP is not necessarily a good predictor of exercise capacity. 
The magnitude of the improvements detected were not necessarily large (e.g. 1.5% 
reduction in 100 m swim time (Kilding et al., 2010); 2.66% improvement in 25 km cycling 
time trial (Johnson et al., 2007), 4% improvement in 4 mile run time (Leddy et al., 2007)) 
however as suggested by Voliantis and colleagues (2001) performance improvements 
smaller than 2% may be important in determining victory in elite sporting events and thus 
remain of practical significance. In the few studies where exercise performance was not 
enhanced by inspiratory muscle training, these results can be explained by potentially 
conflicting training strategies such as concurrent inspiratory and expiratory muscle training 
(Wells et al., 2005); flawed sham devices that could potentially provide a training stimulus 
(Sonetti et al., 2001, Goosey-Tolfrey et al., 2010); poor adherence to the training 
regimen(Goosey-Tolfrey et al., 2010); or small sample sizes resulting in inadequate 
statistical power (McConnell and Romer, 2004b, Williams et al., 2002, Riganas et al., 
2008).  
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Fatigue resistance appears to be enhanced following inspiratory muscle training in athletic 
and normal healthy people (Volianitis et al., 2001, Bailey et al., 2010). In one study of 
trained runners (Leddy et al., 2007) a period of rest (7 days) following cessation of the 
inspiratory muscle training program revealed more pronounced improvements in 
endurance when compared to measurement 1 day following program cessation. 
Inspiratory muscle training has also been shown to accelerate recovery from endurance 
events in trained cyclists (Romer et al., 2002). 
 
It is worth highlighting one randomised trial (Edwards et al., 2008) which compared 
concurrent running training and inspiratory muscle training with running alone (control). 
This study failed to show differences between inspiratory muscle training and control 
groups in MIP (both increased significantly). It is possible that the running training alone 
was sufficient training stimulus to increase MIP in the control group, meaning the short 
inspiratory muscle training period (4 weeks) was inadequate to produce a significant 
between-group change in MIP. However this study did demonstrate significantly enhanced 
5000 m running performance in the inspiratory muscle training group (4.3% compared to 
2.2% in the control) and significantly reduced RPE during week 4 of running training in the 
inspiratory muscle training group alone. These authors have suggested that central 
modulation of dyspnoea may be a critical effect of inspiratory muscle training in terms of 
enhanced exercise performance. 
 
Inspiratory muscle training in athletes results in lower levels of dyspnoea (Bailey et al., 
2010, Gething et al., 2004a, Kilding et al., 2010) and more specifically in a reduced 
estimation of the magnitude of a respiratory load (Kellerman et al., 2000). These findings 
further indicate that inspiratory muscle training’s effect on dyspnoea may be a critical 
determinant of exercise performance success in athletes.  
 
INSPIRATORY MUSCLE TRAINING IN OTHER POPULATIONS 
The efficacy of inspiratory muscle training has been explored in other patient groups. For a 
detailed summary of this literature, please refer to Appendix A. 
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INSPIRATORY MUSCLE TRAINING IN VENTILATOR-DEPENDENT PATIENTS 
Evidence for inspiratory muscle training in ventilator-dependent patients 
Despite some promising early case studies of inspiratory muscle training in ventilated 
patients (Sprague and Hopkins, 2003, Martin et al., 2002, Bissett and Leditschke, 2007), a 
single-centre randomised trial in 2005 concluded that inspiratory muscle training was 
ineffective this group (Caruso et al., 2005). However, this study used ventilator 
manipulations rather than a threshold device and had several limitations. Firstly, the 
inspiratory muscle training was performed at a relatively low intensity (i.e. 10 - 40% of 
maximum) which may not have provided an adequate training stimulus; secondly the low 
number of participants (n =25) may have rendered the study vulnerable to Type 2 errors; 
thirdly, despite attempts to optimise sedation levels, they reported less than ideal 
cooperation from some of their participants, whereas full alert cooperation is considered 
essential in other training protocols(Martin et al., 2002, Sprague and Hopkins, 2003, 
Bissett and Leditschke, 2007); and fourthly the equivalence of ventilator manipulations and 
threshold-device training may be challenged, not least because temporary removal from all 
ventilatory support may be an essential element of successful inspiratory muscle training. 
Based on these limitations, the conclusion that inspiratory muscle training is ineffective for 
ventilated patients was arguably premature. 
 
In contrast two recent randomised trials, both providing inspiratory muscle training via a 
removable threshold device, demonstrated significant improvements in ventilated patients. 
In a study of 41 patients aged 70 or older, Cader and colleagues used 5-minute inspiratory 
muscle training sessions twice daily, commencing at 30% of MIP and increasing intensity 
by 10% daily(Cader et al., 2010). These researchers found a significant increase in 
inspiratory muscle strength (mean difference in MIP of 7.6 cm H2O 95% CI 5.8 to 9.4), and 
a decrease in both the rapid shallow breathing index and weaning time, (mean difference 
1.7 days, 95% CI 0.4 to 3.0). Subsequently, Martin et al(Martin et al., 2011) used high 
intensity interval training (highest tolerable resistance, progressed daily; sets of 6 to 10 
breaths with rests on the ventilator in between) and found that inspiratory muscle training 
with a threshold device resulted in significant increases in inspiratory muscle strength 
(from mean 44.4 to 54.1 cm H2O) whereas no such increase was observable in the control 
group. The treatment group had significantly more patients successfully weaned than the 
control group following 28 days of intervention (treatment group 71%, 95% CI 55% to 84%; 
sham group 47%, 95% CI = 31% to 63%). The number needed to treat for these effects 
was reported as 4 (95% CI 2 to 80). Despite quite different training strategies, both these 
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studies demonstrated that inspiratory muscle training results in increased inspiratory 
muscle strength and favourable weaning outcomes in ventilator-dependent patients. The 
optimal training parameters are yet to be established. 
 
The mechanism of improvement with inspiratory muscle training in ventilated patients has 
not been investigated. The high-intensity training protocols used in both randomised trials 
described above may have provided an adequate training stimulus to halt or reverse the 
atrophy and proteolysis that occurs in patients undergoing mechanical ventilation (as 
described in Figure 2).  
 
 
Figure 2: Model of inspiratory muscle training and enhanced weaning 
from mechanical ventilation 
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Inspiratory muscle training could also attenuate the metaboreflex pathways described 
previously, contributing to enhanced limb muscle perfusion, facilitating early mobilisation 
and thus accelerating recovery. Investigation of these hypotheses is warranted. 
 
Psychological implications of inspiratory muscle training in ventilator-dependent 
patients 
Why would inspiratory muscle training with a threshold device be effective in increasing 
strength and enhancing weaning when ventilator manipulations are not? As discussed 
above, the psychological aspects of ventilator-dependence can be significant. Threshold-
based inspiratory muscle training protocols require patients to gradually develop 
confidence breathing unassisted (i.e. in short bursts off the ventilator whilst supervised and 
encouraged by a physiotherapist). This coached inspiratory muscle training approach may 
build patients’ confidence breathing without ventilatory support, alleviate weaning-related 
anxiety, reduce the perception of effort and dyspnoea, and ultimately increase the 
likelihood of weaning success (see Figure 2). This would be consistent with evidence from 
the sports literature, where perception of effort is considered a critical determinant of 
performance improvements in the absence of physiological changes in response to 
inspiratory muscle training (Edwards et al., 2008). 
 
Safety and feasibility of inspiratory muscle training in ventilator-dependent patients 
The safety of threshold-based inspiratory muscle training in selected ventilator-dependent 
patients has been recently established with stable physiological parameters (blood 
pressure, heart rate, oxygen saturation and respiratory rate) in response to treatment and 
no adverse outcomes reported in an analysis of 195 treatment sessions (Bissett et al., 
2012b) (see Chapter 2). This is corroborated by the two recent randomised trials, neither 
of which reported adverse outcomes in response to treatment (Cader et al., 2010, Martin 
et al., 2011), but contrasts with the study of inspiratory muscle training using ventilator 
manipulations(Caruso et al., 2005) which reported 23 cases (14%) of adverse 
physiological outcomes (i.e. desaturation, tachypnoea, haemodynamic instability and 
arrhythmia). Careful selection of stable, alert and cooperative patients who are able to 
psychologically tolerate the temporary high inspiratory workload of inspiratory muscle 
training should enhance feasibility and reduce potential tachypnoeic or tachycardic 
responses that could be panic-related.  
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There are limitations to the usage of inspiratory muscle training using a threshold device in 
ventilated patients: patients must be alert and able to cooperate with training, they must be 
medically stable and they must not be heavily reliant on high levels of ventilatory support 
(e.g. PEEP < 10 cm H2O, FiO2 < 60%)(Bissett et al., 2012b). Not all critically ill patients will 
be suitable for inspiratory muscle training, particularly in the most acute phase of their 
management. However any patient who is at risk of ventilator-induced respiratory 
dysfunction, particularly those whose mechanical ventilation has exceeded 7 days, should 
be screened for suitability for inspiratory muscle training. Minimising sedation is essential 
to maximise training opportunities and will enable the patient to fully participate in 
comprehensive early physical therapy, of which inspiratory muscle training could be an 
important element. 
 
Summary of respiratory dysfunction and inspiratory muscle training for ventilator-
dependent patients 
In summary, mechanical ventilation results in respiratory dysfunction, with muscle atrophy, 
secondary to disuse proteolysis, and inspiratory muscle shortening due to high PEEP 
leading to impairment of inspiratory muscle force generation capacity. This weakness is 
likely to be further compounded by critical illness polyneuropathy, nutritional impairment 
and the administration of corticosteroids and neuromuscular blocking agents. 
Psychological distress and anxiety is also likely to contribute to ventilator-dependence and 
may hamper weaning efforts. Inspiratory muscle training improves inspiratory muscle 
strength and exercise performance in healthy and athletic people, as well as those with 
chronic disease. Early evidence suggests that inspiratory muscle training increases 
inspiratory muscle strength and reduces weaning times in ventilated patients, with 
enhanced weaning outcomes. Further research is required to elucidate the mechanisms of 
these improvements in ventilated patients, but these are likely to be related to enhanced 
protein synthesis, reduced dyspnoea and psychological readiness to tolerate high 
respiratory workloads.  
 
Clearly not all ventilator-dependent patients are suitable for inspiratory muscle training. 
Nonetheless, given the costs of ventilator-dependence, for both the patient and the health 
care system (Ambrosino and Gabbrielli, 2010) clinicians could screen their patients for 
suitability for inspiratory muscle training and the evidence suggests many may benefit. 
Indeed, these studies provide further impetus for clinicians to maximise alertness in 
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intensive care patients to facilitate training. Further research is needed to determine the 
ideal training parameters, and also to establish whether physiological improvements (as 
reflected in improved inspiratory muscle strength) translate into meaningful improvements 
in patient-centred outcomes such as quality of life, exercise tolerance and functional 
performance (i.e. similar to the benefits observed with inspiratory muscle training in 
chronic lung disease and athletes). Nonetheless, if inspiratory muscle training can hasten 
ventilatory weaning by even one day, then these early studies suggest inspiratory muscle 
training may be a wise investment in the modern intensive care unit.  
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OUTLINE OF THE THESIS 
 
This thesis comprises 5 studies that together describe the feasibility and efficacy of 
inspiratory muscle training in intensive care patients who have experienced a minimum of 
7 days of invasive mechanical ventilation ( 
Figure 3). 
 
In Study 1, the safety and feasibility of inspiratory muscle training in ventilator-dependent 
patients is described. In this study, physiological variables including oxygen saturation, 
blood pressure, heart rate and respiratory rate are reported before, during and after 
inspiratory muscle training sessions in intensive care patients. This study is essential in 
establishing the feasibility of inspiratory muscle training in Study 5. 
 
Study 2 focuses on the clinimetric properties of the Acute Care Index of Function (ACIF) 
as a tool to quantify physical activity levels in intensive care patients, and is a requirement 
for the design of Studies 3, 4 and 5. 
 
Study 3 is an observational study that describes the inspiratory muscle strength, 
endurance and dyspnoea scores of a cohort of patients who have successfully weaned 
from invasive mechanical ventilation. This study compares the cohort to be studied in 
Studies 4 and 5 with those described in previous literature. This is important as 
physiotherapy and ventilation practices have evolved considerably over the past 10 years 
(e.g. focus on early mobilisation, minimisation of sedation and move towards spontaneous 
modes of ventilation).  
 
Study 4 is a randomised trial of inspiratory muscle training in patients who have 
successfully weaned from mechanical ventilation of at least 7 days’ duration, but whom 
were not eligible for inspiratory muscle training whilst mechanically ventilated (e.g. due to 
delirium). This study ascertains whether inspiratory muscle training offers superior benefits 
over usual care in the 2 weeks following weaning from mechanical ventilation, and 
includes measures of dyspnoea, quality of life and physical activity as well as inspiratory 
muscle strength and endurance. 
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Study 5 is a protocol for a randomised trial of inspiratory muscle training commenced while 
patients are ventilator-dependent. This study is presented as a protocol only, as slow 
recruitment has prohibited its inclusion in the current thesis. At time of submission, a total 
of 48 of 70 patients have been recruited since February 2011, and the study will continue 
until the target number of patients is reached (anticipated completion 2017). 
 
Finally, the results of these studies (with the exception of Study 5) will be discussed with 
reference to the existing literature, and recommendations for future studies will be made. 
 
 
Figure 3: Flow of studies included in this thesis. 
Study 1
• Feasibility of IMT in 
Ventilator-dependent 
patients
Study 2
• Reliability and utility of the 
ACIF in ICU patients
Study 3
• Inspiratory muscle 
endurance following 
successful weaning: an 
observational study
Study 4
• IMT to enhance recovery 
from mechanical 
ventilation: RCT
Study 5
• Protocol for RCT of IMT in 
ventilator-dependent 
patients
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CHAPTER 2: Study 1 
 
Inspiratory Muscle Training in Ventilator-Dependent Patients:  
A Feasibility Study 
 
 
 
 
 
 
 
 
This chapter has been published as an original research publication in the peer-reviewed 
journal Intensive and Critical Care Nursing and is reproduced with permission (Appendix 
C): http://www.ncbi.nlm.nih.gov/pubmed/22340987  
Bissett B, Leditschke IA, Green M (2012). Specific inspiratory muscle training is safe in 
selected patients who are ventilator-dependent: a case series. Intensive & Critical Care 
Nursing 28 (2):98-104. 
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INTRODUCTION 
Mechanical ventilation results in significant respiratory muscle weakness which is 
correlated with duration of ventilation (Hermans et al., 2010) and remains detectable 7 
days following successful weaning (Chang et al., 2005a). Evidence indicates that this 
weakness is due in part to excessive atrophy and proteolysis in respiratory muscles 
compared to other skeletal muscles (Levine et al., 2008). This muscle weakness may 
hinder weaning from mechanical ventilation and thus contribute to the known high health 
care costs of prolonged mechanical ventilation (Cox et al., 2007, Unroe et al., 2010). 
Somewhat surprisingly, the possibility of strengthening these weakened respiratory 
muscles is a relatively recent area of research in intensive care medicine. 
 
In ventilated patients, ventilator manipulations have not been found to provide an effective 
training stimulus for inspiratory muscles (Caruso et al., 2005). In contrast, two recent 
randomised trials have demonstrated favourable results with inspiratory muscle training 
using a removable threshold device. The first (Cader et al., 2010) studied inspiratory 
muscle training in 41 ventilated patients aged 70 and older, and found that a training 
regime of 5 minutes twice-daily, commencing at an intensity of 30% of maximum, resulted 
in a significant increase in inspiratory muscle strength (mean difference in MIP of 7.6 cm 
H2O 95% CI 5.8 to 9.4) and a reduction in the weaning period (mean difference 1.7 days, 
95% CI 0.4 to 3.0). The second study (Martin et al., 2011) investigated inspiratory muscle 
training in 69 patients who had failed conventional weaning methods. These researchers 
used a high-intensity interval training strategy (i.e. 4 sets of 6 to 10 breaths), employing the 
highest tolerable resistance. In the inspiratory muscle training group, inspiratory muscle 
strength increased from 44.4 to 54.1 cm H2O (mean values), whereas no significant 
difference was detectable in the sham group. Furthermore there were significantly more 
patients successfully weaned in the inspiratory muscle training group at 28 days following 
initiation of training (treatment group 71%, 95% CI 55% to 84%; sham group 47%, 95% CI 
= 31% to 63%). These results are consistent with several earlier case reports that 
indicated that inspiratory muscle training is associated with increased inspiratory muscle 
strength and favourable weaning outcomes (Bissett and Leditschke, 2007, Martin et al., 
2002, Sprague and Hopkins, 2003).  
 
However, none of these studies specifically measured the physiological responses to 
inspiratory muscle training (i.e. effects of inspiratory muscle training on blood pressure, 
heart rate, respiratory rate or oxygen saturation). Given the potential benefits of inspiratory 
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muscle training, detailed information about the safety and physiological effects of 
inspiratory muscle training in this population would be relevant to clinicians when 
determining whether inspiratory muscle training is suitable for a specific ventilator-
dependent patient. It would also be useful to establish whether supplemental oxygen is 
required to prevent desaturation with inspiratory muscle training in ventilated patients, as 
some studies have included supplemental oxygen (Martin et al., 2002, Sprague and 
Hopkins, 2003) but others have not (Bissett and Leditschke, 2007, Martin et al., 2011).  
 
Furthermore, there is very limited evidence regarding the incidence of adverse events in 
response to inspiratory muscle training (i.e. new arrhythmia, blood pressure or heart rate 
changes > 20% or requiring remedial intervention, oxygen desaturation >10% or requiring 
remedial intervention, detachment of equipment or lines, pneumothorax immediately 
following intervention) (Zeppos et al., 2007). While other physiotherapy interventions in 
intensive care have been found to be safe with an incidence of <0.2% of adverse 
physiological outcomes (Zeppos et al., 2007), it is not known how this relatively novel 
treatment compares with standard physiotherapy in terms of safety.  
 
Thus the present study aimed to answer the following research questions: 
1. Is specific inspiratory muscle training with a threshold device, but without 
supplemental oxygen, safe in selected ventilated patients in terms of both 
physiological responses and adverse events? 
2. Does inspiratory muscle strength increase from baseline to weaning from the 
ventilator with a high intensity interval-based inspiratory muscle training protocol in 
a heterogeneous group of ventilator-dependent patients? 
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METHOD 
Design 
A study of prospectively collected data for a cohort of 10 tracheostomised adults in the 
intensive care unit who had failed to wean from mechanical ventilation and subsequently 
underwent inspiratory muscle training was conducted. Inspiratory muscle training was 
instituted when patients met the suitability criteria described below and was continued 
daily (if clinically appropriate) until successful weaning or death. The study was approved 
by the Australian Capital Territory Health Human Research Ethics Committee and patients 
provided their own informed consent (Appendix B).  
 
Participants 
Patients were selected for inspiratory muscle training if they had failed weaning from 
mechanical ventilation via usual methods (i.e. progressively increasing time spent 
breathing through a humidified t-piece) and met the inclusion criteria for our inspiratory 
muscle training protocol (Bissett and Leditschke, 2007), which requires patients to be alert 
and able to cooperate with training, able to rate their dyspnoea via a modified Borg scale 
(Borg, 1982) by either mouthing words or pointing, requiring stable and not excessive 
ventilatory support (i.e. PEEP < 10 cm H2O, FiO2< 0.60), having a tracheostomy in situ 
and being otherwise medically stable.  
 
Intervention 
A program of daily inspiratory muscle training with a threshold inspiratory muscle trainer 
was initiated. This commercially available device allows the setting of specific training 
intensities between 9 and 41 cm H2O and has been found to be reliable in guaranteeing 
pressure levels independent of patient flow rates (Gosselink et al., 1996).  
 
The training method used was very similar to that described previously (Bissett and 
Leditschke, 2007, Martin et al., 2002, Martin et al., 2011, Sprague and Hopkins, 2003). 
Patients were positioned in the high Fowler’s (high sitting) position and were briefly 
removed from the ventilator, with the inspiratory muscle training device attached directly to 
the tracheostomy via a simple connector (Figure 4). Unlike some previous studies (Cader 
et al., 2010, Martin et al., 2002, Sprague and Hopkins, 2003), no supplemental oxygen 
was applied.  
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Each session the physiotherapist supervised the completion of 3 to 6 sets of 6 breaths at a 
training threshold that generated a rate of perceived exertion (RPE) of between 6 and 8 
out of 10 using a modified Borg scale (Borg, 1982). Inspiratory efforts that did not trigger 
the threshold valve to open, detected by an audible sound, were not counted in the set and 
the patient was instructed to repeat the effort until a successful breath was achieved. 
 
Figure 4: Attachment of the training device to a tracheostomy tube via a 
connector 
 
Rests were allowed between sets as the patient desired, meaning the patient was returned 
to the ventilator with typical rest times of 1 to 2 minutes between sets. Each time the 
patient’s RPE during resisted breaths was lower than 6, the training pressure was 
increased by 2 to 4 cm H2O. Training continued until patients were weaned from the 
ventilator. 
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Outcome measures 
Primary outcome: The primary outcome was the physiological response to inspiratory 
muscle training, as reflected by the following measures: heart rate, mean arterial pressure 
(MAP), oxygen saturation and respiratory rate. Heart rate, respiratory rate and oxygen 
saturation were monitored non-invasively using standard intensive care electrocardiograph 
and pulse oximetry equipment, while MAP was monitored continuously via the arterial line 
where in situ, or non-invasively where the arterial line had been removed. All measures 
were monitored continuously and transcribed from the monitors by the treating therapist 
immediately on completion of each set of inspiratory muscle training (where each set was 
< 10 seconds’ duration). 
 
Secondary outcomes: The number of adverse events (i.e. new arrhythmia, blood pressure 
or heart rate changes > 20% or requiring remedial intervention, oxygen desaturation >10% 
or requiring remedial intervention, detachment of equipment or lines, pneumothorax 
immediately following intervention) (Zeppos et al., 2007) in response to inspiratory muscle 
training was recorded. Inspiratory muscle training training pressures (cm H2O) for a given 
RPE (6 to 8 out of 10, modified Borg scale) were recorded each session as a surrogate of 
inspiratory muscle strength. 
 
Data analysis 
Paired t-tests were used to compare initial (i.e. following set 1) and final (following set 3, 4 
or 5, depending on each patient’s training level) values of each physiological variable 
within the second treatment session. The second session was selected to avoid the 
learning effects and suboptimal intensities likely during the first session, while still 
reflecting the acute response to inspiratory muscle training. A paired t-test was also used 
to compare training pressures on initiation of treatment and on completion. Statistical 
significance was considered as p<0.05. The mean difference (MD) and 95% confidence 
intervals are reported for each variable. 
 
RESULTS 
Flow of participants through the study 
The characteristics of patients who underwent inspiratory muscle training are presented in  
Table 3. 
 
 
-47- 
Adherence to study protocol 
A total of 195 inspiratory muscle training treatment sessions were delivered to the 10 
patients studied. In addition to these sessions, there were more than 50 occasions where 
inspiratory muscle training was scheduled but patients failed to meet the inspiratory 
muscle training suitability criteria on that day (e.g. became cardiovascularly unstable, 
required increased sedation for procedures or investigations). In these instances, 
inspiratory muscle training was suspended until patients met the suitability criteria. Only 1 
patient had no interruptions to their daily inspiratory muscle training. 
 
Table 3: Characteristics of patients, training parameters and weaning outcomes in 
Study 1 
 Sex Age 
(yr) 
Primary 
Diagnosis 
Day 
commenced 
IMT 
ICU 
LOS 
Training 
sessions 
completed 
Highest 
training 
pressure  
Weaning 
outcome 
Patient 1 Female 64 GBS 
 
12 24 10 41 Weaned 
Patient 2 Male 79 Emergency 
bowel 
resection 
17 29 11 38 Weaned 
Patient 3 Male 64 CIDP 
 
30 194 28 31 Weaned 
Patient 4 Female 55 Septicemia 
 
13 28 10 34 Weaned 
Patient 5 Female 74 Interstitial 
pneumonitis 
14 28 6 15 Died 
Patient 6 Female 81 Sepsis, 
oesophageal 
tear 
13 37 3 41 Weaned 
Patient 7 Male 75 GBS 
 
96 237 60 33 Weaned 
Patient 8 Female 51 GBS 
 
17 49 13 38 Weaned 
Patient 9 Male 46 GBS 
 
17 219 34 41 Weaned 
Patient 10 Female 24 Polymyositis 
(GVHD) 
 
13 212 20 11 Died 
IMT = inspiratory muscle training; ICU LOS = Intensive Care Unit Length of Stay; GBS = Guillain-Barre Syndrome; CIDP = Chronic 
inflammatory demyelinating neuropathy; GVHD = Graft vs Host Disease (on background of leukaemia) 
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Safety of inspiratory muscle training 
No adverse events were recorded in response to inspiratory muscle training across the 
195 treatments. Figure 5 demonstrates the physiologic effects of inspiratory muscle 
training for patients undergoing their second inspiratory muscle training session, while still 
physiologically vulnerable from critical illness, but having overcome the learning 
requirements of training in session 1. No significant changes in heart rate (MD 1.3 bpm, 
95% CI -2.7 to 5.3), MAP (MD -0.9 mmHg, 95% CI -6.4 to 4.6), respiratory rate (MD 1.2 
bpm, 95% CI -1.1 to 3.5 bpm) or oxygen saturation (MD 1.2%, 95% CI -0.6 to 3.0) were 
detected in response to treatment (Figure 5). Although one patient experienced a drop in 
oxygen saturation below 90% (from 92%), this was transient, had normalised less than 60 
seconds after return to ventilation and did not require any other intervention, thus was not 
considered to be an adverse event.  
 
 
Figure 5: Physiological parameters following initial and final sets within 1 
IMT training session (where box indicates median and interquartile range 
and whiskers indicate maximum and minimum values).  
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Research question 2 
While individual training patterns varied there was a significant overall increase in training 
pressures (MD 18.6 cm H2O, 95% CI 11.8 to 25.6) (Figure 6). The two patients who did 
not increase their final pressures above 20 cm H2O died due to factors unrelated to 
inspiratory muscle training or ventilatory failure (i.e., pancreatitis, complicated severe 
sepsis). The remaining eight patients successfully weaned from ventilation and were able 
to be discharged to the ward. None required subsequent readmission to the intensive care 
unit. 
 
 
Figure 6: Changes in mean training pressures over entire training period 
for each participant 
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DISCUSSION 
This study demonstrates that a strength-based inspiratory muscle training protocol using a 
threshold device, without supplemental oxygen, is safe for use in selected ventilated 
patients with no deleterious effects on physiological parameters or clinically significant 
adverse events recorded. The high mortality rate (20%) found in this study is not alarming 
given the known mortality of intensive care patients who are ventilated longer than 7 days 
(13% in our unit, internal audit data Canberra Hospital 2009). The wide variation in 
intensive care unit length of stay is not surprising given the heterogeneous patient group.  
 
Our findings contrast with those of Caruso et al (2005) who did not use a threshold device 
but instead used ventilator manipulations to perform inspiratory muscle training. The 
Caruso study failed to detect an increase in maximal inspiratory pressure in the inspiratory 
muscle training group and of 167 treatments, also reported 23 cases (14%) of adverse 
physiological outcomes (i.e. desaturation, tachypnoea, haemodynamic instability and 
arrhythmia). However, Caruso et al used a training intensity of 10 – 40% which may have 
been inadequate for training effects, and included patients from day 2 of ventilation who 
may not have been sufficiently alert to actively participate in training. Furthermore, their 
training method did not require removal from ventilatory support, and thus their findings 
may not be relevant to the threshold inspiratory muscle training method employed in our 
study.  
 
Inspiratory muscle training with a threshold device necessitates disconnection from 
ventilatory support for brief supervised periods and requires patients to fully and actively 
participate in training. There may be important psychological advantages of short, intense 
and safely monitored training sessions where patients can build confidence breathing 
independently. Previously threshold-based inspiratory muscle training has been found to 
have significant psychological benefits in other populations including patients with cystic 
fibrosis (Enright et al., 2004) and healthy people (Chatham et al., 1999).  
 
The improvements in inspiratory muscle training pressures demonstrated in this case 
series are consistent with the inspiratory strength improvements reported in a recent 
randomised trial of inspiratory muscle training in older ventilated patients (Cader et al., 
2010). However our patient sample was more heterogeneous, including younger patients 
and those with known neuromuscular disease. Furthermore, our training regime is a 
strength-based (high resistance, low repetition) protocol as opposed to the endurance 
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protocol (lower resistance, longer duration) used in the study by Cader et al (2010). 
Whereas some ventilated patients may not tolerate the duration of training required in the 
Cader protocol (i.e. 5 minutes breathing through resistance), they may be able to tolerate 
the shorter, more intense training of an interval program (6 high-resistance breaths per set 
with rests between sets).  
 
While the improvements in training pressures observed in this case series cannot be 
attributed to inspiratory muscle training alone (due to the absence of a control group) the 
magnitude of change is consistent with the increased inspiratory muscle strength reported 
by Martin et al(Martin et al., 2011), confirming that the training strategy used in the present 
study is comparable in terms of intensity. We can therefore be confident that our findings 
regarding physiological response and safety are not due to a more conservative training 
protocol, but rather could be applied more generally to high intensity interval-based 
inspiratory muscle training in ventilator-dependent patients. Thus, it seems reasonable to 
conclude that supplemental oxygen is not essential for inspiratory muscle training with high 
intensity interval-based inspiratory muscle training in ventilator-dependent patients as it 
does not result in significant tachypnoea nor oxygen desaturation. 
 
The decision to apply strength training to what is essentially an endurance muscle (the 
diaphragm) may seem curious. However it has been consistently demonstrated in athletic 
populations that strength training of the diaphragm (i.e. high resistance, low duration 
inspiratory muscle training) also enhances endurance (Gething et al., 2004b, Johnson et 
al., 2007, Enright et al., 2006, Bailey et al., 2010). Possible mechanisms include increased 
proliferation of both Type 1 and Type 2 muscle fibres (Ramirez-Sarmiento et al., 2002) and 
reduced lactate production (Brown et al., 2008), which may in turn enhance the muscle’s 
endurance properties. The argument that spontaneous breathing trials alone provide 
sufficient endurance training (i.e. low resistance over a longer period of time) is not 
supported by the residual impaired fatigue resistance found in patients following 
successful weaning (Chang et al 2005), in addition to the substantial proportion of patients 
who fail to wean with this strategy and thus experience prolonged weaning and all the 
associated costs and challenges (Unroe et al 2010).  
 
A limitation of this study is that it did not capture the patient’s subjective experience of 
undergoing inspiratory muscle training. The psychological aspects of ventilator-
dependence should not be under-estimated, with a recent study reporting that up to 88% 
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of patients find the experience of intubation and ventilation moderately to severely stressful 
(Samuelson, 2011). Whether inspiratory muscle training could reduce this stress remains 
to be determined. Anecdotally, our patients not only tolerated inspiratory muscle training, 
but appeared to find the specific feedback of the level of training pressure to be somewhat 
motivating. Future studies should consider capturing the patient’s perspective in analysing 
the utility of inspiratory muscle training in this group. 
 
Further randomised trials are indicated to determine which type of inspiratory muscle 
training protocol is optimal and whether inspiratory muscle training attenuates ventilator-
associated respiratory muscle weakness or reduces the duration of ventilation for intensive 
care patients across the spectra of age and acuity. In the interim, threshold-based 
inspiratory muscle training can be considered a safe and feasible treatment option in 
selected ventilated patients and may be a useful adjunct to ventilatory weaning. In the 
context of a multidisciplinary approach to critical care rehabilitation, inspiratory muscle 
training may be an important element of a comprehensive treatment strategy. Future 
studies should also consider whether the known strength gains of inspiratory muscle 
training translate into meaningful patient-centred outcomes such as functional ability and 
quality of life. 
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CHAPTER 3: Study 2 
 
The Acute Care Index of Function in Intensive Care Patients: 
A reliability and utility study 
 
 
 
 
This chapter has been published as an original research publication in the peer-reviewed 
journal Heart and Lung and is reproduced with permission (Appendix C): 
http://www.ncbi.nlm.nih.gov/pubmed/26542832  
Bissett B, Green M, Marzano V, Byrne S, Leditschke IA, Neeman T, Boots R, Paratz J (2016). 
Reliability and utility of the acute care index of function in intensive care patients: an 
observational study. Heart and Lung (in press).  
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INTRODUCTION 
Over the past decade, clinicians working in intensive care units have started to recognise 
the adverse effects of immobility. Lack of early mobilisation in intensive care patients is 
associated with longer duration of hospital stay (Morris et al., 2008), and increased risk of 
readmission and mortality (Morris et al., 2011). In contrast, early mobilisation of intensive 
care patients results in shorter duration of ventilation, better functional outcomes and 
reduced delirium (Schweickert et al., 2009). Not surprisingly, there has been a worldwide 
paradigm shift towards early mobilisation and rehabilitation of intensive care patients 
(Harrold et al., 2015, Schweickert et al., 2009), including those who in the past may have 
been managed with deep sedation and immobility.  
 
The shift towards early rehabilitation in intensive care has been enabled through a 
willingness of multidisciplinary teams to overcome the barriers to early mobilisation 
(Leditschke et al., 2012, Harrold et al., 2015, Honiden and Connors, 2015), including 
minimisation of sedation which is thought to contribute to delirium and poor outcomes (Hall 
et al., 2009). Through effective collaboration of nursing, medical and physiotherapy staff, 
intensive care patients are now achieving higher levels of physical function in the acute 
phase of their illness, including mobilisation whilst still ventilator-dependent (Harrold et al., 
2015). However, while we explore the limits of physical function in ICU patients, the lack of 
accurate and reliable tools to quantify physical function in this group presents a new 
challenge.  
 
There has been recent interest in establishing the clinimetric properties of tools which can 
robustly describe physical function in a heterogeneous ICU population (Parry et al., 
2015a). In the last 3 years, tools have been designed to specifically measure physical 
function in intensive care patients such as the Physical Function in ICU Tool (P-FIT) 
(Denehy et al., 2013), the Chelsea Critical Care Physical Assessment tool (CPax)(Corner 
et al., 2014) and the ICU Mobility Scale (IMS)(Hodgson et al., 2014). All these tools have 
demonstrated inter-rater reliability. However to our knowledge, none of these tools have 
been used to measure physical function for intensive care survivors beyond their intensive 
care admission. While early physical rehabilitation in intensive care is of great importance, 
much of the rehabilitation continues beyond intensive care discharge. A tool that could be 
used to describe physical function across the continuum of intensive care and 
rehabilitation would be advantageous in terms of allocating rehabilitation resources, as 
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well as determining which interventions improve physical function in the short and long 
term for intensive care survivors. 
 
The Acute Care Index of Function (ACIF) tool was developed in 1988 to measure the 
physical function of patients with acute neurological problems (Roach and Van Dillen, 
1988) (Figure 7). It has excellent inter-rater reliability (intraclass correlation coefficient 
0.98) and validity in patients with neurological disease (Van Dillen and Roach, 1988). More 
recently it has been suggested that the ACIF is currently utilised by clinicians to measure 
physical function in other patient populations, including those with cardiopulmonary 
disease, however this evidence is purely anecdotal (Scherer and Hammerich, 2008). 
Although the tool was developed 27 years ago, and length of stay may have changed over 
this time for acute care patients, its construct validity remains relevant, covering four main 
domains of function including mental status, bed mobility, transfers and mobility. The utility 
of the ACIF in broader patient populations is appealing due to its ready availability, low 
cost and minimal training required.  
 
For the past five years, we have been utilising the ACIF to map the physical function 
trajectories of intensive care patients from intensive care unit admission through to hospital 
discharge (Bissett et al., 2012d, Latham et al., 2013). Due to the lack of established 
clinimetric properties of the ACIF in an intensive care population, the objectives of this 
study were to establish the inter-rater reliability of the ACIF in a heterogeneous sample of 
intensive care patients, and in the absence of a gold-standard by which to test validity, to 
describe the relationship between the ACIF and the IMS. As a crude approximation of 
construct validity, we also sought to ascertain whether ACIF scores at intensive care 
discharge could predict the recovery trajectory beyond the intensive care stay.  
 
Thus the aims of Study 2 were to answer the following questions: 
1) Does the ACIF have acceptable inter-rater reliability in a heterogeneous sample of 
intensive care patients? 
2) What is the relationship between the ACIF and the IMS? 
3) Can the ACIF measured at intensive care discharge predict hospital discharge 
destination?  
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METHOD 
Ethics, consent and permissions 
This study was approved by the Australian Capital Territory Health Human Research 
Ethics Committee (ETH.14.213), including a waiver of patient consent as the study did not 
require change to usual practice for the patient. All 8 staff provided verbal consent to 
participate in this study. 
 
Design and setting 
In this prospective observational study, data was collected from September to December 
2014 inclusive in a 31-bed tertiary ICU (Canberra, Australia) with a mixed surgical / 
medical population, including trauma patients. This ICU has a standard practice of minimal 
sedation and early mobilisation, as described elsewhere (Leditschke et al., 2012).  
 
Participants 
A convenience sample of 8 physiotherapists participated in the study including the senior 
intensive care physiotherapist, two senior physiotherapists each with more than 10 years’ 
experience, as well as the rotating junior staff working in the intensive care unit throughout 
the duration of the study. No staff were excluded from the study. 
 
The patients were selected as a convenience sample of all intensive care patients from 
Day 3 of admission onwards, such that whenever 2 physiotherapists were simultaneously 
involved in the assessment of a patient in intensive care during the study period, the 
patient was enrolled in the study. Day 3 of intensive care stay was selected to exclude 
patients who were admitted to the intensive care unit with minor illness or for observation 
only (e.g. following elective surgery without complication) as these patients rarely require 
substantial assistance to regain independent function. Apart from those whose intensive 
care unit stay was shorter than 2 days, no patients were excluded from the study. 
 
Measures 
The outcome measures used included the ACIF tool as previously published (Roach and 
Van Dillen, 1988) (Figure 7) where a score of 1.00 indicates no loss of function, and a 
score of 0.00 indicates worst possible function. Sub-components of the ACIF include 
‘Mental Status’, ‘Bed Mobility’, ‘Transfers’ and ‘Mobility’. No adaptations were made from 
the original tool.  
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Figure 7: Acute Care Index of Function tool for quantifying physical 
function (Reproduced with permission). 
 
 
All health professionals involved in the study attended a 30 minute briefing about the use 
of the tool and the processes involved in the study. Whenever 2 assessors were present 
throughout a patient assessment in intensive care, each assessor independently 
completed an ACIF form (one electronic, one paper-based). The paper-based forms were 
stored in a locked filing cabinet and were not accessible to any other staff until study 
completion.  
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The assessor completing the electronic ACIF form also completed an IMS score, an 11-
point ordinal scale of function (Hodgson et al., 2014), where a score of 0 indicates function 
is ‘nothing’ and 10 indicates ‘walking independently without a gait aid’. ACIF and IMS 
scores were routinely collected electronically for all intensive care patients at least once 
per week beyond Day 3 of admission, and on intensive care unit discharge.  
 
Data including duration of ventilation, duration of intensive care stay, duration of hospital 
stay and hospital discharge destination for each patient were obtained from hospital 
databases by research nurses not directly involved in the project. We grouped discharge 
destination as ‘home’ or ‘not home’, as in our experience patients who discharge directly 
home from our facility require substantially less rehabilitation than those who either require 
further rehabilitation in another facility prior to discharge home, or those whose final 
discharge destination is a residential care facility. 
 
Data analysis 
Extrapolating from previous studies of inter-rater reliability in functional measures 
(Hodgson et al., 2014, Van Dillen and Roach, 1988) a sample size of 100 ACIF 
assessments was chosen, allowing a power of 80% (p = 0.05) to detect a difference of 
0.10 on the ACIF scale. To determine inter-rater reliability, we calculated Intra-class 
Correlation Coefficients (ICC (1,1)) for total ACIF scores as well as subcomponent ACIF 
scores, using variance components analysis to account for variance both between 
assessors and within individual patients. We used parametric correlation to describe the 
relationship between ACIF scores and IMS scores, with significance at the p< 0.05 level. 
To explore the sensitivity and specificity of ACIF scores at intensive care discharge to 
predict hospital discharge destination, we created a dichotomous variable (discharge 
home versus not home) and generated a receiver operating characteristic (ROC) curve. 
Based on our previous research (Latham et al., 2013), we chose an ACIF level of 0.40 
level a priori to test sensitivity and specificity. Statistical analyses were performed using 
SPSS version 22.  
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RESULTS 
Participants 
Eight assessors, all physiotherapists, participated in the study (male = 1), with a mean 
clinical experience of 8.4 years (range 1.5 – 19 years). Assessors reported that, following 
their usual assessment procedures, completion of the ACIF tool took approximately 1 to 2 
minutes. 
 
A total of 100 patient assessments were included in the study, from 42 unique patients (11 
female).  
Table 4 
Table 3 describes the demographic data of these 42 patients, including their hospital 
length of stay and hospital discharge destination. 
 
Table 4: Characteristics of patients included in Study 2 
Patient Characteristics N= 42 
Age (yr), mean (SD, range) 59 (19, 16-88) 
Sex, n female (%) 11 (26) 
APACHE II on ICU admission (0-30), mean (SD) 19 (7) 
Duration of ICU Stay (days) (mean ± SD) (range) 19 ± 29 days (2 – 119) 
Hospital Length of Stay (mean ± SD) (range) 51 ± 37 days (6 – 141) 
Duration of mechanical ventilation (mean ± SD) (range) 12 ± 25 days (0 – 118) 
Discharged home from hospital (%) 15 (35%) 
Discharged to rehabilitation / other hospital (%) 18 (43%) 
Did not survive hospital admission (%) 9 (21%) 
SD = Standard Deviation; APACHE II = Acute Physiology and Chronic Health Evaluation Score 
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Inter-rater reliability 
The total ACIF scores measured throughout the study period ranged from 0.00 to 0.90 out 
of 1.00, with a mean score of 0.30 (standard deviation 0.23). On 10 occasions, total ACIF 
was rated as 0 (floor effect of 0/1.00= 10%) while no patients scored 1.00 (ceiling effect of 
1.00/1.00 = 0%). The correlation between total ACIF scores between independent 
assessors across the 100 patient assessments is represented in Figure 8. 
 
 
Figure 8: Correlation between total ACIF scores for 2 independent 
assessors in intensive care patients 
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Intra-class Correlation Coefficients (1,1) for ACIF scores (including sub-components) are 
presented in Table 5, with an ICC of 0.94 for total ACIF scores, indicating extremely strong 
agreement between assessors.  
 
Table 5: Inter-rater reliability of the Acute Care Index of Function in intensive care 
patients 
 
 
 
 
 
 
 
 
  
ACIF COMPONENT ICC VALUE 
Mental Status 0.83 
Bed Mobility 0.81 
Transfers 0.93 
Mobility   0.94 
Total ACIF score 0.94 
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Relationship between ACIF and IMS 
IMS scores ranged from 0 to 10 across the 100 assessments. Total ACIF scores were 
strongly correlated with IMS scores (r = 0.84, p = 0.01). However there was notable spread 
of ACIF scores within each IMS category as represented in Figure 9. 
 
 
Figure 9: Correlation between total ACIF scores and IMS scores  
in intensive care patients 
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Utility of ACIF in predicting discharge destination 
Of the 42 individual patients included in this study, 15 were discharged directly home from 
hospital, 9 died in hospital, and the remainder were discharged to other hospitals for 
further rehabilitation prior to discharge home. ACIF scores at intensive care discharge had 
good discrimination for predicting discharge home (area under ROC = 0.79, 95% CI 0.64 – 
0.89) (Figure 10). An ACIF score of < 0.40 on intensive care discharge predicted hospital 
discharge to a destination other than home (i.e. another hospital, residential care home or 
death) with a sensitivity of 0.78 (specificity of 0.47).  
 
 
Figure 10: Receiver operating characteristic curve for ACIF score on 
intensive care discharge predicting discharge directly home from hospital 
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DISCUSSION  
The major finding of this study, that the ACIF has very strong inter-rater reliability (ICC 
0.94), is consistent with previous clinimetric investigation of the ACIF (Van Dillen and 
Roach, 1988). Although the inter-rater reliability of the ACIF in this study is not as high as 
that found by Van Dillen and Roach (1988) in patients with neurological impairment (ICC 
0.98 – 1.00), the previous study was in a less naturalistic setting (using video footage) 
where one would anticipate higher concordance. In contrast, our study required in vivo 
application of the tool in an authentic clinical environment, and our results confirm that the 
excellent inter-rater reliability of the ACIF is not limited to neurological patients but also 
extends to intensive care patients. 
 
Both the ACIF (ICC 0.94) and IMS (ICC 0.8) (Hodgson et al., 2014) have acceptable inter-
rater reliability to be useful in an intensive care context. Whilst this study demonstrated 
that the ACIF and IMS correlate strongly across the spectrum of physical function in 
intensive care patients, there was significant spread of ACIF scores within each IMS 
category. This spread could be attributed to the fact that ACIF captures more subtle 
dimensions of function within each category, due to the broader ranges of activities 
covered and the distinction between levels of assistance required for various tasks. These 
differentiated degrees of function may be useful in measuring change over time, 
particularly for patients who make slow progress. Furthermore, the ACIF includes mental 
status as an element of overall function, which IMS does not. Mental functioning may be 
important in ascertaining patients’ levels of independence with physical function as they 
recover from their intensive care admission (e.g. safety awareness or capacity for learning 
new tasks).  
 
A limitation of this study is that it did not make direct comparisons with the P-FIT. The 
recently modified P-FIT incorporates gait cadence, knee extension and shoulder flexion 
measures, as well as assessment of the level of assistance required for sit-to-stand. 
However, these can only be assessed if patients meet the criteria for wakefulness, 
otherwise they are assigned a score of zero (Denehy et al., 2013). Previous studies have 
quantitatively described the significant floor effect (32%) of the P-FIT which may limit its 
usefulness in the intensive care unit, particularly early in the intensive care admission 
(Nordon-Craft et al., 2014). In contrast, we found that the ACIF had only a small floor effect 
(10%) and no ceiling effect in intensive care patients from Day 3 of admission onwards. 
Moreover, the ACIF does not require specific measures (e.g. muscle testing) to be 
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conducted in addition to a standard physiotherapy functional assessment, and is typically 
completed in one to two minutes. Accordingly, we do not use the P-FIT in our intensive 
care unit and have instead found the ACIF to be a time-efficient routine functional measure 
which differentiates functional performance across the spectrum.  
 
Like both the P-FIT and the CPax, we found that the ACIF has predictive utility for hospital 
discharge destination from intensive care discharge. Patients at intensive care discharge 
whose ACIF scores are below 0.40 could be identified as high risk for not returning directly 
home, and this may be important for allocation of rehabilitation resources. In the absence 
of a gold standard with which to compare, this predictive utility also provides some crude 
evidence of construct validity of the ACIF in intensive care patients. 
 
Future studies may compare the relative merits of the ACIF and the CPax for measuring 
physical function in intensive care patients. Like the ACIF, the CPax is completed by 
physiotherapists within 1 to 2 minutes following a standard assessment, and has robust 
inter-rater reliability and construct validity (Corner et al., 2014). In contrast to the P-FIT, the 
CPax does not have substantial floor (3.2%) or ceiling (0.8%) effects. However, the CPax 
differs from the ACIF in that it also captures respiratory function and cough, but does not 
include mental status. The relative value of these subcomponents should be explored, as 
they may have an impact on the usefulness of each measure. Furthermore, to our 
knowledge the CPax has not been used to describe recovery trajectories beyond intensive 
care stay. While the authors of the CPax suggest that there will never be a single tool to 
capture physical function across hospital admission (Corner et al., 2014), our preliminary 
work suggests that the ACIF tool may achieve this (Latham et al., 2013) and deserves 
further investigation.  
 
Recently the Functional Independence Measure (FIM) has also been used to describe the 
trajectory of recovery for intensive care survivors (Herridge et al., 2015). The FIM is well-
established as a reliable and valid measure of physical function in the rehabilitation setting 
(Hamilton et al., 1994). However in Australia, the FIM requires both purchase of a licence 
and specific training, including credentialing of staff every two years. As the ACIF is freely 
available and does not require specific training, the ACIF has been a more feasible 
alternative to adopt in our institution. 
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We agree that clinicians and researchers around the world should establish a core set of 
physical function outcome measures for intensive care patients (Parry et al., 2015b). Both 
clinicians and researchers need measurement tools that are readily available, efficient and 
easy to use, inexpensive and clinimetrically sound. Ideally, a single tool could be used to 
measure a patient’s physical function from intensive care unit admission right through to 
hospital discharge. This study provides some evidence that the ACIF should be 
considered in this discussion, in view of its excellent reliability and apparent construct 
validity in intensive care patients, as well as its efficiency and affordability. Future studies 
should compare the relative merits of the available tools for measuring physical function in 
intensive care survivors, not just in intensive care but across the whole pathway of 
recovery.  
 
The results of this study have clinical relevance for health professionals working in acute 
care settings. Firstly, in our experience, early mobilisation is only feasible in intensive care 
when nurses and physiotherapists collaborate effectively at the bedside and prioritise this 
time-consuming intervention. We now have a tool which can accurately and reliably 
measure the fruit of that collaboration. Secondly, ACIF scores will allow intensive care 
clinicians to objectively describe improvements in the physical function trajectory of a long-
term intensive care patient, which can feel frustratingly slow at times. This information can 
also be shared with the patient to improve their sense of progress and self-efficacy. Thirdly 
and perhaps most importantly, ACIF scores at intensive care discharge can be used to 
inform discussion between intensive care staff and subsequent carers. In our facility, it is 
the experienced acute care nurses who are most likely to coordinate discharge plans and 
referrals for further rehabilitation for intensive care survivors. Thus ACIF scores are 
relevant to all acute care clinicians as they strive to maximise the physical function of 
patients even beyond intensive care discharge.  
  
CONCLUSION: 
The ACIF has excellent inter-rater reliability in intensive care patients. Whilst strongly 
correlated with the IMS, the ACIF also strongly predicts the likelihood of discharge home 
compared to another facility. The ACIF should be considered in the establishment of a 
core set of functional outcome measures for intensive care survivors.  
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CHAPTER 4: Study 3 
 
Inspiratory Muscle Endurance is Impaired Following Successful 
Ventilatory Weaning: An Observational Study 
 
 
 
 
 
 
This chapter has been published as an original research publication in the peer-reviewed 
journal Heart and Lung and is reproduced with permission (Appendix C): 
http://www.ncbi.nlm.nih.gov/pubmed/25455911  
Bissett B, Leditschke IA, Neeman T, Boots R, Paratz J (2015). Weaned but weary: one third 
of adult intensive care patients mechanically ventilated for 7 days or more have impaired 
inspiratory muscle endurance after successful weaning. Heart and Lung 44 (1):15-20. 
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INTRODUCTION 
Intensive care unit patients frequently experience peripheral muscle wasting and these 
changes are detectable very early in the admission. Early rapid proteolysis occurs in the 
diaphragm muscles of ventilated patients (Levine et al., 2008). Inspiratory muscle 
weakness, manifesting as a reduction in maximum inspiratory pressure (MIP), is also 
associated with limb muscle weakness in intensive care patients (De Jonghe et al., 2007). 
Thus proteolysis of both the skeletal muscles and diaphragm are likely to complicate 
illness and affect the recovery trajectory for many intensive care patients. 
 
The resulting diaphragmatic weakness is a potential contributor to difficulty in weaning 
from mechanical ventilation (Bissett et al., 2012a). However, few studies to date have 
measured functional endurance of the diaphragm in this patient group. This is surprising, 
as diaphragmatic endurance, rather than force, is required to achieve breathing 
independently of the mechanical ventilator. 
 
In 2005 Chang and colleagues (Chang et al., 2005a) demonstrated that respiratory muscle 
endurance is impaired for some time after successful weaning from mechanical ventilation. 
In addition, impaired endurance is negatively associated with duration of mechanical 
ventilation (r = -0.65, p = 0.007).  
 
To our knowledge, the relationship between respiratory muscle weakness (impaired 
strength or endurance) and global functional measures in intensive care patients (e.g. 
Barthel Index, Acute Care Index of Function) has not been explored. Functional status (i.e. 
the ability to transfer and mobilise independently) is important for longer term outcomes 
and quality of life. It is plausible that difficulty breathing, secondary to residual respiratory 
muscle weakness, may impact on the functional status of intensive care survivors. It is 
therefore important to establish the relationship between respiratory muscle weakness and 
physical function in intensive care patients. 
 
Perceived exertion may also impact on functional status, but remains uninvestigated. In 
the context of mobilising intensive care patients, patient dyspnoea or perceived exertion 
during exercise is likely related to inspiratory muscle weakness. In athletes, perception of 
dyspnoea may be the limiting factor during high-intensity endurance exercise (Edwards 
and Walker, 2009). Whether this contributes to functional limitation in mobilising intensive 
care patients warrants investigation.  
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Thus the aim of this study was to answer the following questions: 
1. In adult intensive care patients who have been recently weaned from 7 days or 
more of mechanical ventilation, is inspiratory muscle endurance impaired?  
2. Is there a relationship between inspiratory muscle weakness, functional status and 
perceived exertion following successful ventilator weaning in this group? 
 
METHOD 
Design 
This prospective observational study is a sub-study of a larger trial (Bissett et al., 2012d) of 
outcomes in intensive care patients ventilated for 7 days or longer. The present study 
analyses the baseline data collected for 43 participants eligible for inclusion in the post-
weaning study between February 2011 and December 2013. The study was approved by 
the Australian Capital Territory Health Human Research Ethics Committee and patients 
provided their own written informed consent. 
 
Setting 
This prospective study occurred in a single tertiary 22 bed mixed medical / surgical 
intensive care unit in Canberra, Australia. This unit practices minimal sedation and early 
rehabilitation as the standard of care, whereby both nursing and physiotherapy staff 
facilitate sitting out of bed and mobilisation of patients as early as possible (in the absence 
of established contraindications)(Leditschke et al., 2012).  
 
Participants 
All patients ventilated for 7 days or longer were screened for inclusion in this study once 
successfully extubated for 48 hours. Patients were included if they were able to provide 
informed consent, were alert (Riker Sedation and Agitation Scale = 4)(Riker et al., 1999) 
and able to participate actively in inspiratory muscle training, and rate their dyspnoea via a 
modified Borg scale (Borg, 1982). Patients were excluded if they were <16 years of age, 
pregnant, had heart rates, respiratory rates, blood pressure or oxygen saturation outside 
stated limits, had active infection (Bissett et al 2012b) or were likely to be palliated 
imminently. Patients were also excluded from the study if they had participated in specific 
inspiratory muscle strengthening while ventilated. Figure 11 illustrates the flow of patients 
through the study. The most frequent reason for exclusion was impaired neurological 
status with an inability to follow commands (n=62). 
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Figure 11: Flow of participants through Study 3 
 
Variables and measures 
The primary measure was inspiratory muscle endurance, measured as the Fatigue 
Resistance Index (FRI). Using the same protocol described previously by Chang and 
colleagues (Chang et al., 2005a), this test compares Maximum Inspiratory Pressures 
(MIP) before and after a 2 minute loading challenge, where patients breathe through a 
resistance of 30% of MIP. MIP is measured from residual volume using a handheld device 
(MicroRPM Respiratory Pressure Meter), in accordance with the protocol recommended 
by the American Thoracic Society and European Respiratory Society(Green et al., 2002). 
This requires patients to inhale maximally from residual volume, sustaining the effort for at 
least one second. Efforts are repeated three times to ensure less than 20% variability 
between measurements. This method of measuring MIP is both reliable and valid using 
portable handheld devices (Hamnegard et al., 1994). FRI is calculated as the post-
challenge MIP divided by the pre-challenge MIP (scores <1.00 indicate the presence of 
fatigue).  
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The secondary measures include patients’ rate of perceived exertion (RPE) using a 
modified Borg scale (0 – 10) (Borg, 1982) which has acceptable reliability and validity in 
intensive care unit patients (Powers and Bennett, 1999). Patients self-reported their RPE 
both at rest and during peak exercise. As peak exercise varied between patients (e.g. from 
sitting on the edge of the bed, to mobilising around the intensive care unit) depending on 
ability, patients were asked to report the highest exertion they experienced during any form 
of exercise on the day of measurement. All MIP, FRI and RPE measures were completed 
by specifically trained research staff. 
 
Global function was measured by the treating physiotherapist using the Acute Care Index 
of Function (ACIF) tool(Scherer and Hammerich, 2008) which has good inter-rater 
reliability (Van Dillen and Roach, 1988) and construct validity (Roach and Van Dillen, 
1988) in acute neurological patients.  
 
Data analysis 
Based on a previous study (Chang et al., 2005a), it was estimated that a sample size of 16 
patients would be required to detect a change in 10% of MIP when measuring FRI 
(correlation co-efficient of >0.6). Normalized values for MIP scores were calculated using 
the method outlined by Evans and colleagues (Evans and Whitelaw, 2009). Parametric 
correlations were performed between variables, with statistical significance considered as 
p<0.05. Due to the skewed nature of the RPE data, non-parametric correlations were also 
calculated (Spearman’s Rho) but results were consistent with parametric calculations and 
thus are not reported. All statistical analyses were performed using SPSS version 22. 
 
RESULTS 
Participants 
The characteristics of the 43 patients (30 male, 13 female) included in the study are 
summarised in Table 6. The most common diagnosis in this cohort was pneumonia (n = 9) 
followed by sepsis (n=7) and multitrauma (n = 6). The mean duration of ventilation was 
10.8 days (range 7 - 26 days) (seeTable 7), with most patients ventilated in spontaneous 
(pressure support) modes for the majority of their ventilation period (mean 8.9 days, range 
1 – 24 days). The other 2 modes of ventilation used were synchronised intermittent 
mandatory ventilation (SIMV) and pressure control ventilation plus (PCV+). Sedation was 
used in all patients (predominantly propofol), with a mean sedation-free period of 4.8 days. 
-72- 
There was wide variability in functional level (ACIF scores), ranging from 8 to 92 (mean 
40.3).  
 
Table 6: Characteristics of participants in Study 3 
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Table 7: Characteristics of participants and summary of measures in Study 3 
 
 
While the mean FRI was below 1.0 (0.90, SD 0.319), there was considerable spread in the 
sample (Figure 12), such that 15 (37%) of patients scored less than 0.80, while 4 (10%) 
scored above 1.20, including one notable outlier at 2.0.  
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Figure 12: Frequency distribution of fatigue resistance index, where 
scores below 1.0 indicate a drop in strength after an endurance challenge 
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There was also wide variability in MIP scores (Figure 13), with one patient scoring 86% of 
their predicted MIP (87). This patient had an FRI of 1.06, i.e. no evidence of fatigability. In 
contrast, the patient with the lowest MIP score (6) had an FRI of 0.33, indicating severely 
impaired fatigue resistance. MIP was significantly positively correlated with FRI (r = 0.39, p 
= 0.01).  
 
 
Figure 13: Frequency distribution of maximum inspiratory pressure (cm 
H2O) 
 
There was a weak positive trend (see Figure 14b), but no significant correlation between 
MIP scores and functional (ACIF) scores (r = 0.243, p = 0.121).   
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a) 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
c)  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Correlations between measures: a) between MIP (cm H2O) and 
FRI scores. b) between MIP (cm H2O) and ACIF scores. c) between RPE 
scores at rest and during exercise. 
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Of the 43 patients, 17 (40%) reported an RPE greater than zero at rest. While RPE at rest 
was strongly correlated with RPE during exercise (r = 0.78, p <0.01)(Figure 14c), there 
were no significant correlations between RPE and ACIF, MIP or FRI (see Table 3). 
Duration of ventilation and APACHE II scores were not correlated with ACIF, MIP or FRI 
(Table 8). 
 
 
Table 8: Correlations between variables in Study 3 (Pearson r) 
 
 
DISCUSSION 
The results of this study provide further evidence that inspiratory muscle endurance is 
often impaired in intensive care patients who have been recently weaned from mechanical 
ventilation of at least 7 days duration, even if the patients have been ventilated 
predominantly with spontaneous modes (e.g. pressure support). However there does not 
appear to be a close relationship between inspiratory muscle weakness and either function 
or perceived exertion in this cohort. 
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Our findings regarding impaired fatigue resistance (FRI 0.90) within 48 hours of weaning 
from mechanical ventilation are consistent with previous findings (Chang et al., 2005a). 
Chang and colleagues demonstrated a mean FRI of 0.88 in a group of 20 participants who 
had been ventilated for a mean of 4.6 days and were followed up on average 7 days 
(range 2 – 16) following weaning. The consistency in the magnitude of the observed FRI 
deficit suggests that impairments in FRI may be mostly attributable to changes that occur 
within the first few days of ventilation, rather than following weaning. This early change 
would be consistent with clinical studies showing proteolysis occurring within 69 hours of 
controlled ventilation (Levine et al., 2008) and recent physiological studies demonstrating 
reduced muscle fibre cross-sectional area and reduced protein to DNA ratios (29%) in 
skeletal muscles within the first 3 days of intensive care admission (Puthucheary et al., 
2013).  
 
However, the fact that the relatively longer duration of ventilation in our group (mean 10.5 
days) did not result in lower FRI scores is in contrast with the finding by Chang et al that 
FRI is negatively correlated with duration of ventilation (r = -0.65, p = 0.007). In the present 
study there was only a non-significant negative association between FRI and duration of 
ventilation (r = -0.20, p = 0.20). This may be explained by the predominance of 
spontaneous modes (e.g. pressure-support ventilation) used in the current study (see 
Table 6), whereas patients in Chang’s cohort were predominantly ventilated using 
controlled methods.  
 
It is not surprising that RPE scores at rest were strongly correlated with RPE scores during 
exercise. A patient feeling short of breath at rest is highly likely to feel more exertional 
distress when they exercise as the metabolic demand for oxygen increases. In this study, 
40% of patients reported an RPE greater than zero at rest indicating an elevated work of 
breathing. However it was unexpected that RPE scores were only weakly correlated with 
fatigue resistance or functional scores, as it was expected that poor inspiratory fatigue 
resistance would manifest as increased perceived exertion as the work of breathing 
increases during exercise. It is possible that some participants have difficulty using the 
Modified Borg Scale to rate their perceived exertion and dyspnoea, or that the scale is 
insufficiently sensitive to detect relationships at this level. However to our knowledge there 
is no other readily available standardised tool to measure perceived exertion or dyspnoea 
in this context. The development of a sensitive standardised tool to measure exertion in 
critically unwell patients could be helpful in future. 
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The lack of correlation between MIP and function could also partly be explained by deficits 
in motor control. While inactivity leads to early muscle proteolysis, it is highly likely that 
inactivity also affects neural programming. In studies of specific inspiratory muscle training, 
early apparent improvements in MIP scores (e.g. within 2 weeks of training) could be 
attributed to more efficient motor programming (Huang et al., 2003) rather than muscle 
hypertrophy. Thus it is likely that there is not a simple linear relationship between strength 
and function, and neural factors should be considered in future studies. 
 
As 60% of patients in this study rated their perceived exertion as zero during exercise, it is 
also possible that ‘peak exercise’ (e.g. mobilisation with assistance away from the bed 
space) was of insufficient intensity to challenge inspiratory muscles. If these recently 
weaned patients do not perceive any raised exertion, the training intensity may be 
inadequate. Even in an intensive care unit where early mobilisation is the standard of care, 
we may be yet to determine the limitations of exercise in the critically ill. However, the 
patient’s perceived exertion is likely to be an important determinant of exercise capacity. In 
athletes working at peak exercise, exercise performance can be limited by the perception 
of exertion, even in the absence of peripheral biomarkers of fatigue (Edwards and Walker, 
2009). The evidence that this perception of exertion is modifiable in athletes with training 
of the respiratory muscles may also have implications for recently weaned intensive care 
patients. It is possible that the 37% of patients demonstrating reduced FRI in this study 
may benefit from targeted training of their inspiratory muscles. inspiratory muscle training 
can hasten weaning in older intensive care patients (Cader et al., 2010) but to our 
knowledge this remains uninvestigated in the post-weaning period. This is an important 
area of future research. 
 
The limitations of this study include the fact that these results may be valid only for 
intensive care patients who have been weaned in a unit where minimal sedation and early 
mobilisation are the norm. It is plausible that FRI, MIP and ACIF scores would differ 
considerably in patients undergoing deep sedation and bed rest as early deep sedation 
independently delays extubation and increases mortality (Shehabi et al., 2012). 
Furthermore, the failure to find correlations between these variables may be attributable to 
the relatively small sample size, although this study was larger than previous studies 
(Chang et al., 2005a).  
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Despite these limitations, the consistency of the primary measure (FRI) with previous 
studies confirms that impaired fatigue resistance is detectable in at least a third of 
intensive care patients within the first few days following weaning. These results have 
implications for all clinicians working with intensive care patients in the immediate post-
weaning period. Medical and nursing staff can reassure patients that it is common to 
experience raised perceived exertion following weaning, even at rest, as this is a 
foreseeable consequence of prolonged mechanical ventilation. As dyspnoea is complex 
and multifactorial in weaning from mechanical ventilation (Bissett et al., 2012a), the 
psychological benefits of acknowledgement and reassurance may be important for the 
patient’s experience.  
 
Furthermore, clinicians should be aware that recently weaned patients may report high 
RPE levels during exercise, particularly if RPE is raised at rest. However, in our 
experience, raised RPE is not necessarily a barrier to participation in early rehabilitation in 
intensive care and physiotherapists and nurses can work together to optimise patients’ 
exercise capacity even in the presence of inspiratory muscle weakness. 
 
In conclusion, in intensive care patients recently weaned from mechanical ventilation of 
duration 7 days or longer, impaired respiratory endurance is detectable in one third of 
patients. Impaired respiratory muscle endurance is associated with inspiratory muscle 
weakness. Inspiratory muscle weakness does not appear to be closely associated with 
functional measures or perceived exertion 48 hours following successful weaning in an 
intensive care unit where early mobilisation and minimal sedation are the standard of care.  
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CHAPTER 5: Study 4 
 
Inspiratory Muscle Training to Hasten Recovery from  
Mechanical Ventilation: A Randomised Trial 
 
 
 
 
 
 
 
 
 
 
This chapter has been accepted as an original research publication in the peer-reviewed 
journal Thorax and is currently in press. 
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INTRODUCTION 
Invasive mechanical ventilation causes respiratory muscle weakness in intensive care unit 
(ICU) patients(Levine et al., 2008). After 18 to 69 hours of controlled mechanical 
ventilation, diaphragm proteolysis and atrophy occurs(Levine et al., 2008) and respiratory 
muscle weakness has been observed both while patients are mechanically ventilated(De 
Jonghe et al., 2007) and following successful extubation(Chang et al., 2005a, Bissett et al., 
2015b). Persistent respiratory muscle weakness may contribute to the residual 
dyspnoea(Bissett et al., 2015b), impaired physical function(Iwashyna et al., 2010, Bissett 
et al., 2015b) and poor quality of life(Cuthbertson et al., 2010) observed in ICU survivors. 
 
Inspiratory muscle training (IMT) is a relatively novel training strategy to improve 
inspiratory muscle strength in intensive care patients. Threshold-based IMT is performed 
using a handheld device which provides carefully titrated constant resistance on inspiration 
only. A pre-set threshold level of pressure is required to open a one-way valve and allow 
inspiratory flow, which is important in ensuring accurate titration of resistance as some 
other IMT devices are flow-dependent which means the resistance varies with patient 
effort. Using a threshold IMT device the level of inspiratory pressure required to open the 
valve is increased over time to provide an ongoing training load as the patient’s inspiratory 
muscles become stronger. IMT improves respiratory muscle strength in patients 
undergoing invasive mechanical ventilation(Bissett and Leditschke, 2007, Cader et al., 
2010, Martin et al., 2002, Martin et al., 2011, Condessa et al., 2013) and a recent 
systematic review suggested that IMT performed prior to extubation enhances weaning 
success, although it does not appear to reduce rates of reintubation or likelihood of 
survival(Elkins and Dentice, 2015).  
 
However, participation in threshold-based IMT while mechanically ventilated requires 
patients to be alert and cooperative with training(Bissett et al., 2012b). For many reasons, 
intensive care patients may not be suitable candidates for IMT whilst ventilator-dependent 
(e.g. due to sedation or delirium) and may only have sufficient cognitive capacity to 
participate in training once weaned from mechanical ventilation. Although case studies 
have shown improvements in inspiratory muscle strength with IMT(Chang et al., 2005b), 
there have been no randomised trials of IMT in intensive care patients in the post-
extubation period. 
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As residual inspiratory muscle impairment has been demonstrated in intensive care 
survivors ventilated for 7 days or longer(Chang et al., 2005a, Bissett et al., 2015b), we 
conducted a randomised trial to establish the effects of post-extubation IMT in a 
heterogeneous sample of intensive care patients who had been invasively ventilated for at 
least 7 days. Primary endpoints included inspiratory muscle strength and endurance 
following 2 weeks of training. This 2 week time frame was selected pragmatically, as pilot 
data indicated that most intensive care survivors remained inpatients during this 2 week 
period and would receive supervised physiotherapy. To date, no studies of IMT in 
intensive care patients have included patient-centred outcomes or rates of readmission to 
ICU. Therefore secondary endpoints included health-related quality of life, dyspnoea and 
functional levels after 2 weeks of training. Post-intensive care length of stay, rate of 
intensive care readmission and in-hospital mortality were also explored. We hypothesized 
that in the IMT group, improvements in inspiratory muscle strength and fatigue resistance 
would lead to reduced dyspnoea, improved quality of life and physical function, and lower 
rates of intensive care readmission and in-hospital mortality compared to the control 
group(Bissett et al., 2012d) . 
 
MATERIALS AND METHODS 
Design 
We conducted a single-centre randomised trial with concealed allocation (computer-
generated random-number sequence, managed by off-site administrative staff and 
obtained via telephone by the chief investigator following enrolment), assessor-blinding 
and intention to treat analysis (Bissett et al., 2012d). The study was approved by the 
Australian Capital Territory Health Human Research Ethics Committee and the University 
of Queensland Medical Research Ethics Committee, and the published study 
protocol(Bissett et al., 2012d) (trial registration ACTRN12610001089022) complied with 
the CONSORT guidelines for clinical trials(Moher et al., 2001). 
 
Participants, therapists, centre 
All patients invasively mechanically ventilated for 7 days or longer were screened for 
eligibility. Patients were deemed eligible if they had been successfully weaned from 
mechanical ventilation (>48 hours), and within the 7 days following successful weaning 
they met the inclusion criteria (aged ≥ 16 years, able to provide informed consent, and 
alert and able to participate in training with a Riker(Riker et al., 1999) score of 4). Patients 
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were excluded if they had participated in inspiratory muscle training while mechanically 
ventilated, declined to participate, were pregnant, were not alert or able to participate with 
training, were experiencing significant pain or distress that interfered with breathing 
capacity, were deemed medically unstable or for palliation (i.e. death likely in the next few 
weeks). Based on a priori power calculations, a total of 70 participants was required to 
detect a 0.10 change in the primary outcome measures with a power of 0.80 (inflating 
group size by 15% to allow for known mortality of 12.8%(Bissett et al., 2012d)). Although 
the minimal clinically important difference in MIP scores has not been established in this 
patient group, the 0.10 change level was selected based on previous studies of inspiratory 
muscle strength and fatigue resistance in intensive care survivors(Chang et al., 2005a, 
Chang et al., 2005b) to allow comparisons to be drawn between studies. All participants 
provided informed written consent to participate in the study. 
 
Training was supervised by registered physiotherapists specifically trained in delivering 
inspiratory muscle training as described in our previously published protocols(Bissett et al., 
2012b, Bissett et al., 2012d). Therapists could not be blinded to group allocation. The 
study was conducted in an Australian tertiary hospital (Canberra Hospital) where usual 
intensive care practice includes minimal sedation and early proactive 
mobilisation(Leditschke et al., 2012). A second site was also included (Calvary Hospital), 
however no patients were recruited from this site due to failure to meet eligibility 
requirements. 
 
Intervention 
Participants were randomised to receive either usual care (control group) or inspiratory 
muscle training in addition to usual care (IMT group) for 2 weeks following enrolment. 
Usual care physiotherapy included an individually tailored and supervised program of 
interventions which included any of the following: assisted mobilisation, secretion 
clearance treatments including positive expiratory pressure techniques, deep breathing 
exercises without a resistance device and upper and lower limb exercises. 
 
IMT was performed using the Threshold IMT inspiratory muscle trainer (Threshold IMT 
device HS730, Respironics NJ, USA). This device was used with the mouthpiece, or a 
flexible connector if required to attach to a tracheostomy (Figure 15). Where a 
tracheostomy remained in situ, IMT was always performed with the cuff inflated to ensure 
accurate loading. The physiotherapist prescribed an intensity of 50% of MIP for the first 
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training set, but then quickly increased this to the highest tolerable intensity that allowed 
the participant to just complete the 6th breath in a set of 6 breaths, with 5 sets of 6 breaths 
completed each session.  Patients were allowed to rest between sets until they felt ready 
to commence the next set, which was typically less than 1 minute of resting. The intensity 
was increased daily by the physiotherapist across the training period to provide an 
adequate training stimulus. This was achieved by manually increasing the threshold 
resistance by 1-2cm H2O until the participant could only just open the poppet valve on the 
6th breath in each set. Training commenced on the day of enrolment and continued once 
daily (weekdays only) for 2 weeks. A sham device was not used for comparison as 
previous studies of IMT have found the sham device may provide a training effect in 
participants with very low baseline strength(Cheah et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 15: Inspiratory muscle training via a tracheostomy.  
Note the flexible tubing connecting the inspiratory muscle trainer to the closed 
suction device. 
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Measures 
Primary endpoints:  
Measures of inspiratory muscle performance were recorded on enrolment and at the end 
of the intervention period 2 weeks later by 6 specifically-trained research nurses blinded to 
group allocation. Inspiratory muscle strength was assessed as maximum inspiratory 
pressure (MIP), measured as previously described(Bissett et al., 2012d) using a portable 
MicroRPM Respiratory Pressure meter (CareFusion, San Diego, USA) in accordance with 
the protocol described by the American Thoracic Society and European Respiratory 
Society(Green et al., 2002). This device has been shown to have excellent reliability in 
measuring MIP in non-ventilated participants (ICC 0.83-0.90)(Dimitriadis et al., 2011). Raw 
MIP scores were normalised using the method described by Evans et al(Evans and 
Whitelaw, 2009) and have been presented as percentage of predicted values to account 
for known variation of MIP with age and gender. Inspiratory muscle fatigue was measured 
using the fatigue-resistance index (FRI) technique described by Chang and 
colleagues(Chang et al., 2005a), based on the Maximum Incremental Threshold Loading 
test described in the American Thoracic Society / European Respiratory Society 
guidelines(Clanton et al., 2002).The pre-specified endpoint was the between-group 
difference in change in outcome measures (i.e. the change from enrolment to 2 week 
follow-up values). 
 
Secondary endpoints:  
Measures of quality of life, dyspnoea and physical function were completed on enrolment 
and 2 weeks later. Quality of Life was measured using the SF-36v2 tool (acute 1 week 
time frame) (under license QualityMetric USA) and the EQ-5D-3L tool (under license 
EuroQol International). These tools were administered by research nurses blinded to 
group allocation. The SF-36 tool has demonstrated reliability, responsiveness, construct 
and criterion validity and is responsive to clinical improvement in an intensive care 
population(Hayes et al., 2000). The EQ-5D-3L tool has also been used in intensive care 
patient follow-up(Granja et al., 2003) and is likely to give a more general measure of 
health-related quality of life than the SF-36. 
 
Dyspnoea was measured using a Modified Borg Dyspnoea scale, where dyspnoea is a 
patient-reported categorical score out of 10, which has acceptable reliability and validity in 
patients undergoing mechanical ventilation(Powers and Bennett, 1999). Dyspnoea was 
recorded both at rest (sitting comfortably in the chair or bed) and during exercise (the peak 
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exercise activity experienced in the previous 24 hours) by research nurses blinded to 
group allocation. 
 
Functional level including mental status, bed mobility, transfers and mobility, was 
assessed using the Acute Care Index of Function (ACIF)(Roach and Van Dillen, 1988) 
which has excellent inter-rater reliability in intensive care patients(Bissett et al., 2015a). 
Scores on enrolment were completed by physiotherapists blinded to group allocation, 
however follow-up ACIF scores were recorded by the treating physiotherapist who was not 
blinded to group allocation.  
 
Other secondary endpoints included rate of intensive care unit readmission, requirement 
for reintubation, post-ICU hospital length of stay and in-hospital mortality. These data were 
extracted from hospital databases by research nurses blinded to group allocation. Post-
hoc analysis of participants who died during the hospital admission included retrospective 
calculation of the risk of death based on acute physiology and chronic health evaluation 
(APACHE II) scores. 
 
Data analysis 
The intent-to-treat (ITT) population was defined as all 70 randomised participants. The per-
protocol population was defined as all participants with both enrolment and 2 week follow-
up data. All analyses were repeated in both the ITT and per-protocol populations. Paired t-
tests were used to compare within group differences. Mixed linear models were used to 
assess the between-group difference of the changes between enrolment and follow-up 
measures, including age and APACHEII scores as covariates. Diagnostic plots (predicted 
means versus Pearson's residuals) were generated to assess model assumptions. 
Mortality data were analysed using chi square and Fisher’s exact test. Statistical 
significance was set as p<0.05. All analyses were done using SPSS version 21. 
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RESULTS 
Flow of participants through the study 
The flow of participants is presented in Figure 16. Between February 2011 and August 
2015, 70 participants were recruited to participate in the study with 34 allocated to the IMT 
group and 36 to the control group. Participant characteristics are presented in Table 9 and 
are similar between IMT and control groups, except for a higher percentage of male 
participants in the IMT group (71 vs 58%).  
The most frequent reason for exclusion from the study was poor neurological status with 
resultant inability to provide consent. Six participants were lost to follow-up in each group, 
most commonly due to transfer to another hospital within the study period. Two 
participants died within the intervention period, both in the IMT group. Two participants 
died after the intervention but prior to hospital discharge, both in the IMT group. Thus the 
total mortality in the treatment group was 12%, compared to 0% in the control group. 
Where patients were lost to follow-up regarding the primary outcome measures, other 
post-intervention secondary measures were still obtained through hospital databases 
(Table 12). 
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Figure 16: Flow of participants through Study 4 
 
  
Control Group 
 Usual 
physiotherapy 
(including 
respiratory 
treatment and 
mobilisation)  
 
Patients ventilated > 7 days,  
 Successfully weaned from mechanical 
ventilation > 48 hours 
(n = 264) 
Excluded (n = 194) 
 Low neurological status (TBI, CVA) (n = 82) 
 Participation in IMT whilst ventilated (n = 40) 
 Delirium / agitation (n = 28) 
 Medically unstable (n=17) 
 Declined to participate (n = 8) 
 Imminent palliation (n=8) 
 Intellectual disability (n = 6) 
 Unable to communicate (n=3) 
 Facial fractures (n=2) 
Measured MIP, FRI, QOL, Dypsnoea and ACIF 
Randomised (n = 70) 
(n = 34)     (n = 36) 
IMT Group 
 Inspiratory muscle 
training (2 weeks) 
 Usual physiotherapy 
(including respiratory 
treatment and 
mobilisation)  
Day 14 Measured MIP, FRI, QOL, Dyspnoea and ACIF 
 (n = 28)      (n = 30) 
Lost to follow-up = 6 
 died (n = 2) 
 reintubated and 
ventilated in ICU (n=1) 
 transferred to another 
hospital (n = 2) 
 other reason (n = 1) 
Lost to follow-up = 6 
 reintubated and 
ventilated in ICU (n=1) 
 transferred to another 
hospital (n = 1) 
 unable to complete 
testing (n = 1) 
 other reason (n = 3) 
 
Recorded hospital discharge destination, post-ICU length of stay 
 (n = 28)      (n = 30) 
Hospital 
Discharge 
Died in-hospital 
following study 
completion (n=2) 
Died in-hospital 
following study 
completion (n=0) 
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Table 9: Characteristics of Participants in Study 4 
 
Characteristic Randomised 
(n = 70) 
Lost to follow-up 
(n = 12) 
 IMT 
(n = 34) 
Control 
(n = 36) 
IMT 
(n = 6) 
Control 
(n = 6) 
Age (yr), mean (SD) 59 (16) 59 (13) 67 (11) 50 (10) 
Gender, n males (%) 24 (71) 21 (58) 4 (67) 2 (33) 
Diagnosis, n (%)     
Sepsis 4 (12) 9 (25) 0 (0) 1 (17) 
Pneumonia 4 (12) 7 (19) 0 (0) 0 (0) 
Multitrauma 6 (18) 8 (22) 0 (0) 2 (33) 
CVA   1 (3) 1 (3) 0 (0) 0 (0) 
Respiratory Failure 4 (12) 1 (3) 0 (0) 0 (0) 
Cardiothoracic Surgery 1 (3) 1 (3) 2 (33) 0 (0) 
Abdominal Surgery 3 (9) 1 (3) 2 (33) 0 (0) 
Encephalopathy / Seizures 3 (9) 4 (11) 1 (17) 1 (17) 
Other 8 (24) 4 (11) 1 (17) 2 (33) 
 
 
APACHE II scores, mean (SD) 
 
 
20.1 (7.8) 
 
 
22.9 (8.3) 
 
 
23.5 (9.0) 
 
 
19.3 (12.0) 
 
       Highest SOFA score, mean (SD) 
 
7 (4) 
 
8 (4) 
 
4 (2) 
 
7 (5) 
 
Length of ICU stay (days), mean (SD) 15 (6) 
 
13 (8) 
 
20 (7) 
 
9 (1) 
 
Total duration of ventilation (days), mean (SD) 
 
11 (4) 
 
10 (2) 
 
14 (7) 
 
8 (1) 
 
Duration of PSV (days), mean (SD) 
 
10 (4) 
 
9 (3) 
 
12 (7) 
 
7 (1) 
 
IMT = Inspiratory Muscle Training group, CVA = cerebrovascular accident, APACHE II = acute physiology and chronic 
health evaluation score; SOFA = sequential organ failure assessment score; ICU = intensive care unit, PSV = pressure 
support ventilation; SD = standard deviation. 
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Compliance with trial protocol 
In the IMT group, across the 34 participants, 85% of all intended IMT treatments (potential 
10 treatments for each patient) were completed. 23 participants (67%) completed more 
than 90% of the prescribed IMT sessions, while 2 (6%) participants completed 20% or less 
of the prescribed IMT sessions. The most frequent reason for lack of completion was 
participant refusal due to generalised fatigue. IMT was generally well-tolerated and no 
adverse effects were reported during or immediately after training in any participant. No 
participants in the control group inadvertently received inspiratory muscle training. Two 
participants (both in the control group) were discharged home prior to completion of the 
two week intervention period, however they attended the outpatient department for 
completion of outcome measures. 
 
Effect of intervention 
The intention-to-treat and per-protocol analyses yielded entirely congruent results, 
therefore only the intention-to-treat analysis is presented. Changes in outcome measures 
within and between groups are summarized in Table 10 and Table 11. MIP improved in 
both groups, with a statistically significant greater increase in the IMT group than the 
control group (17% in IMT group vs 6% in control, p = 0.024) ( Figure 17a). No statistically 
significant change in FRI was observed for either group at the end of the study period 
(0.03 vs 0.02, p=0.81) (Figure 17b).  
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Table 10: Comparisons within groups for outcome measures in Study 4 
OUTCOME 
 
GROUPS 
 Week 0 
 Estimated Marginal Mean (SEM) 
 Week 2 
Estimated Marginal Mean (SEM) 
 
 IMT 
(n = 34) 
Control 
(n = 36) 
 IMT 
(n = 34) 
Control 
(n = 36) 
 
MIP % predicted 
 
44 
(5) 
40 
(5) 
 61*** 
(5) 
47* 
(5) 
 
Fatigue 
resistance index / 
1.00 
0.86 
(0.05) 
0.96 
(0.05) 
 0.89 
(0.05) 
0.98 
(0.05) 
 
QOL: SF-36 0.43 
(0.02) 
0.47 
(0.02) 
 0.51** 
(0.02) 
0.51 
(0.02) 
 
QOL: EQ5D 41 
(4) 
51 
(4) 
 55** 
(4) 
53 
(4) 
 
ACIF /1.00 0.36 
(0.04) 
0.43 
(0.04) 
 0.61*** 
(0.04) 
0.68*** 
(0.04) 
 
RPE rest /10 2.0 
(0.4) 
1.3 
(0.4) 
 1.1 
(0.4) 
0.9 
(0.4) 
 
RPE exercise /10 3.2 
(0.5) 
2.4 
(0.5) 
 2.7 
(0.5) 
2.6 
(0.5) 
 
       
SEM = standard error of the mean, IMT = Inspiratory Muscle Training group, MIP = maximum inspiratory pressure, QOL 
= Quality of Life (SF-36 or EQ5D tools), ACIF = Acute Care Index of Function, RPE = rate of perceived exertion. * = p 
<0.05. ** = p < 0.01. *** = p < 0.001.  
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Table 11: Differences within and between groups for each outcome measure at 2 
weeks in Study 4 
 
Outcome 
 
 Differences within 
groups 
Differences between groups  
(Mixed Model Analysis) 
  Week 2 minus Week 0 
Mean (SEM) 
   
 
 
  IMT 
(n = 34) 
Control 
(n = 36)  
Difference between groups 
(95% confidence interval) 
 p value 
MIP % 
predicted 
 
 17 
(4)  
6 
(3) 
11 
 (2 to 20) 
 p=0.024* 
 
 
Fatigue 
resistance 
index / 1.00 
 0.03 
(0.05) 
 
0.02 
(0.5) 
 
0.02  
(-0.15 to 0.12) 
 p=0.816 
QOL: SF-36  0.08 
(0.02) 
 
0.04 
(0.02) 
 
0.05 
(-0.01 to 0.10) 
 
 p=0.123 
QOL: EQ5D  14 
(4) 
 
2 
(4) 
 
12 
(1 to 23) 
 p=0.034* 
ACIF /1.00  0.25 
(0.04) 
 
0.25 
(0.04) 
 
0.00 
(-0.12 to 0.12) 
 
 p=0.974  
 
RPE rest  /10  -0.8 
(0.4) 
 
-0.4 
(0.4) 
-0.4  
(-1.5 to 0.7) 
 p=0.483 
RPE exercise 
/10 
 -0.5 
(0.4) 
 
0.2 
(0.4) 
 
- 0.7  
(-1.8 to 0.4) 
 p=0.223 
 
 
       
SEM = standard error of the mean, IMT = Inspiratory Muscle Training group, QOL = Quality of Life (SF-36 or EQ5D 
tools), ACIF = Acute Care Index of Function, RPE = rate of perceived exertion. * = p <0.05. ** = p < 0.01. *** = p < 0.001. 
All analyses are intention-to-treat. 
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Figure 17: Inspiratory muscle changes in both groups in Study 4 
Inspiratory muscle changes in both groups: A) Changes in Maximum Inspiratory Pressure scores pre and 
post intervention, B) Changes in Fatigue Resistance Index pre and post intervention. The box is drawn from 
the 25th percentile to the 75th percentile, the whiskers are drawn at 1.5 times inter-quartile range, with 
outliers represented with dots. 
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Both quality of life measures demonstrated statistically significant improvements from 
baseline in the IMT group only (mean difference = 14, p = 0.001 for EQ5D; mean 
difference = 0.08, p = 0.001 for SF-36) (Figure 18a and Figure 18b). Between groups, the 
difference in EQ5D scores was higher in the IMT group (14 vs 2, p=0.034). There was no 
statistically significant difference in SF-36 scores, although the point estimates suggested 
a potential benefit (mean difference = 0.05, 95% CI = -0.01 – 0.10). 
 
Both groups demonstrated significant improvements in functional outcomes, as measured 
by the ACIF (Figure 18c); however, these improvements did not differ between groups 
(0.25 vs 0.25, p=0.974). Changes in dyspnoea scores both at rest and during exercise 
were not statistically significant either within or between groups across the intervention 
period. 
 
There were no significant differences between groups for post-ICU length of stay, 
reintubation rate or ICU readmission (Table 12). However in-hospital mortality was higher 
in the IMT group (p=0.051) with 4 deaths, 2 during the 2 week intervention period and 2 
following the intervention period (Table 13).  
 
-96- 
 
Figure 18: Quality of life and functional measures in both groups in Study 4 
Quality of life and functional measures in both groups: a) Changes in EQ5D scores pre and post intervention, b) 
Changes in SF36 scores pre and post intervention, c) Changes in Acute Care Index of Function pre and post 
intervention. The box is drawn from the 25th percentile to the 75th percentile, the whiskers are drawn at 1.5 
times interquartile range, with outliers represented with dots. 
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Table 12: Comparisons between groups for post-intervention outcome measures in 
Study 4 
 
 
Outcome 
Randomized 
(n = 70) 
 IMT 
(n = 34) 
Control 
(n = 36) 
Post-ICU hospital length of stay, mean (SEM) 35 (8) 
 
37 (9) 
 
Number of participants re-admitted to ICU, n (%)  
 
 
6 (18) 
 
8 (22) 
 
Number of participants re-intubated, n (%)  
 
6 (18) 
 
8 (22) 
 
In-hospital mortality,n (%) 4 (12)# 
 
0 (0) 
 
IMT = Inspiratory Muscle Training group, SEM = standard error of the mean.  
# p =0.051 between IMT and control groups. 
 
 
Table 13: Characteristics of participants in Study 4 who died during hospital 
admission 
 
Age, 
Gender 
Main Diagnosis 
on ICU 
admission 
APACHE II 
score  
(Risk of Death) 
Cause of Death  
(during or after intervention 
period) 
Co-morbidities 
74,  
Male 
Perforated 
duodenal ulcer 
24 
(0.65) 
Major hemorrhage secondary 
to perforated duodenal ulcer  
(during)  
HTN, GORD, 
dyslipidemia 
 
78, 
Female 
Coronary artery 
bypass grafting 
 
 
39 
(0.93) 
Septic shock, aortic dissection, 
acute renal failure  
(during) 
IHD, NIDDM, HTN, 
hyperlipidemia, 
hypothyroidism, 
GORD  
 
61,  
Male 
Coronary artery 
bypass grafting 
 
24 
(0.07) 
Multiple organ failure, 
decompensated chronic liver 
disease & encephalopathy  
(after) 
Alcoholic liver disease, 
HTN, GORD, AF  
 
40,  
Male 
Hepatorenal 
syndrome 
25 
(0.15) 
Pleural effusion, renal failure & 
fluid overload +/- dilated 
cardiomyopathy  
(after) 
Alcoholic liver 
cirrhosis, GORD, 
hypercholesterolemia, 
recurrent septicemia, 
recurrent syncopal 
episodes   
APACHE II = acute physiology and chronic health evaluation score, HTN = hypertension, GORD = gastroesophageal 
reflux disease, IHD = ischaemic heart disease, NIDDM = non-insulin-dependent diabetes mellitus, AF = atrial fibrillation. 
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DISCUSSION 
We have shown for the first time that in the post-extubation period, participants who 
complete 2 weeks of IMT have greater improvement in respiratory muscle strength than 
those who do not train. This is congruent with previous studies of IMT in mechanically 
ventilated patients(Cader et al., 2010, Martin et al., 2011, Condessa et al., 2013) and with 
the rapid strength gains within 2 weeks of commencing IMT previously described in 
healthy cyclists (e.g. increased MIP scores by 8.4%(Johnson et al., 2007)). It is possible 
that some of the apparent strength gains could be attributable to a learning effect, given 
the similarity between the IMT technique and the MIP testing manoeuvre. However, in 
intensive care patients rapid atrophy has been observed in both skeletal(Puthucheary et 
al., 2013) and respiratory muscles(Levine et al., 2008) within the first few days of 
admission. With an adequate training stimulus, some of these changes could be reversible 
within a relatively short timeframe. Regardless of the underlying mechanism of 
improvement, the apparent strength gains in this cohort translated into benefits in quality of 
life, which is arguably a more important patient-centred outcome than inspiratory muscle 
strength. 
 
Our inability to demonstrate an improvement in inspiratory muscle endurance in the IMT 
group is somewhat surprising, as IMT has been shown to increase proliferation of both 
Type 1 and Type 2 inspiratory muscle fibres(Ramirez-Sarmiento et al., 2002) and 
endurance benefits of IMT have been reported after 8 weeks of training in patients with 
chronic obstructive pulmonary disease(Hill et al., 2006), after 11 weeks of training in 
athletes(Volianitis et al., 2001) and after 4 weeks of training in recreationally active people 
(Bailey et al., 2010). While it is possible that the specific training regime employed in our 
study translates into strength benefits alone, it is more likely that the duration of training 
was insufficient to effect a measurable improvement in endurance, or that the FRI is 
insufficiently sensitive to detect subtle changes in endurance over such a short time frame. 
A more sustained constant loading test may have better elucidated changes in inspiratory 
muscle endurance, however our experience with these participants resonated with that of 
Chang and colleagues(Chang et al., 2005a) who found a limited tolerance for even the 
basic 2 minute FRI test. Thus measuring inspiratory muscle endurance in this patient 
group remains a challenge.  
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The statistically significant improvements in quality of life in the IMT group, as measured 
with the EQ5D tool (Figure 18a), warrant further exploration. The magnitude of change in 
EQ5D scores (14 in the IMT group compared to 2 in the control) is likely to be clinically 
important in this group which struggles with poor quality of life following weaning. While the 
IMT group commenced from a lower baseline EQ5D score (41 in the IMT group compared 
to 51 in the control) we believe it is unlikely that there was a ceiling effect in this cohort, as 
scores at 2 weeks remained well below maximal values (i.e. mean 54% across both 
groups). We would expect quality of life to continue a slow trajectory of improvement 
beyond the ICU stay(Herridge et al., 2011) but it is possible that IMT provides an 
advantage early in this trajectory.  
 
Although the IMT group expressed improved quality of life using the EQ5D tool, the effect 
was less marked when assessed by the SF36. This may reflect difficulty in completing all 
components of the longer SF36 questionnaire. One of the challenges in ICU outcomes 
research is the effect of residual cognitive impairment(Iwashyna et al., 2010) and fatigue 
on a participant’s ability to complete lengthy quality of life assessment tools. The reasons 
for improved quality of life in the absence of a demonstrated effect on respiratory 
endurance, dyspnoea or functional level, remain unclear. 
 
Improvements in inspiratory muscle strength did not have a clinically or statistically 
significant impact on the other patient-centred outcomes in this study. While physical 
function improved similarly in both groups, it is likely that other aspects of treatment (e.g. 
whole body exercise and gait retraining) had a stronger influence on recovery of physical 
function than IMT. The fact that both groups improved in terms of physical function may 
reflect the high standard of usual care in this unit, which includes early rehabilitation and 
mobilisation. Thus, the findings of this study may only be generalisable to acute settings 
where early mobilisation and rehabilitation are the norm. Furthermore, the failure of IMT to 
significantly affect reintubation rates or length of stay may be attributable to the small 
sample size, as the effect size of IMT may be very small in relation to the many other 
variables that impact on these clinically significant outcomes. Future studies of IMT in the 
post-weaning period should be adequately powered to further clarify these relationships.  
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The difference in in-hospital mortality between groups was unexpected, although the 
mortality in the IMT group (12%) was close to that anticipated in the trial design (12.8%). 
To our knowledge, no increase in mortality has been reported with IMT in any population 
to date, including ventilated intensive care patients, or patients with chronic obstructive 
pulmonary disease or heart failure. As summarised in Table 13, none of the deaths 
appeared to be related directly to IMT or respiratory complications. Given the small 
number of study participants and heterogeneity of diagnoses, further study of the impact of 
IMT on in-hospital mortality is indicated before robust conclusions about mortality can be 
drawn. 
 
Limitations of this study include a loss to follow up of 17%, which should have been partly 
offset by the planned sample size augmentation of 15% to account for anticipated 
mortality. A lack of follow-up of primary outcomes beyond 2 weeks is another limitation. 
Moreover, some patients may benefit from ongoing IMT beyond a 2 week training period, 
particularly as most did not return to 100% of predicted MIP values during this study. In 
patients with chronic obstructive pulmonary disease, IMT has longer-term benefits 
including lower rates of hospitalisation over a 12 month period(Beckerman et al., 2005). It 
is possible therefore that IMT in the post-extubation period has ongoing effects which 
should be assessed further. 
 
With regard to the training device, a ceiling effect was problematic in 2 participants whose 
MIP exceeded 82 at baseline. As the maximum resistance setting on the device is 
41cmH2O, it was impossible to provide training at greater than 50% of MIP in these 2 
participants. While all other participants commenced at 50% MIP intensity during the 
training period, 16 participants (47%) achieved the 41cmH2O maximal setting on the 
device at some point during the 2 week period, limiting further incremental training. Thus 
our study may have underestimated the potential impact of IMT. In future studies of IMT 
we recommend using a device with the capacity to provide higher training intensities, such 
as an electronic device(Langer et al., 2015). Furthermore, future studies may target those 
with identifiable strength deficits, as these may constitute a subgroup which is most likely 
to benefit from training, while those with high baseline values have probably diluted the 
potential benefits of training in our cohort. 
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This study is the first to demonstrate the value of IMT for patients in the post-extubation 
period. IMT can be considered an effective strategy to reverse some of the residual 
inspiratory muscle weakness which is common following prolonged mechanical ventilation, 
and may enhance quality of life in these patients with just 2 weeks of training. Future 
studies of intensive care patients in the post-extubation period should further explore the 
impact of IMT on quality of life, as well as the longer term effects of IMT in this group, 
including effects on mortality.  
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CHAPTER 6: Study 5 
 
Protocol for a Randomised Controlled Trial of Inspiratory Muscle Training to 
Hasten Recovery from Mechanical Ventilation 
 
 
 
 
 
 
 
 
This chapter has been published in the peer-reviewed journal BMJ Open and is 
reproduced with permission (Appendix C): 
http://bmjopen.bmj.com/content/2/2/e000813.abstract  
Bissett B, Leditschke IA, Paratz J, Boots R (2012). Protocol: Inspiratory Muscle training for 
Promoting Recovery and Outcomes in Ventilated patients (IMPROVe): a randomised 
controlled trial. BMJ Open 2;2 (2):e000813. 
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INTRODUCTION 
Mechanical ventilation used in intensive care units, whilst often essential in the 
management of respiratory failure, can result in respiratory dysfunction and inspiratory 
muscle weakness (Tobin et al., 2010). Even patients who can successfully wean from 
mechanical ventilation may suffer impaired fatigue resistance of the inspiratory muscles 
following successful weaning (Chang et al., 2005a). Inspiratory muscle weakness has 
been associated with difficulty weaning from mechanical ventilation (De Jonghe et al., 
2007) and the degree of weakness is correlated with the duration of ventilation (Chang et 
al., 2005a, De Jonghe et al., 2007). One case-control study demonstrated that mechanical 
ventilation results in increased proteolysis and atrophy in the diaphragm muscle, while 
other skeletal muscles are spared (Levine et al., 2008). Clearly inspiratory muscle 
weakness is likely to be at least one of the factors that could contribute to difficult and 
prolonged weaning from mechanical ventilation (Bissett et al., 2012c). 
 
Inspiratory muscle training with a threshold device has been used in patients with chronic 
lung disease for many years, resulting in not just increased inspiratory muscle strength, 
but also increased inspiratory muscle endurance, reduced dyspnoea and increased 
exercise tolerance and quality of life (Shoemaker et al., 2009). Since 2002, case reports of 
inspiratory muscle training in ventilator-dependent patients have suggested that inspiratory 
muscle training is associated with favourable weaning outcomes (Sprague and Hopkins, 
2003, Martin et al., 2002, Bissett and Leditschke, 2007). More recently, two randomised 
trials (Cader et al., 2010, Martin et al., 2011) using different training strategies have 
demonstrated benefits of inspiratory muscle training for ventilated patients, including 
statistically significant increases in inspiratory muscle strength (Martin et al., 2011, Cader 
et al., 2010) reduced weaning time by a mean of 1.7 days (Cader et al., 2010) and a 
higher rate of successful weaning at day 28 (71% compared to 47%)(Martin et al., 2011) . 
However the generalisability of these results is limited by the sub-groups studied (aged 
over 70(Cader et al., 2010), failed to wean(Martin et al., 2011)) as well as the sedation and 
rehabilitation approaches used in the investigating centres units. It is not yet known 
whether similar results would apply to a more heterogeneous group of intensive care 
patients in an Australian context. For example an approach of minimal sedation and early 
active rehabilitation may result in different training effects and relative benefits of 
inspiratory muscle training. It is also not known which training parameters are optimal. 
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In an analysis of 195 inspiratory muscle training treatments in ventilated patients, 
inspiratory muscle training was found to be safe with zero adverse outcomes and stable 
physiological parameters in response to training (blood pressure, heart rate, oxygen 
saturation and respiratory rate)(Bissett, 2012). However, the mechanisms of improvement 
with inspiratory muscle training in ventilated patients have not been investigated. It is 
theoretically feasible that a high-intensity training protocol could provide an adequate 
training stimulus to halt or reverse diaphragmatic atrophy and proteolysis (Levine et al., 
2008). As has been shown in athletes, inspiratory muscle training could also attenuate a 
sympathetically-mediated metaboreflex, resulting in enhanced limb muscle perfusion (Witt 
et al., 2007). This improved limb perfusion could facilitate early mobilisation, resulting in 
enhanced functional capacity or quality of life.  
 
The following protocol outlines the process by which we intend to answer some of these 
questions with regards to inspiratory muscle training in a heterogeneous group of patients 
who have been ventilator-dependent for seven days or longer in our Australian intensive 
care unit setting. The protocol describes a randomised trial of patients who commence 
inspiratory muscle training whilst still ventilated. 
 
STUDY OVERVIEW: 
This trial (RCT1) examines the effects of inspiratory muscle training on post-weaning 
outcomes for patients who undergo mechanical ventilation for at least 7 days and 
commence training while ventilator-dependent. This trial was registered with the Australia 
New Zealand Clinical Trials Registry December 13 2010 (ACTRN12610001089022). 
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Aims: 
RCT1 aims to answer the following questions: 
1. Does inspiratory muscle training, commenced while mechanically ventilated, affect 
the fatigability of respiratory muscles following weaning from prolonged mechanical 
ventilation (> 7 days)?  
2. Does inspiratory muscle training, commenced while mechanically ventilated, affect 
the duration of ventilation required or the rate of reintubation in these patients? 
3. Is there a measurable difference in the stress response and / or anabolic response 
in patients undergoing inspiratory muscle training, compared to routine 
physiotherapy? 
4. Does inspiratory muscle training affect dyspnoea, quality of life or functional 
measures or post-intensive care length of hospital stay following successful 
ventilatory weaning? 
 
Hypotheses: 
The hypotheses are that inspiratory muscle training will reduce inspiratory muscle 
fatigability, dyspnoea and possibly duration of ventilation and post-intensive care length of 
hospital stay, and will improve quality of life and functional measures in this population 
without concomitant increases in the stress response or detectable changes in muscle 
anabolism. 
 
 
METHOD: 
The randomized controlled trial will be conducted, with the anticipated flow of patients 
described in Figure 19. Randomisation for the study will be provided through a computer 
generated random number sequence, managed off-site by clerical staff unconnected with 
the study, and accessible to the investigators only via telephone to ensure concealed 
allocation. All intensive care patients will be screened daily for study eligibility by the senior 
intensive care physiotherapist. Eligible participants will be invited to participate and 
subsequently enrolled by the chief investigator and baseline measures completed prior to 
allocation. 
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A total of 70 participants will be required for RCT1. On the basis of data extrapolated from 
previous case series this provides a power estimate for expected differences in fatigue 
resistance indices between the groups of 0.8, if α = 0.05. Sample sizes have been inflated 
15% to account for the known mortality of this patient population (12.8%) (Canberra 
Hospital intensive care unit audit data 2009).  
 
Subjects: 
Subjects will be recruited from Canberra Hospital intensive care unit (Canberra, Australia). 
Patients mechanically ventilated for more than 7 days who are alert and able to co-operate 
with training (Riker sedation agitation score(Riker et al., 1999) of 4) and can provide 
informed consent will be randomised (computer generated random number sequence, 
concealed allocation) to receive either inspiratory muscle training or usual physiotherapy 
care. Usual physiotherapy care typically involves deep breathing exercises (without a 
resistance device), manual hyperinflation (Blattner et al., 2008), secretion clearance 
techniques, assisted mobilisation (Schweickert et al., 2009, Morris et al., 2008) and upper 
and lower limb exercise as indicated. 
 
 
Figure 19: Flow of participants through Study 5.  
 (N.B. RCT2 refers to the patients already described in Study 4). 
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Inclusion criteria 
All patients admitted to the intensive care unit who: 
 are mechanically ventilated through invasive means for 7 days or longer 
 are aged ≥ 16 years 
 are alert and able to co-operate with training (Riker score 4) 
 are able to provide informed consent 
 are haemodynamically stable and requiring minimal ventilatory support (i.e. PEEP 
≤10) 
 
Exclusion criteria 
Patients will be excluded from RCT 1 if they are: 
 undergoing non-invasive ventilation only 
 aged < 16 years 
 unwilling to consent or not able to provide informed consent 
 previously included in RCT 1 (i.e. patients readmitted to intensive care) 
 pregnant 
 mechanically ventilated less than 7 days 
 not alert or able to co-operate with training (Riker score < 4 or > 4) 
 requiring high levels of ventilatory support (e.g. PEEP > 10 cm H2O, FiO2 > 0.60, 
nitric oxide, nebulised prostacycline, high frequency oscillation) and / or where the 
treating team (medical and / or physiotherapy) deems risks of brief disconnection 
from ventilation unacceptable 
 medically unstable (e.g. new cardiac arrhythmia, acutely septic) where the treating 
team (medical and / or physiotherapy) consider interference with ventilatory support 
could compromise patient’s recovery; and / or are deemed suitable for palliation 
 experiencing significant pain which interferes with breathing capacity (e.g. fractured 
ribs): inspiratory muscle training could be reconsidered when pain is controlled and 
patient is able to participate 
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Outcome measures:Table 14 summarises the outcome measures used in Study 5. 
Table 14: Outcome measures used in Study 5 
OUTCOME MEASURE Timing of Assessment  
Fatigue Resistance Index (FRI) (Primary 
outcome measure) 
 24 hours post weaning 
 7 days post weaning 
 
Maximum Inspiratory Pressure (MIP) 
 
 Commencement of training 
 24 hours post weaning 
 7 days post weaning 
 
Quality of Life / Functional assessments  
 (SF-36, EQ-5D, Acute Care Index of Function) 
 
 Commencement of training 
 7 days post weaning 
 
Rate of Perceived Exertion (RPE) at rest and 
during training 
 
 Commencement of training 
 7 days post weaning 
 
Duration of mechanical ventilation (days)  
 
Duration of weaning (from commencement of 
pressure-support only to 24 hrs ventilator-free) 
 
 
 
 
 
 
Post ICU-discharge length of hospital stay (days)  
 
Hospital discharge destination (including in-
hospital mortality) 
 
 
 
 
ICU readmission rates  
 
Reintubation rates (%) – defined as reintubation 
required within 48 hours of extubation 
 
 
 
 
Urinary cortisol, creatinine and urea levels 
 Commencement of training 
 Day 7 of training 
 
 
 
Interventions, samples and assays:  
Muscle trainer: 
Inspiratory muscle training will be performed using the Threshold inspiratory muscle trainer 
(Threshold IMT device HS730, Respironics NJ, USA). This device has been validated in 
both healthy patients and those with chronic lung disease (Gosselink et al., 1996) and is 
superior to alternative flow-resistance devices due to its reliability in ensuring prescribed 
pressures are achieved regardless of participant’s flow rate (Gosselink et al., 1996).  
 
The training parameters are based on previously published case studies (Bissett and 
Leditschke, 2007, Martin et al., 2002, Sprague and Hopkins, 2003) and are consistent with 
evidence-based inspiratory muscle training guidelines in patients with chronic lung disease 
(Hill et al., 2010) which recommend that high intensity interval training is well tolerated and 
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optimises outcomes (Hill et al., 2006). The physiotherapist prescribes the highest tolerable 
intensity that allows the participant to just complete the 6th breath in a set of 6 breaths 
(Martin et al., 2011). The intensity is gradually increased by the physiotherapist across the 
training period to provide adequate training stimulus. Training is performed daily on week 
days, with the physiotherapist assisting the patient to perform 5 sets of 6 breaths each 
session. Between sets, patients are returned to the ventilator for a rest period as required 
(typically less than 60 seconds). The whole training session takes less than 10 minutes per 
day.  
 
Training will be provided by either the chief investigator, senior intensive care 
physiotherapist or a physiotherapy department staff member who has been trained and 
credentialed in the technique in accordance with our previously published protocol (Bissett 
and Leditschke, 2007).  
 
Respiratory strength and fatigue measurement 
Inspiratory muscle strength will be measured as maximum inspiratory pressure (MIP), in 
accordance with the protocol described by the American Thoracic Society and European 
Respiratory Society (Green et al., 2002). Briefly, this technique requires the patient to 
maximally inhale from residual volume into a hand-held pressure manometer and sustain 
the effort for more than 1 second. Nose  clips are not required. The patient is coached to 
ensure adequate lip seal around the mouth piece and achieve maximum voluntary effort, 
and the effort is repeated until at least 3 measurements have less than 20% variability 
between them (Green et al., 2002).  
 
The device used to perform MIP testing is a portable MicroRPM Respiratory Pressure 
meter (CareFusion, San Diego, USA) (Australian Therapeutic Goods Administration 
approval 166760). Such hand-held devices have demonstrated reliability and validity 
(Hamnegard et al., 1994) and are easy to use at the bedside in intensive care or ward 
environments. The device will be zeroed and calibrated before each measurement. 
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The method of determining fatigue resistance capacity is the protocol used by Chang and 
colleagues (Chang et al., 2005a) and is based on the Maximum Incremental Threshold 
Loading test described in the American Thoracic Society / European Respiratory Society 
guidelines (Clanton et al., 2002). Following successful weaning from mechanical 
ventilation (i.e. within 24 – 48 hours), the patients’ fatigue resistance (FRI) is calculated. 
Following 3 MIP measurements (as above), participants breathe through inspiratory 
resistance (through the Threshold inspiratory muscle training device) equivalent to 30% of 
the initial MIP for 2 minutes. This level of resistance has been selected as the preliminary 
trials by Chang et al indicated that resistance equivalent to 50% of MIP resulted in severe 
dyspnoea (Chang et al., 2005a). If the participant is not able to inspire at 30% of their MIP, 
no resistance is applied. MIP measurements are repeated at 2 minutes.  
 
During the loading task, the testing will be ceased if the RPE is ≥ 7, pulse oximetry 
saturation falls > 10% from initial values or to < 90%, or the heart rate increases by> 30 
beats per minute. FRI is calculated comparing the pre- and post-loading values of the MIP 
(i.e. Post MIP / Pre MIP). The FRI procedure is repeated 7 days post successful weaning 
from ventilation. 
 
Cortisol & urea sampling  
Patients with an indwelling catheter in situ will have 24 hours urine at baseline and Day 7. 
Urine will be assayed for cortisol, creatinine and urea using High Performance Liquid 
Chromatography. 
 
Dyspnoea (shortness of breath): 
Dyspnoea will be measured using a Modified Borg scale (RPE categorical score out of 10) 
which has been found to have acceptable reliability and validity in patients undergoing 
mechanical ventilation (Powers and Bennett, 1999). RPE will be recorded both at rest and 
during exercise at successful weaning (24 hours) and 1 week post weaning (by a blinded 
assessor).  
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Quality of Life and Functional measures: 
Quality of Life is measured using the SF-36v2 tool (acute 1 week time frame) and the EQ-
5D tool as one combined survey. The SF-36 tool has demonstrated reliability, 
responsiveness, construct and criterion validity and is responsive to clinical improvement 
in an intensive care population(Hayes et al., 2000). The EQ-5D tool has also been used in 
intensive care patient follow-up (Granja et al., 2003) and is likely to give a more global 
measure of health-related quality of life. The survey will be completed on enrolment and 7 
days following successful weaning.  
 
Functional level will be measured using the Acute Care Index of Function (ACIF) which 
has good levels of inter-rater reliability (Van Dillen and Roach, 1988) and construct validity 
(Roach and Van Dillen, 1988) in acute neurological conditions.  
 
TERMINATION CRITERIA: 
An individual would be withdrawn from the study in the case of death, withdrawal of 
consent or ability to participate actively. Should a patient in the view of the treating 
physician not tolerate the intervention, for whatever reason, the patient may be withdrawn 
from the study, however follow up data including FRI would still be collected and all data 
collected will be analysed on an intention to treat basis. Adverse outcomes are not 
anticipated, due to the demonstrated safety of the technique in our own pilot data (Bissett, 
2012), and the lack of documented adverse sequelae in other studies (Martin et al., 2002, 
Sprague and Hopkins, 2003, Martin et al., 2011, Cader et al., 2010). 
 
According to a recent multi-site study on the safety of physiotherapy intervention in 
intensive care (Zeppos et al., 2007), the following criteria would cause the treating 
therapist to cease the intervention immediately and alert on-site medical attention (i.e. 
senior intensive care registrar): alteration in blood pressure > or < 20% resting; alteration 
in heart rate < or > 20% resting; new arrhythmia; oxygen desaturation > 10%; pulmonary 
artery pressure (systolic) > 60 mmHg; suspected pneumothorax; agitation risking 
detachment of equipment or lines or requiring increase sedation. Should such an episode 
occur, the participant’s suitability for remaining in the trial would be reviewed by the Chief 
Investigator, in consultation with senior intensive care medical staff. 
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MINIMISING BIAS: 
Outcome measures will be taken by blinded assessors, however therapists providing the 
intervention cannot be blinded.  
 
Patients will be informed that the study is investigating different types of ‘breathing 
exercises’, without reference to a device, thus allowing blinding of the patients. Although a 
sham comparison would be ideal, most sham interventions with the threshold device have 
used low training pressures (e.g. 9 – 11 cm H2O). The concern is that for the weakest 
patients, this level of training can be challenging. In our pilot case series(Bissett, 2012) 
several participants trained for several sessions with pressures below 15 cm H2O 
pressure, generating RPE scores of > 7. Our observations are also substantiated by the 
work of DeJonghe et al(De Jonghe et al., 2007) who were able to quantify the median MIP 
for ventilated patients who have returned to consciousness as only 30 cm H2O. That is, a 
mere 9 cm H2O training pressure would equate to 30% of MIP, and 30% intensity has 
shown training benefits in patients with chronic obstructive pulmonary disease (Preusser et 
al., 1994, Lisboa et al., 1994, Sanchez Riera et al., 2001). Thus it would be difficult to use 
a true sham without risking inadvertent ‘training’ of the weakest patients. As an alternative 
to a true ‘sham’ comparison, the control participants will receive daily coached breathing 
exercises (deep breathing or demand ventilation exercises without a threshold device) to 
minimise the potential Hawthorne effect. 
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PROPOSED METHODS OF DATA ANALYSIS: 
 
Data will be analysed using both an intention to treat and per protocol analysis with a carry 
forward analysis for missing data. Mean changes scores, standard deviations and 95% 
confidence intervals will be calculated between groups for pre and post intervention. It is 
anticipated that the analysis will use a combination of t-tests, chi square tests and 
repeated measures ANOVA (or non-parametric equivalents) as appropriate. If missing 
data is a problem a mixed model may be used. There will be a baseline comparison of 
age, gender, APACHE II scores, highest SOFA score, and length of stay. There will be a 
priori stratification of those participants with known neuromuscular disease (e.g. Guillain 
Barre, Motor Neurone Disease, Myaesthenia Gravis).  
 
Predictive Modeling: 
A sub-study of RCT1 will analyse the correlation between inspiratory muscle training 
pressures (cm H2O) and duration of weaning (hours off ventilator in a 24 hour period). If 
possible a mathematical model linking these two variables will be described. 
 
CONTINGENCIES: 
Should participant recruitment prove slow to reach the required sample size for this study, 
the study duration may be increased by 6 to 12 months as required, pending ongoing 
ethics approval.  
 
DATA MANAGEMENT: 
A custom-designed database will store de-identified patient data in a secure password-
protected file accessible only to designated research office staff. Data will be entered by 
blinded research office staff from hard copies which are stored in a locked office. Data 
completeness will be reviewed by research office staff quarterly and cross-referenced with 
existing medical records. The investigators will only have access to the database on 
completion of the study.  
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CONCOMITANT INTERVENTIONS: 
All usual physiotherapy interventions, including early mobilisation as is the standard of 
care in both ICUs, will be allowed. No specific medical or surgical interventions are 
disallowed for trial participants other than those described in the exclusion criteria above. 
 
ETHICS AND DISSEMINATION 
Ethics approval has been gained for these studies through these institutional committees:  
1. Australian Capital Territory Health Human Research Ethics Committee (ETH 
10.10.370) 
2. University of Queensland Medical Research Ethics Committee (2010001488) 
Any adverse events connected with the trial would be immediately reported to these 
committees as well as registered through the hospital risk management system. 
The results of this study will be presented at national and international intensive care and 
physiotherapy conferences, and will be submitted for publication in peer reviewed journals 
particularly focused on intensive care medicine. 
 
DISCUSSION 
The findings of this study would be highly relevant to intensive care staff who address the 
challenges of ventilatory weaning and physical rehabilitation. Any intervention which can 
hasten weaning from mechanical ventilation, or recovery following intensive care stay, is 
highly likely to reduce overall length of stay and may reduce associated morbidity and 
mortality. In addition to the individual patient benefits that this will produce, there is the 
potential for a substantial community economic benefit due to reduced hospital costs. 
 
If efficacy of inspiratory muscle training can be demonstrated, this could lead to a change 
in intensive care practice internationally across disciplines, including physiotherapy, 
respiratory therapy, nursing and intensive care medicine. Ultimately, the people most likely 
to benefit from this study are the patients, with improved understanding of methods to 
optimise treatment and minimise the complications of prolonged mechanical ventilation. 
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UPDATE & ETHICAL DISCUSSION OF CONTINUATION OF STUDY 5 
Recruitment for Study 5 commenced in February 2011, and following screening of 282 
patients, 48 of the required 70 participants have been enrolled in the study (as of 
December 2015). Based on current recruitment rates the new projected time frame for 
completion of this study is December 2017. Since February 2011, there have been no 
adverse events associated with any of the IMT sessions and as expected, based on Study 
1, these have been well-tolerated by patients. 
 
In light of the unexpected in-hospital mortality findings in Study 4, we deemed it prudent to 
conduct an interim analysis of in-hospital mortality in Study 5. As stated in the protocol for 
Study 5, we anticipated high mortality in this group and inflated sample sizes by 10% to 
allow for this. Indeed the mortality rate in Study 4 (4 of 70, 5%) was not surprising, 
although the fact that all 4 deaths were in the IMT group was unexpected. As of November 
2015, there does not appear to be an association with in-hospital mortality in Study 5, with 
small numbers of patients dying in both treatment and control groups prior to hospital 
discharge.  
 
We have provided feedback to the ACT Health Human Research Ethics Committee about 
the unexpected mortality finding in Study 4, including the specific causes of death (i.e. 
Table 13) which appear to be unrelated to respiratory failure. We have also reiterated that 
Study 4 was underpowered for mortality and the finding is particularly fragile given the very 
small numbers involved. The fact that 2 of the patients died weeks after cessation of IMT 
(2 and 5 weeks respectively) makes it difficult to directly link the mortality finding with the 
intervention. In this context, and in light of the fact that no other study of IMT in ventilator-
dependent patients to date has reported increased mortality, we have been encouraged by 
the committee to continue Study 5 and will continue to monitor in-hospital mortality closely.  
 
It is also hoped that the examination of cortisol levels in Study 5 will further enhance 
understanding of any stress response associated with IMT. Although the results of Study 1 
suggest that high-intensity IMT is well-tolerated physiologically, the cortisol results will 
further contribute to our understanding of the safety of IMT in ventilator-dependent 
patients.   
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Thus as a research team we are confident that we have extensively explored the reasons 
behind the unexpected mortality finding in Study 4, and are satisfied that it is ethically 
sound to continue completion of Study 5 as per the advice of the ethics committee. 
Although the timeframes required for completion of Study 5 prohibit its inclusion in this 
thesis (due to slow recruitment), this final element of the project will continue to be 
overseen by this research team to ensure it is completed to the highest possible standard 
and the results are disseminated widely. Extension of ethical approval through the ACT 
Health Human Research Ethics Committee has been accordingly obtained until 2017.          
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CHAPTER 7: DISCUSSION 
 
FINDINGS AND CONCLUSIONS 
The major findings of this project are that patients who undergo mechanical ventilation for 
more than 7 days are likely to develop deficits in inspiratory muscle strength, with 
approximately one third also developing impaired inspiratory muscle endurance following 
successful ventilatory weaning. These deficits occur even when patients have been 
managed with spontaneous modes of ventilation and early proactive mobilisation. Further, 
this project has demonstrated that inspiratory muscle training is feasible and safe in 
selected mechanically-ventilated patients who are alert and able to participate with 
training. However, for those who cannot participate in inspiratory muscle training while 
ventilated, it would appear that following successful ventilatory weaning, 2 weeks of 
inspiratory muscle training improves inspiratory muscle strength and quality of life, but 
does not improve inspiratory muscle endurance.  
 
A secondary finding of this project has been the establishment of the clinimetric properties 
of the Acute Care Index of Function, an outcome measure that has been used to quantify 
physical function and activity levels of patients in intensive care. It has excellent inter-rater 
reliability and reasonable construct validity of the Acute Care Index of Function in intensive 
care patients, allowing it to be validly used as an outcome measure in the other studies in 
this project.  
 
Since this project commenced in 2010, there has been an increase in research into 
inspiratory muscle training in mechanically-ventilated patients. Since 2011, 9 randomised 
trials of inspiratory muscle training in intensive care patients have been published (Cader 
et al., 2010, Martin et al., 2011, Condessa et al., 2013, Dixit and Prakash, 2014, Elbouhy 
et al., 2014, Ibrahiem et al., 2014, Mohamed et al., 2014, Pascotini et al., 2014, Shimizu et 
al., 2014), and the results of these studies have been summarised in 2 systematic reviews 
with meta-analyses (Moodie et al., 2011, Elkins and Dentice, 2015). While the meta-
analyses confirmed that inspiratory muscle training in ventilator-dependent patients 
increases respiratory muscle strength and facilitates weaning (Moodie et al., 2011, Elkins 
and Dentice, 2015), there is wide variability in both patient selection and training programs 
used across the studies. For example, Cader et al (2010) studied inspiratory muscle 
training in patients aged over 70 but excluded those with tracheostomies. Given that many 
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long-term patients in intensive care will require tracheostomy beyond seven days of 
mechanical ventilation, this exclusion criterion limits the usefulness of the findings of this 
study. Patients in the study by Martin et al (2011) were a subset of intensive care patients 
who had failed to wean from mechanical ventilation and underwent training in a 
specialized weaning unit. These patients had experienced several weeks of mechanical 
ventilation prior to commencing training, and therefore may be at much higher risk of 
respiratory muscle weakness than a typical cohort of intensive care patients. In contrast, 
Condessa et al (2013) did not demonstrate improvements in weaning rates in their 
intensive care patients, but this may be due to selecting a patient cohort who had only 
been mechanically ventilated for 48 hours and therefore have less strength deficit initially. 
Moreover, these researchers only used a training intensity of 40% of maximum inspiratory 
pressure, which may be an inadequate training stimulus to achieve the strength and 
weaning benefits demonstrated in other studies. Given the heterogeneity of both patients 
and training parameters used across the studies to date, further research is needed to 
identify the intensive care patients who would benefit most from inspiratory muscle 
training, as well as the ideal training parameters. Study 5, described in Chapter 6, will add 
to this body of knowledge, particularly as it includes patients of all ages who were 
ventilated for 7 days or longer, via both endotracheal tubes and tracheostomies. 
Furthermore it focuses on patient-centred outcomes including physical function and rate of 
perceived exertion, which other studies in this field have not yet explored. 
 
CONTEXT OF THE FINDINGS 
All studies completed in this project were undertaken in an intensive care unit where 
minimisation of sedation is the standard practice. This may limit the generalisability of the 
findings of the project, particularly as many intensive care units around the world are still 
exploring ‘sedation interruption’ as opposed to complete alertness as the standard of care 
for intubated and ventilated patients. Early mobilisation is also standard practice in this 
unit, including for ventilated patients (Leditschke et al., 2012). In contrast, other studies of 
inspiratory muscle training have been performed in units where patients do not actively 
participate in any other rehabilitation (Condessa et al., 2013), or where the amount of 
rehabilitation activity was reduced during the training period (e.g. Martin et al (2011) 
reduced duration and intensity of rehabilitation activities by approximately 50%). It is 
conceivable that mobilisation and whole body rehabilitation may affect inspiratory muscle 
strength and endurance, and therefore possible that units which do not practice early 
rehabilitation may have different outcomes with inspiratory muscle training in their patients 
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relative to those demonstrated in this project. The relationship between whole-body 
exercise and specific respiratory muscle function is yet to be studied in the intensive care 
context, but given the relationships between inspiratory muscle strength and exercise 
performance in athletes (as described in Chapter 1), the relative effects of global and 
specific exercise training deserve further exploration in this patient group.    
 
Over the past 5 years there has been a proliferation of research into the effects of early 
mobilisation and rehabilitation in intensive care (Morris et al., 2011, Team Investigators et 
al., 2015, Stiller, 2013). While recent suggestions that physiotherapists should focus on 
early mobilisation as a matter of priority(Stiller, 2013) may have changed the landscape of 
physiotherapy practice in many units, this suggestion is unlikely to have had a local impact 
across the life of this project as early mobilisation and rehabilitation were already the norm 
(Leditschke et al., 2012). Thus despite the relatively long duration of Studies 3, 4 and 5, it 
would not be expected that the international shift in intensive care physiotherapy paradigm 
would have compromised the findings of this study. Furthermore, as described in Study 3, 
early progressive mobilisation and rehabilitation does not safeguard against respiratory 
muscle impairment and dyspnoea as a consequence of prolonged mechanical ventilation. 
This information is valuable to clinicians who are focusing on early rehabilitation as 
dyspnoea may limit exercise tolerance in these patients. Thus the findings of this project 
are highly relevant to the contemporary intensive care unit which focuses on early 
proactive rehabilitation.     
 
Despite the recent evidence in favour of inspiratory muscle training in intensive care 
patients, it is not yet standard practice in most intensive care units around the world. A 
recent study of French physiotherapists revealed that although many claim to provide 
inspiratory muscle training to facilitate weaning, only 16% of those surveyed used an 
evidence-based approach, and only 2% titrated a suitable training intensity from maximal 
inspiratory pressure (Bonnevie et al., 2015). This study revealed that most 
physiotherapists considered diaphragmatic breathing control a form of inspiratory muscle 
training. Based on evidence from many populations (including athletes and those with 
chronic disease, as outlined in Chapter 1), accurately titrated high resistance is key to 
obtaining benefits from inspiratory muscle training, whereas there is no evidence to date 
that deep breathing exercises (without resistance) improve outcomes for ventilator-
dependent patients. Thus clinicians should be deterred from confusing deep breathing 
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exercises with inspiratory muscle training which requires carefully titrated resistance 
training at precise pressures.  
 
STRENGTHS AND LIMITATIONS OF THE STUDIES 
The strengths of the studies contained in this project include the fact that they were 
performed in a modern tertiary intensive care unit with the usual resources and staffing 
levels available in Australia. Thus the assessments and treatments studied have occurred 
in a realistic clinical setting. Furthermore, the robustness of design in Study 4 has 
minimised bias through randomisation with concealed allocation, blinded outcome 
assessors for the primary outcomes, dyspnoea and quality of life scores, and intention-to-
treat analysis. As with most studies of physiotherapy interventions, it was not possible to 
blind physiotherapists delivering the interventions in this project. Furthermore, Acute Care 
Index of Function assessments in these studies were performed by the treating 
physiotherapist who was not blinded to the intervention. This pragmatic approach may 
have introduced some bias regarding functional outcomes. Nonetheless, it is a strength of 
these studies that patient-centred outcome measures were included, as few studies of 
inspiratory muscle training in intensive care patients have considered the importance of 
physical function and quality of life. 
 
A limitation of the studies in this project is lack of longer term follow-up beyond hospital 
discharge. Given the benefits of inspiratory muscle training observed in Study 4 within 2 
weeks of training, it would be valuable to know whether these benefits were preserved in 
the subsequent weeks and months. It would also be worthwhile exploring whether there 
was any ongoing association between inspiratory muscle strength and quality of life for 
these patients. Furthermore, it would be informative to examine mortality in the longer term 
for the participants in Study 4, specifically to ascertain whether the trend in favour of the 
control group persisted beyond hospital discharge.  
 
The fact that these studies were conducted in a single unit may limit the extrapolation of 
the findings to intensive care units with very different practices. All patients that 
participated in Studies 1, 3 and 4 were alert, able to provide consent and participate 
actively. In intensive care units where patients are mostly sedated, patients will be unable 
to participate in the inspiratory muscle training described in the protocols for Studies 1, 4 
and 5. Even following successful weaning, patients who have experienced prolonged 
sedation may suffer the residual effects of long-term sedation on cognitive function (i.e. 
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delirium), and may not be able to participate adequately in inspiratory muscle training. 
Thus sedation practices must be considered when determining whether the findings of this 
project could be applied to intensive care units around the world. 
 
Similarly, in units where early mobilisation is not standard practice, it is unknown whether 
the impact of inspiratory muscle training would be different. Given the wide variety in 
practices of early mobilisation around Australia (Berney et al., 2013) and the world 
(Chawla et al., 2014, Malone et al., 2015, Nydahl et al., 2014), it is probably prudent to 
limit extrapolations of these findings to units with similar practices regarding mobilisation 
and rehabilitation.  
 
In light of these concerns regarding external validity, these studies should be replicated in 
other intensive care units around the world to ensure the robustness and generalisability of 
the findings. Ideally these studies should be powered to detect changes in both quality of 
life and in-hospital mortality. 
  
CLINICAL IMPLICATIONS 
The findings of this project have several implications for clinicians working in intensive 
care. The results from Study 3 suggest that clinicians can anticipate considerable 
inspiratory muscle weakness, manifesting as elevated dyspnoea both at rest and during 
exercise, in patients recently weaned from mechanical ventilation of at least 7 days’ 
duration. This knowledge can be used by medical, nursing and allied health clinicians to 
reassure patients that their symptoms are normal and, based on Study 4, are likely to 
improve within 2 weeks. Furthermore, if physiotherapists wish to enhance inspiratory 
muscle strength and quality of life in these patients, they may use high-intensity inspiratory 
muscle training and anticipate positive results within 2 weeks in the majority of patients.   
 
This project also provides clinicians with confidence that inspiratory muscle training can be 
performed safely in selected ventilator-dependent patients. If physiotherapists use the high 
intensity interval-approach described in Study 1, the patient is likely to maintain adequate 
oxygenation without supplemental oxygen, and they are likely to remain cardiovascularly 
stable. However the efficacy of this training approach for ventilator-dependent patients is 
yet to be demonstrated, and the results of Study 5 will be highly relevant to clinicians with 
regards to prioritising this intervention.  
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Based on the findings of Study 2, intensive care physiotherapists may confidently utilise 
the Acute Care Index of Function to quantify the functional trajectory of intensive care 
patients. Most importantly, clinicians can identify patients with a score of less than 0.40 at 
intensive care discharge, and proactively direct rehabilitation resources towards these 
patients, or use this information to guide discharge planning. This information will be of 
great clinical relevance not just to physiotherapists, but also the whole multidisciplinary 
team who continue to care for the patient following discharge from intensive care.  
 
FURTHER RESEARCH  
While this project has demonstrated the value of inspiratory muscle training in the post-
weaning period, it would be worthwhile determining whether such benefits also occur when 
inspiratory muscle training is commenced while patients are mechanically-ventilated. While 
Study 1 established the safety of high-intensity interval training for selected ventilator-
dependent patients, the protocol outlined in Chapter 6 (Study 5) is a robust exploration of 
the efficacy of inspiratory muscle training in this group, including important patient-centred 
outcomes like physical function, dyspnoea and quality of life. The consistency of measures 
between Studies 4 and 5 will also allow valuable comparisons to be made in future. 
 
This project has highlighted numerous challenges with studying long-term intensive care 
patients, including the intermittent delirium and impaired cognition which can make 
completion of lengthy outcome measures problematic in this patient group. Future studies 
may benefit from selecting outcome measures which do not require sustained attention 
spans (i.e. selecting EQ5D in preference to SF36). Furthermore, these studies have 
highlighted the limitations of simple spring-loaded inspiratory muscle trainers, which can 
thwart training efforts through a ceiling effect at an intensity of 41 cm H2O. Since this study 
was designed, there has been much progress in the development of electronic inspiratory 
muscle training devices (Langer et al., 2015) which have a much wider training bandwidth 
and may therefore be better suited to training intensive care patients. The feasibility and 
utility of these devices deserves exploration in both ventilator-dependent and 
spontaneously breathing intensive care patients. 
 
As one of the findings of Study 4 was that quality of life appears to improve with just 2 
weeks of inspiratory muscle training, this is worth exploring in a larger multi-centre study 
which is powered to detect improvements in quality of life. Such a study should ideally 
evaluate the effects of inspiratory muscle training beyond the initial 2 week training period. 
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Given that many of the patients in Study 4 had not yet returned to 100% of their predicted 
values of maximum inspiratory pressure by 2 weeks, there is potential benefit from 
continuing training for several more weeks and evaluating the impact on quality of life and 
dyspnoea symptoms over several months.  
 
Finally, the trend towards higher mortality in the treatment group in Study 4 should be 
further investigated with a longer term follow-up of this patient cohort to determine whether 
mortality remains elevated between the groups in the longer term. It will be valuable to 
collect follow-up data from this cohort specifically comparing morbidity and mortality 
between 1 and 5 years of intensive care survival.  
 
CLOSURE 
The findings of this project have been disseminated widely, including presentation at the 
European Society of Intensive Care Medicine (2011), the Australian Physiotherapy 
Association Conference (2011), International Physical Medicine and Rehabilitation 
Conference (2013), Australia New Zealand Intensive Care Society Scientific Meeting 
(2013, 2015) and the Canberra Health Annual Research Meeting (2011, 2014, 2015). An 
abstract for Study 4 has also been submitted to the American Thoracic Society conference 
for 2016.  
 
As reproduced with permission in Appendices B to F, the literature review and studies 
have been published in both Australian and international peer-reviewed journals. Copies of 
these articles have been provided to funding bodies and ethics review committees for their 
records. Furthermore, the results have been presented to stakeholders including staff in 
the intensive care unit and physiotherapy department at Canberra Hospital, as well as the 
University of Queensland.  
  
All data has been de-identified and stored electronically in the Canberra Hospital Intensive 
Care Research office in accordance with ethical requirements. The ACT Health Human 
Ethics Review Committee has been advised of the in-hospital mortality results described in 
Study 4.  
 
Recruitment for Study 5 has commenced and at time of thesis submission, is at 48 of 70 
patients (since February 2011). This study has extension of ethics approval to continue 
until recruitment has been finalised (anticipated 2017).  
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SUMMARY 
The combined findings of this project have implications for the current practice of 
physiotherapy and intensive care medicine. First, clinicians can recognise inspiratory 
muscle weakness and fatigability as a likely consequence of prolonged mechanical 
ventilation. These residual impairments are likely to manifest as dyspnoea both at rest and 
during exercise for many patients in the post-weaning period. Second, inspiratory muscle 
weakness can be at least partly reversed with high-intensity inspiratory muscle training in 
the post-weaning period, with just two weeks of daily training resulting in improvements in 
both inspiratory muscle strength and quality of life. Third, inspiratory muscle training is safe 
in selected ventilator-dependent patients and supplemental oxygen is not required to 
maintain respiratory and cardiovascular stability during and after training. Fourth, the Acute 
Care Index of Function is reliable and valid in intensive care patients, and can be used to 
predict hospital discharge destination. This new information provides the ability to target 
rehabilitation and direct resources to patients who require it most. These combined 
findings are a patient-centred and clinically-meaningful contribution to the existing body of 
knowledge regarding rehabilitation of intensive care patients.  
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APPENDIX A:  
The effects of inspiratory muscle training in other populations 
 
Given the efficacy of inspiratory muscle training in both athletes and patients with chronic 
obstructive pulmonary disease, is it not surprising that inspiratory muscle training has 
increasingly been explored in other patient populations. Although neither the quality nor 
quantity of the evidence in other groups is comparable to that previously described, it is 
worth comparing the application of inspiratory muscle training in different states of 
pathology as this give further insight into possible causative mechanisms and ideal training 
parameters. Furthermore, patients admitted to intensive care often have several 
comorbidities (e.g. chronic heart failure or kidney failure), which makes discussion of 
inspiratory muscle training in these groups all the more pertinent. 
 
Chronic heart failure 
Early published case studies of inspiratory muscle training in chronic heart failure (Mancini 
et al., 1995, Cahalin et al., 1997) were compromised by low adherence to training 
protocols (e.g. 63%), low training intensity (e.g. 20% MIP) and lack of a control group. An 
early randomised trial of inspiratory muscle training in chronic heart failure was also 
confounded by a potentially ineffective sham comparison, where 15% of MIP may have 
provided a training effect in the control group (Johnson et al., 1998), while another early 
randomised trial was also limited by high drop-out rates and ineffective blinding (Weiner et 
al., 1999). In the context of these shortcomings, improvements in MIP of up to 32% were 
reported (Cahalin et al., 1997) with most of this change detectable in the first 2 weeks of 
training, which is similar to findings in healthy people described previously. 
 
Two subsequent randomised trials (Dall'Ago et al., 2006, Padula et al., 2009) both 
employed a relatively low training intensity (30% MIP) for 12 weeks training 20 - 30 
minutes per day. While both studies found significant improvements for chronic heart 
failure patients in terms of MIP (e.g. 115%)(Dall'Ago et al., 2006) and dyspnoea, the study 
of the home-based nurse-supervised program (Padula et al., 2009) failed to detect 
significant changes in quality of life as measured by the SF-36 tool. In contrast, the 
inspiratory muscle training program supervised once-weekly by a physiotherapist (Dall'Ago 
et al., 2006) demonstrated not just improvements in exercise performance and quality of 
life (as measured by the Minnesota Living with Heart Failure Questionnaire), but also 
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improved circulatory power and oxygen uptake kinetics. Importantly, this study also 
showed that the improvements in MIP and quality of life were sustained up to 12 months 
following cessation of training. A contemporaneous study (Laoutaris et al., 2007) further 
showed that high intensity training (60% MIP) resulted in superior benefits compared to 
low intensity training (15% MIP) in terms of exercise tolerance and dyspnoea measures. 
Moreover, this latter study also showed that inspiratory muscle training was not associated 
with significant anti-inflammatory effects in patients with chronic heart failure. 
 
Studies which selectively studied chronic heart failure patients with inspiratory muscle 
weakness found significant effects for inspiratory muscle training in terms of oxygen 
uptake or adaptions of blood flow distribution. Using a relatively low training stimulus (30% 
MIP) and an endurance-type protocol (30 minutes per day for 12 weeks), Winkelmann and 
colleagues (2009) failed to show significant results for exercise tolerance and quality of life 
in patients with chronic heart failure, but did detect significant improvements in VO2max and 
MIP in the training group. For patients with known inspiratory muscle weakness, 
inspiratory muscle training has also been shown to increase blood flow to limbs during 
exercise (Chiappa et al., 2008) as well as improve oxygen uptake efficiency (Stein et al., 
2009) when patients trained at 30% of maximal intensity for 30 minutes daily for 12 weeks. 
These results provide some clues as to how inspiratory muscle training may enhance 
exercise capacity in chronic heart failure and are not dissimilar to findings in athletic 
populations. These findings also reinforce the importance of identifying patients with 
inspiratory muscle weakness and targeting them selectively with inspiratory muscle 
training.  
 
Chronic kidney disease  
The benefits of inspiratory muscle training have been explored to a limited extent in 
patients with chronic kidney disease. In a randomised trial of patients undergoing 
haemodialysis (Pellizzaro et al., 2013), patients who underwent inspiratory muscle training 
3 times per week for 10 weeks at an intensity of 50% of maximum inspiratory pressures 
demonstrated greater gains in inspiratory muscle strength than those who completed only 
peripheral exercise or no exercise while on dialysis. Greater gains were also seen with the 
inspiratory muscle training group compared with the control group in distance walked 
during the 6 minute walk test (65 m versus -0.5 m respectively). This study also 
demonstrated benefits of inspiratory muscle training with regards to sleep, which was 
significantly greater in the inspiratory muscle training group than both the peripheral 
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training and control groups. While no other studies of inspiratory muscle training have 
explored sleep benefits specifically, these findings deserve further exploration in other 
populations where poor sleep impacts on quality of life.  
 
It is not yet known whether inspiratory muscle training may benefit patients with chronic 
kidney failure in the pre-dialytic phase of the disease. However given the known 
detrimental impact of chronic kidney disease on health-related quality of life (Unruh and 
Hess, 2007), it would be worth exploring whether the benefits seen in the dialytic 
population also extend to those managing the disease in the earlier phases.  
 
Cystic Fibrosis 
There are only a few articles published which investigate the effects of inspiratory muscle 
training in cystic fibrosis. One study of inspiratory muscle training in children with cystic 
fibrosis (Sawyer and Clanton, 1993) found that 10 weeks of daily training at 60% of MIP for 
30 minutes resulted in increased inspiratory muscle strength (13%), increased exercise 
capacity (10%) and subjectively enhanced sputum clearance. This is one of very few 
studies in the inspiratory muscle training literature to describe an increase in lung volumes 
(i.e. vital capacity 14%, total lung capacity 11.6%) as a result of inspiratory muscle training. 
The authors speculated that this change in lung volume may be in part due to the young 
age of the participants involved, who may still be benefiting from alveolar multiplication.  
 
A more recent randomised study of inspiratory muscle training in adults with cystic fibrosis 
(Enright et al., 2004) found further evidence that inspiratory muscle training increases both 
lung volumes and diaphragm thickness, but also improves psychosocial status and 
exercise capacity. However these benefits were found at a training intensity of 80% of 
MIP, and not at 20% of MIP. This also compares with a previous non-randomised trial of 
16 patients with cystic fibrosis (de Jong et al., 2001) which found that 6 weeks of training 
at an intensity of 40% of MIP resulted in increased inspiratory muscle strength, but not 
measures of exercise capacity, lung volumes, dyspnoea or fatigue. Overall, these results 
echo the findings in the wider literature that intensity of inspiratory muscle training is 
critical. 
 
In 2008 a Cochrane systematic review (Houston et al., 2008) of inspiratory muscle training 
in cystic fibrosis found the overall quantity and quality of research in this field so limited 
that meta-analysis was not possible, and suggested that clinicians consider using 
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inspiratory muscle training on a case by case basis. Given the slow emergence of 
convincing evidence for the efficacy of inspiratory muscle training in patients with chronic 
lung disease over the past few decades, where early studies were similarly confounded by 
variable training equipment and low intensities, it is arguably premature to dismiss the 
potential of inspiratory muscle training to improve quality of life, lung function and exercise 
tolerance in both children and adults with cystic fibrosis. Specific quantitative analysis of 
the impact of inspiratory muscle training on sputum clearance would be useful in this 
particular patient group. 
 
Asthma in children 
Whilst most trials of inspiratory muscle training have used training frequencies of between 
3 and 7 days per week, one study of inspiratory muscle training in asthmatic children aged 
between 8 and 12 (Lima et al., 2008) was unusual in that training was performed just twice 
a week for 7 weeks. Particularly in paediatric patients, minimising treatment sessions may 
enhance training compliance. Although this study showed improvements in MIP, maximum 
expiratory pressure and peak expiratory flow (a key indicator of disease severity in 
asthma), the interpretation of the results are limited by the fact that inspiratory muscle 
training was delivered in combination with deep breathing exercises, purse-lipped 
breathing and fractionated breathing, while control participants experienced education 
only; thus it is impossible to isolate the true effect of inspiratory muscle training alone in 
this study. Nonetheless, given the positive results reported, the question of optimal training 
frequency with inspiratory muscle training remains unanswered in this patient group.  
 
Pre-operative surgical patients 
As patients undergoing thoracic or abdominal surgery are at risk of postoperative 
pulmonary complications (Haines et al., 2013, Scholes et al., 2009, Reeve et al., 2010, 
Wynne and Botti, 2004), the idea that inspiratory muscle training may provide a degree of 
prophylaxis against postoperative pulmonary complications is attractive. For patients 
undergoing cardiac surgery, 2 weeks of daily pre-operative inspiratory muscle training 
reduced post-operative decline in lung function and gas exchange compared to a control 
group (Weiner et al., 1998). In this study significantly more patients in the control group 
required longer than 24 hours of mechanical ventilation, and whether this is attributable to 
the effects of inspiratory muscle training, or is rather a confounding variable, remains to be 
determined.  
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A more recent investigation of patients undergoing cardiac surgery(Hulzebos et al., 2006), 
which selectively included those at high risk of post-operative pulmonary complications, 
found that 2 to 4 weeks of preoperative inspiratory muscle training resulted in significantly 
lower post-operative pulmonary complications in the inspiratory muscle training group 
(18%) compared to the control group (35%). These authors also reported a trend towards 
shorter length of stay but this failed to reach statistical significance despite the large 
sample size (n = 279). 
 
There is limited evidence to support the use of pre-operative inspiratory muscle training to 
prevent postoperative pulmonary complications in abdominal surgery, with a one pilot 
study (Dronkers et al., 2008) showing trends towards increased inspiratory muscle 
strength and less atelectasis in the inspiratory muscle training group. However the small 
sample size (n = 20) and lack of statistical significance (p = 0.07) means these results 
must be interpreted with caution. A second pilot study (Kulkarni et al., 2010) compared 2 
weeks of pre-operative inspiratory muscle training, deep breathing exercises, incentive 
spirometry and no therapy. Whilst this study observed a significant post-operative 
preservation of MIP in the inspiratory muscle training group only, it was also confounded 
by a small sample size (20 per group) and a high drop-out rate (> 25%) with a lack of 
intention-to-treat analysis. This study also reported surprisingly low levels of postoperative 
pulmonary complications, perhaps because it deliberately excluded those with known or 
suspected respiratory infections. As acknowledged by the authors, it may be useful to 
selectively study those at high risk of developing postoperative pulmonary complications in 
determining the true clinical usefulness of preoperative inspiratory muscle training in 
abdominal surgery patients. 
 
While research into the effects of inspiratory muscle training as a pre-operative 
intervention is in its infancy, it would not be surprising if surgeons welcome the potential of 
pre-operative inspiratory muscle training as a standard measure in the near future, 
considering the low financial burden and potential benefit in terms of post-operative 
outcomes. 
 
Spinal cord injury 
Since the mid-1990s several studies have specifically describe the effects of inspiratory 
muscle training in patients with spinal cord injury. The first (Rutchik et al., 1998), a case 
series of 10 patients with chronic spinal cord injury (level C4 – C7 for longer than 1 year), 
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observed that inspiratory muscle training for 15 minutes twice daily for 8 weeks resulted in 
improvements in lung volumes (i.e. forced vital capacity, vital capacity, total lung capacity 
and functional residual capacity). However a reduction in dyspnoea in the experimental 
group did not reach statistical significance, possibly due to the small sample size. 
Furthermore, changes in lung volumes and dyspnoea were not maintained 6 months 
following cessation of inspiratory muscle training.  
 
The second observational study (Wang et al., 2002) focused on sleep-disordered 
breathing in 14 patients with traumatic spinal cord injury. While these researchers detected 
a small increase in MIP and a small reduction in carbon dioxide levels during sleep 
following 6 weeks of inspiratory muscle training, this study was confounded by limited 
monitoring of the treatment intervention, where patients saw the therapist only every 
second week, and furthermore no attempt was made to increase the training intensity over 
time. Thus the adherence to the training protocol and the training stimulus itself may be 
questioned. Furthermore, the conclusions that can be drawn from this and the previous 
observational study are limited due to the absence of a control group. 
 
A third study (Liaw et al., 2000) randomly allocated 20 patients with acute spinal cord 
injury (level C4 -C7 for less than 6 months) to either inspiratory muscle training or control 
groups, where inspiratory muscle training was performed for 15 minutes twice daily for 6 
weeks. These authors found greater improvements in lung volumes in the inspiratory 
muscle training group (i.e. total lung capacity, vital capacity, forced expiratory volume in 1 
second) but also found significant improvements in dyspnoea in the inspiratory muscle 
training group compared to control. However, the absence of an intention-to-treat analysis, 
in the context of several drop-outs, may be of concern in interpreting these results. 
 
Whilst promising, these initial results must be interpreted with caution as all studies 
employed a resistance device where intensity was flow-dependent and adequate training 
stimulus cannot be guaranteed. More recently an observational study of 8 patients with 
spinal cord injury at levels C4-C7 (Silveira et al., 2010) used a threshold device to provide 
inspiratory muscle training at 30% of MIP for 30 minutes on weekdays for 8 weeks. While 
improvements in MIP and forced vital capacity were observed at the end of the program, 
the lack of a control group was a major limitation. Further randomised studies of inspiratory 
muscle training in spinal cord injury using threshold-based devices would be useful in 
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determining whether high intensity inspiratory muscle training produces similar, or 
potentially greater, benefits in this population. 
 
Amyotrophic Lateral Sclerosis 
A randomised trial of inspiratory muscle training in 19 patients with amyotrophic lateral 
sclerosis (Cheah et al., 2009) failed to find significant results in terms of changes in lung 
volumes or inspiratory muscle strength. It is possible that the early training parameters 
used (weeks 1 to 4) were of inadequate intensity (15 – 60% of sniff nasal inspiratory 
pressure) to induce change, particularly in the context of the wider literature where high 
intensity training has been vital. It is also possible that the lack of significant results was 
due to the small sample size.  
 
Moreover there were significant issues with the sham training used: by removing the 
spring-loaded valves from the inspiratory muscle training devices to produce sham devices 
for the control group, there was an audible difference in the training between those with 
intact devices and those using a sham. This lack of audible noise invalidated the blinding 
of the assessors and possibly of the patients as well. Furthermore, the fact that the control 
group also increased their lung volumes significantly suggests that in this patient group, 
the sham device provided some degree of training effect, masking the overall effect of 
inspiratory muscle training. When studying patients with low baseline level of inspiratory 
muscle strength, such as those with amyotrophic lateral sclerosis, motor neurone disease 
or long term ventilator-dependent patients, the potential training effects of the sham device 
must be carefully considered. 
 
Parkinson’s disease 
One study has investigated the effect of inspiratory muscle training in patients with 
Parkinson’s Disease (Inzelberg et al., 2005). Despite a small sample size (n = 20), this 
randomised trial found that 30 minutes of inspiratory muscle training performed 6 days per 
week for 12 weeks resulted in significant improvements in inspiratory muscle strength and 
perception of dyspnoea in the inspiratory muscle training group. Of interest, the training 
parameters were very similar to those described above in the study of patients with 
amyotrophic lateral sclerosis and similarly found no significant change in lung volumes 
following inspiratory muscle training. The failure of to detect changes in health-related 
quality of life in this study raises interesting questions regarding the importance of 
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dyspnoea for functional performance in this patient group and these deserve further 
exploration.  
 
Myaesthenia Gravis 
The benefits of inspiratory muscle training have also been studied in patients with 
myasthenia gravis, with one randomised trial (Fregonezi et al., 2005) demonstrating that a 
combined program of inspiratory muscle training and purse-lipped breathing resulted in 
significant improvements in inspiratory muscle strength, endurance and chest wall mobility. 
While this study failed to detect changes in lung function (as measured by spirometry), it 
unusually detected an improvement in maximum expiratory pressures as a result of 
inspiratory muscle training. Given the well-accepted specificity of inspiratory muscle 
training, the authors speculated that this surprising result may be due to enhanced chest 
wall mobility in this particular patient group. These results must be interpreted with caution, 
due to the combination of therapies applied. 
 
Muscular Dystrophy 
There is limited evidence regarding the effect of inspiratory muscle training in patients with 
Muscular Dystrophy. One randomised trial (Wanke et al., 1994) used specially-designed 
equipment to provide inspiratory muscle training through a resistive circuit whilst still 
ensuring adequate flow. This small study showed improvements in MIP only in those 
patients whose baseline vital capacity exceeded 25% of predicted values. Interestingly, 
when improvements did occur, these were still detectable up to 6 months following 
completion of the inspiratory muscle training program. These authors concluded that 
inspiratory muscle training may be beneficial in the early stages of muscular dystrophy. A 
subsequent long-term observational study of patients with either muscular dystrophy or 
spinal muscular atrophy (Koessler et al., 2001) found that patients could train up to 2 years 
with daily inspiratory muscle training, resulting in increased MIP, however the 
improvements appeared to plateau at 10 months. Nonetheless, a plateau may be 
preferable to respiratory deterioration in this particular patient group.  
 
Poliomyelitis 
A non-randomised study of 10 patients with prior poliomyelitis and part-time ventilator-
dependence (Klefbeck et al., 2000) observed increased endurance capacity from 10.7 to 
16.7 cm H2O following 10 weeks of daily inspiratory muscle training. However the clinical 
significance of this change could be questioned and furthermore only 7 of 10 patients 
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completed the training, thus further research would be required to describe the effect of 
inspiratory muscle training on this patient group. 
 
Multiple Sclerosis 
There is some evidence that a 10 week regime of daily inspiratory muscle training 
improves inspiratory muscle weakness (MIP) as well as lung function (FEV1, FVC) in 
patients with multiple sclerosis (MS)(Fry et al., 2007). However this trial only included 
patients with mild to moderate physical disability. Another randomised trial of inspiratory 
muscle training in patients with severe MS (Klefbeck and Hamrah Nedjad, 2003) (i.e. 70% 
wheelchair bound and 30% bedridden) also demonstrated increased MIP following a 10 
week inspiratory muscle training program, but failed to demonstrate any spirometric 
changes. This may be due to the reduced training frequency (every other day) or rather a 
reflection of the severity of the underlying pathology. Future studies of inspiratory muscle 
training in patients with MS should consider patient-centred variables such as quality of life 
to determine the clinical usefulness of inspiratory muscle training in this population. 
 
Healthy elderly 
One small pilot double-blind randomised trial of inspiratory muscle training in healthy 
elderly patients (Aznar-Lain et al., 2007) found that 8 weeks of inspiratory muscle training 
5 times per week, with 8 – 10 sets of 5 breaths at 50 – 80% of MIP, resulted in increased 
MIP, enhanced exercise tolerance and increased physical activity in the inspiratory muscle 
training group. This study also demonstrated increased VO2max in the experimental group, 
a finding less commonly reported in studies of younger healthy or athletic patients. 
However, interpretation of this study’s findings is compromised by its small sample size, as 
well as the fact that the control group had a significantly higher body mass index and were 
less physically active at baseline than the treatment group.  
 
Other conditions 
Inspiratory muscle training has also been reportedly used to treat inspiratory muscle 
weakness in a wide variety of pathological conditions including laryngeal papilloma 
(Sapienza et al., 1999), idiopathic diaphragm paralysis (Chatham et al., 2009, Petrovic et 
al., 2009), bilateral abductor vocal fold paralysis (Baker et al., 2003), and exercise-induced 
inspiratory stridor (Dickinson et al., 2007). Most authors describe a high-intensity regime 
resulting in increases in inspiratory muscle strength, reductions in dyspnoea and one 
group of researcher described successful weaning from nocturnal non-invasive ventilation 
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(Petrovic et al., 2009). While this latter result was described in the context of an absence 
of change in phrenic nerve latency, suggesting that spontaneous recovery was not a 
factor, all these results must be interpreted with caution as they are case reports only and 
further clinical trials are required to ascertain the true efficacy of inspiratory muscle training 
in the presence of these conditions. 
 
Summary of inspiratory muscle training in other populations 
There is very strong evidence that inspiratory muscle training improves inspiratory muscle 
strength in athletes and patients with chronic obstructive pulmonary disease, and some 
evidence that similar results can also be obtained in patients with chronic heart failure, 
cystic fibrosis, degenerative neurological conditions and spinal cord injury. Whilst there is 
strong evidence that inspiratory muscle training also improves exercise performance in 
athletes and patients with chronic obstructive pulmonary disease, this is yet to be clearly 
demonstrated in other patient groups. Regardless of patient presentation or sporting 
arena, it would appear that intensity and modality of training are critical to the success of 
any inspiratory muscle training regime. Also, the perception of dyspnoea may be affected 
by inspiratory muscle training and the link between inspiratory muscle weakness, 
dyspnoea and functional performance deserves further consideration. There is much 
potential to further investigate the potential benefits of inspiratory muscle training across a 
wide spectra of pathological conditions, with particular focus on patient-centred outcomes 
including exercise tolerance and quality of life. 
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APPENDIX C: Licences and Permissions:  
 
 Permission / Entitlements to include published articles in thesis: 
a) Anaesthesia and Intensive Care 
b) Intensive and Critical Care Nursing (Elsevier) 
c) Heart and Lung 
d) BMJ Open 
e) Patient consent form (BMJ) relating to Figure 15 
 Licences: 
a) SF36 Quality of Life Survey Instrument 
b) EQ5D Quality of Life Survey Instrument 
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ANAESTHESIA AND INTENSIVE CARE: 
 
INTENSIVE & CRITICAL CARE NURSING: 
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HEART AND LUNG:  
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BMJ OPEN: 
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PATIENT CONSENT FORM (Figure 15): 
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SF36 LICENCE AGREEMENT (and extension) 
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EQ5D LICENCE & REGISTRATION: 
 
 
